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OVER-EXPRESSION, PURIFICATION AND CRYSTALLISATION OF THE
ALTERNATIVE   OXIDASE  
SUMMARY
The alternative oxidase (AOX) is an integral monotopic membrane protein which
branches from respiratory chain at the point of the Q-pool in the mitochondria of all
flowers, some fungi, and some protists such as the human parasite Trypanosoma brucei.
The aim of this project is threefold: to establish an over-expression and purification
protocol for recombinant Sauromatum guttatum alternative oxidase (SgrAOX); to use
expressed SgrAOX for structural analysis such as crystallography; and finally to use in
silico methods to model the alternative oxidase protein. Of these three, only the first and
last  have  been  attempted  previously, with  varying  success.  The  second,  namely
structural analysis, has never been attempted with SgrAOX.
In  order  to  achieve  the  aims  of  this  project,  primarily  laboratory-based protein
production were used, in conjunction with downstream analysis using structural biology
techniques. The in silico modelling was carried out using a wide range of algorithms
freely available on the World Wide Web.
Results  of  this  project  are:  the  determination  of  an  over-expression  system and
purification protocols in two E.coli  strains,  producing enough protein to  use for the
second  objective  detailed above.  While  no  crystal  structure  has  been  obtained,
significant steps toward identifying a protocol for rAOX crystallisation have been made.
Results from structural analysis support modelling predictions and give novel insights
into the thermostability of the protein. New and detailed homology models have been
created  and  critically  evaluated,  with  a  very recent  crystal  structure  from  our
collaborators providing a unique set of data for model evaluation.
The outcome of this project has contributed towards the determination of conditions
under which SgrAOX protein may form crystals, and therefore bringing the acquisition
of a SgrAOX protein structure closer.
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1Chapter 1
General Background
1.1 Respiration and the alternative oxidase
1.1.1 Cellular energy and the respiratory chain
Fundamental to the functioning of every cell is the provision of energy in a readily 
utilisable form. This is provided by the universal energy currency, adenosine triphosphate 
(ATP),  the  hydrolysis  of  which  releases  30.5kJmol-1 of  energy  under  physiological 
conditions (Gajewski  et al., 1986). In eukaryotes, the majority of ATP is supplied during 
the process of respiration,  taking place in the mitochondria and surrounding cytoplasm. 
During aerobic respiration, the energy harvested from consumed glucose is used to catalyse 
the phosphorylation of adenosine diphosphate (ADP) by inorganic phosphate (Pi), to make 
ATP. This catalysis is endergonic, and is the final step in a series of complex and intricate 
enzymatic interactions. 
Ultimately,  the process of ATP production begins in the cell cytoplasm with the 
sequential  hydrolysis  and  decarboxylation  of  glucose,  resulting  in:  the  conversion  of 
glucose  to  pyruvate;  the  substrate-level  phosphorylation  of  ADP;  and  the  reduction  of 
nicotinamide adenine dinucleotide (NADH). The pyruvate produced during glycolysis is 
then decarboxylated and transported into the mitochondria as the substrate of Kreb’s cycle, 
the next stage of respiration. Although the Kreb’s cycle is ostensibly a process where the 
two-carbon substrate is converted to a six-carbon compound and then decarboyxlated in a 
step-wise  manner,  important  products  are  released  –  reduced NAD and  reduced  flavin 
adenine dinucleotide (FADH2). It is these products which are necessary for the initiation of 
the  final  stage  of  respiration  –  oxidative  phosphorylation  –  rather  than  the  carbon 
compounds metabolised from the glucose molecule during glycolysis and Kreb’s.
2Oxidative phosphorylation takes place on the inner membrane of the mitochondria, 
and is carried out by a group of enzymes collectively known as the respiratory or electron 
transport  chain  (ETC).  In  animals,  the  ETC is  formed of  a  series  of  membrane-bound 
complexes,  the  roles  of  which  are  as  follows  and  are  illustrated  in  Figure  1.1  below. 
Complex  I  (NADH  dehydrogenase),  and  Complex  II  (succinate  dehydrogenase)  strip 
electrons from NADH and succinate molecules (by way of reduced FADH2) respectively. 
In addition, Complex I translocates protons across the inner mitochondrial membrane to the 
intermembrane space. The electrons from these complexes are then passed into a pool of 
ubiquinone (Q), which is mobile within the inner mitochondrial membrane. The ubiquinone 
becomes reduced to ubiquinol (QH2),  before becoming re-oxidised by Complex III  (bc1 
complex),  and the  electrons  gained  from this  reduction  are  transferred  to  Complex  IV 
(cytochrome c oxidase)  via  the reduction and subsequent  oxidation of  cytochrome c,  a 
small molecule which is able to move laterally along the membrane. It is cytochrome c 
oxidase that facilitates the final step of electron transfer – the four-electron reduction of 
oxygen to water. 
Electron transfer through the ETC is facilitated by reducing iron ions, which are 
subsequently oxidised back to their original state (i.e. Fe3+ + e-→ Fe2+ → Fe3+) to allow 
passage of further electrons in the same manner. The iron ions are not found alone; they 
exist  as  metal-metal  or  metal-nonmetal  clusters  within  domains  of  the  respiratory 
complexes, as shown in the schematic below, Figure 1.2. Each subsequent complex (with 
the exception of Complex II, which feeds into the Q-pool directly rather than forming part 
of the linear chain) has a greater redox potential (i.e. a greater affinity for electrons, E) than 
the previous complex, thus ensuring the unidirectional flow of electrons through the chain. 
This is also true of the associated donors and acceptors, which are not found within the 
enzymes themselves.  Reduced NADH – the initial  electron  donor – has  a lower redox 
potential  than  oxygen  –  the  final  electron  acceptor.  Since  redox  potential  is  inversely 
proportional  to free energy (ΔG;  when the value of ΔE is positive,  the value of ΔG is 
negative),  when electrons  are accepted by a complex with higher electron affinity,  free 
3energy made is available. It is this relationship which accounts for the ability of Complexes 
I,  III  and IV to translocate  protons  across  the inner  membrane from the  matrix  to  the 
intermembrane  space  which  would  otherwise  be  energetically  unfavourable. This 
translocation  of  protons  across  the  membrane  establishes  a  large  enough  protonmotive 
force to enable the assembled protons to move back through the membrane, via the trans-
membranous  enzyme,  ATP  synthase.  It  is  this  movement  of  protons  that  results  in 
rotational catalysis of the ATP synthase, causing the phosphorylation of ADP and release of 
ATP, in an otherwise energetically unfavourable direction (Mitchell, 1961).
1.1.2 The respiratory chain and the alternative oxidase
In addition to the traditional  electron transport  chain,  all  plants,  some fungi and 
some  protists  contain  an  additional  oxidase  known  as  the  alternative  oxidase.  The 
alternative  oxidase  is  a  monotopic  membrane  protein,  found in  the inner-mitochondrial 
membrane and branching from the traditional electron transport chain at the point of the 
ubiquinone  pool  (Storey,  1976;  Rich  and  Moore,  1976;  Rich  1978).  Intriguingly,  the 
alternative oxidase (AOX) is non-protonmotive (Bendall and Bonner, 1971; Moore et al., 
1978), and instead facilitates the four-electron reduction of oxygen to water and oxidation 
of  ubiquinol  to  ubiquinone  (Rich  and  Moore,  1976;  Moore  and  Siedow,  1991).  The 
alternative oxidase is insensitive to a number of respiratory inhibitors which are known to 
affect the other components of the respiratory chain such as cyanide (cytchrome c oxidase 
inhibitor; Keilin and Hartee, 1938; van Buuren et al., 1972) and antimycin A (cytochrome c 
reductase inhibitor; Chance and Williams, 1956; Rieske et al., 1967; for a concise review 
see Ikuma, 1972 and more recently Moore  et al., 2013, in press). Instead, the alternative 
oxidase  is  sensitive  to  inhibition  by  hydroxamic  acids  such  as  salicylhydroxamic  acid 
(Schonbaum et al., 1971), and propyl gallate (Siedow and Bickett, 1981). More recently, it 
has been confirmed that the Trypanosomal alternative oxidase,  TAO, is sensitive to the 
antifungal  agent  ascofuranone  (Yabu  et  al.,  2003;  Minagawa  et  al.,  1996),  which  has 
proven to be a promising chemotherapeautic agent for the treatment of the Human African 
4Figure 1.1 – The basic electron transport chain of mitochondria. The complexes in order from left-to-right 
with PDB accession numbers: Complex I (NADH deyhdrogenase; 3M9S Efremov et al., 2010), Complex II 
(succinate dehydrogenase; 2WDV Ruprecht et al., 2009), Q-pool, Complex III (cytochrome c reductase; 
1BE3 Iwata et al., 1998), cytochrome c, Complex IV (cytochrome c oxidase; 1OCO Yoshikawa et al., 1998) 
and ATP synthase (1C17 and 1E79 – Rastogi and Girvin 1999 and Gibbons et al., 2000). Red arrows denote 
the movement of protons, while black arrows indicate electron flow and reactions occurring in the matrix. The 
alternative oxidase is located on the leaflet of the matrix-facing membrane between Complexes II and III.
5Figure 1.2 – A diagrammatic representation of the reaction centres responsible for electron transfer in 
the inner mitochondrial membrane. Arrows represent oxidation and reduction as electrons pass from 
NADH dehydrogenase to cytochrome oxidase. Dashed arrows show proton translocation across the 
membrane, but do not indicate the exact site of proton shuttling. Succinate dehydrogenase, shown here in 
orange, is membrane-bound in vivo but feeds into the Q-pool independently of NADH deyhdrogenase so is 
placed separately.
Trypanosomaisis (HAT) also known as African sleeping sickness. The current treatments 
for HAT are either ineffective or toxic (cf Fairlamb, 2003).
1.2 Distribution and function of the alternative oxidase
The alternative oxidase is ubiquitous in all plants (McDonald  et al., 2002), and is 
also found in several other species – including several human parasites (summarised below 
in Table 1.1). The function of AOX in each case varies depending on the species.
The role of the alternative oxidase in thermogenic plant tissues is well established – 
the  heat  released  from the  non-protonmotive  reduction  of  oxygen  to  water  is  used  to 
volatilise aromatic compounds found in the spathes, in order to attract insect pollinators 
(Meeuse, 1975; Meeuse and Raskin, 1988). The resulting smell is unsavoury to humans and 
often likened to rotting flesh,  but attracts  flies  and other  carrion insects which become 
6trapped for a short time in the base of the plants before being released, covered in pollen. A 
thermal image demonstrating the heat generated during this phase in a thermogenic lily 
found across the UK is shown below in Figure 1.3.
Kingdom Examples Reference(s)
Fungi Candida albicans
Pichia anomala
Chlamydomonas 
reinhardtii
Veiga et al., 2003
Protista Trypanosoma bruceii
Cryptosporidium parvum
Blastocystis hominis
Chaudhuri et al., 1996
Suzuki et al., 2004
Stechmann et al., 2008
Williams et al., 2010
Archaebacteria Novosphingobium 
aromaticivorans
Finnegan et al., 2003
Animalia Crassostrea gigas
Meloidogyne hapla
Ciona intestinalis
McDonald and Vanlerberghe, 
2004
Table 1.1 – A summary of the presence of AOX in several kingdoms.
The largest thermogenic lily,  Amorphophallus titanum,  is referred to colloquially  as the 
“corpse”  flower;  one  of  its  smaller  relatives  is  known  as  the  “dead  horse”  lily 
(Helicodiceros muscivorus).
However,  the role of the alternative oxidase is less apparent in non-thermogenic 
plants, fungi, and other species, for which there have been several suggested functions of 
the  AOX  protein.  According  to  the  findings  of  several  groups  working  with  non-
thermogenic and fungal models,  the alternative oxidase appears not to be constitutively 
expressed, but rather expressed when the organism experiences stress (such as ageing in 
potato slices; Hiser and McIntosh, 1990), or disruption of the respiratory chain (such as the 
7Figure 1.3 – Thermal imaging of an Arum maculatum lily during thermogenesis. Image A shows an A. 
maculatum lily found in the grounds of the University of Sussex, UK. The brown-coloured spadix in the 
centre of the white and green spathe undergoes thermogenesis to volatilise aromatic compounds which attract 
insect pollinators. The heat generated during this phase is demonstrated in Image B, showing an infrared 
thermal image of the same plant captured by a FLIR E45 camera. The thermogenesis is driven by the non-
protonmotive reduction of oxygen to water by the alternative oxidase enzyme. The images above are taken 
from Wagner et al., (2008) with the author's permission.
effects  of  chloramphenicol  in  Neurospora  crassa;  Lambowitz  et  al.,  1989).  More 
specifically  in  relation  to  non-thermogenic  plants,  it  has  been  suggested  by  Bahr  and 
Bonner  (1972)  and  Lambers  (1982)  that  the  AOX  could  be  an  energy  over-flow 
mechanism, deployed when other respiratory chain components cease to function normally. 
This has been supported by the findings of Moore  et al. (1988), Miller  et al. (1993) and 
Carré et al. (2011), showing that the AOX can be stimulated by both a highly-reduced Q-
pool and the α-keto acid, pyruvate. A build up of pyruvate in the cell may indicate a halting 
8of the Kreb’s cycle,  meaning that  NADH is not being regenerated for use in the ETC. 
Without electron transfer continuing via the alternative oxidase, normal function of both 
glycolysis and the Kreb’s cycle would cease, suggesting that unused pyruvate may act as 
the molecular trigger for a feed-forward mechanism, stimulating alternative oxidase activity 
to ultimately  reduce pyruvate levels  (reviewed in detail  by  Finnegan et  al., 2004).  The 
nature of expression of alternative oxidase in times of stress therefore  is  temporary,  in 
which respiratory efficiency is sacrificed for survival.
Another theory of the role of the alternative oxidase was suggested by Purvis and 
Shewfelt (1993), whereby the AOX acts as a mechanism for the removal of reactive oxygen 
species  (ROS)  generated  within  the  organism,  should  the  other  respiratory  chain 
components be unable to do so (for example, in the presence of inhibitors). This has been 
supported by findings suggesting that the alternative oxidase can reduce observable ROS 
numbers in plants cells  in vivo,  as reported by Maxwell  et al.  (1999) and Zheng  et al. 
(2008).
In recent years, much research has been conducted to establish the function of the 
alternative  oxidase  in  human  parasites  such as  such as  Trypanosoma brucei  (causative 
agent  of  HAT)  and  Cryptosporidium  parvum (causative  agent  of  cryptosporidiosis,  a 
common disease found world-wide, with outbreaks in the UK in recent years). In the case 
of the former,  it  was noted that trypanosomes appeared to express an atypical  array of 
mitochondrial  components  when the  organism was in  the  infectious  bloodstream form. 
Grant  and  Sargent  (1960;  1961)  and  Clarkson et  al. (1989)  noted  that  there  were  no 
cytochromes expressed, and moreover that the sole terminal oxidase was in fact a plant-like 
alternative quinol oxidase, branching at the point of the Q-pool. Subsequent studies have 
shown that inhibiting the function of the AOX in bloodstream form trypanosomes with the 
inhibitor ascofuranone leads to the death of the parasite (Minagawa et al., 1996; Nihei et  
al., 2002). In this case, the ability of the trypanosomal alternative oxidase to reduce oxygen 
through to water is thought to allow respiration to continue despite the lack of cytochromes 
9(Chaudhuri et al., 2006) thus ensuring the survival of the parasite in the hostile environment 
of the host’s bloodstream.
The alternative oxidase is not expressed in humans, or indeed any higher mammals, 
so the TAO makes an ideal drug target. Current treatments for African Sleeping Sickness 
are often ineffective and dangerous to the patient. If effective treatments can be developed 
for AOX inhibition in those infected with Trypanosomes, then these treatments may well be 
suitable for therapeutic use against other parasites which rely on AOX for survival such as 
C. parvum and Blastocystis hominis, both of which cause disease in humans.
1.3 Structural biology of the alternative oxidase from experimental observations
1.3.1 Identification of the alternative oxidase from thermogenic tissues
Although  it  is  now  accepted  that  both  cyanide-resistant  respiration  and  heat 
producing capabilities in thermogenic plants are a result of the alternative oxidase, these 
two  observable  characteristics  were  not  always  thought  to  be  linked.  When  Lamarck 
commented on the ability of certain plants to raise their own temperature above ambient 
(1778, as cited in Vanlerberghe and McIntosh, 1997), he did not propose any mechanism 
by which this heat could be generated. The first mechanism to be proposed was suggested 
some 160 years later by Van Herk, who postulated that the thermogenic capabilities of lilies 
could be explained by the presence of a non-cytochrome flavoprotein (1937, as cited in 
Vanlerberghe and McIntosh, 1997). This remained the best theory of heat generation on a 
molecular level until attempts were made to isolate what is now known to be the alternative 
oxidase, 50 years later.
Prior  to  initial  attempts  to  isolate  the  molecule  responsible  for  both  cyanide-
resistance and heat generation from thermogenic tissues, James and Elliott (1955) localized 
the cyanide-resistant respiration to the mitochondria. Subsequently, attempts to identify the 
cause  of  cyanide-resistance  were  made  by  Huq  and  Palmer  (1978),  who  isolated 
mitochondria from the spadices of the lily Arum maculatum, commonly found in the UK in 
secluded woodland areas.  Huq and Palmer’s  analysis  of  the mitochondria  revealed that 
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once the cyanide-resistant portion of the protein content had been isolated, no cytochrome 
could be detected; similarly, no EPR signal corresponding to iron could be identified. They 
concluded that the activity was likely due to a non-cytochrome flavoprotein, as Van Herk 
had suggested (1937, as cited in Vanlerberghe and McIntosh, 1997), and furthermore that 
no  iron-sulphur  clusters  were  present  in  the  isolated  species.  Almost  ten  years  later, 
mitochondria from A. maculatum were isolated by Bonner et al., (1986) and their analysis 
of the  A. maculatum mitochondria  indicated that  both the heat  generation and cyanide-
resistance was in fact provided by a quinol oxidase iron-containing protein, rather than a 
flavoprotein as previously suggested by Van Herk and Huq and Palmer. At the same time, 
Elthon and McIntosh (1986) were isolating the mitochondria from another thermogenic lily, 
Sauromatum guttatum, and observed that the activity of the quinol oxidase – the alternative 
oxidase – was approximately  ten  times more  active  in  the days  leading up to  anthesis 
(flowering), and that at the end of this period the cytochrome pathway activity decreased by 
92%. They postulated that the alternative oxidase must therefore be a constituent of the 
traditional  electron  transport  chain,  but  that  activity  was  regulated  in  order  to  prevent 
energy wastage through heat production when it was not required. Following on from this 
work,  Rhoads  and  McIntosh  (1991)  presented  the  first  alternative  oxidase  sequence, 
derived from S. guttatum mRNA found in thermogenic tissues, allowing expression of the 
alternative oxidase in recombinant systems.
1.3.2 Recombinant protein expression
Due to the observed instability and short enzyme life of alternative oxidases isolated 
from native tissues (as recorded in Moore and Siedow, 1991 amongst others), a key goal 
has been to express recombinant AOX isozymes with the intention of increasing life-span 
and improving stability. Therefore, in addition to the groups who have attempted to isolate 
AOX  from  thermogenic  plant  tissues,  several  have more  recently  expressed  various 
recombinant  alternative  oxidases  in  yeast  (Schizosaccharomyces  pombe;  Albury  et  al., 
1996) and bacteria (Escherichia coli; Kumar and Söll, 1992 and Fukai et al., 1999). Much 
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of the work conducted using wild-type/mutant recombinant protein (Albury  et al., 2001; 
Nakamura et al., 2005) has vastly increased our understanding of the kinetic and structural 
properties of the alternative oxidase (Moore,  et al., 1995a; Berthold,  et al., 2000). Use of 
the S. pombe system has provided a eukaryotic expression system, where the isozymes can 
be targeted to the mitochondria. However, purification from the yeast system has not been 
particularly successful due to the lower levels of protein expression observed. However, the 
use of various strains of E. coli have proven useful for purification studies, leading to the 
production of purified protein stable enough for use in crystallography (Kido et al., 2010), 
EPR (Berthold et al., 2002; Moore et al., 2008), FTIR (Maréchal et al., 2009), as well as 
circular dichroism (detailed in this thesis). While expression in a prokaryotic system does 
not allow for the interaction of the alternative oxidase with a eukaryotic electron transport 
chain, it does provide a mechanism for the production of larger quantities of more stable 
protein than could be extracted from native samples.
In order to distinguish the activity of the alternative oxidase expressed in bacterial 
membranes  using  spectroscopic  assays,  it  has  been  necessary  to  inhibit  the  activity  of 
Complex III using the antibiotic antimycin A as this shares the quinol substrate with the 
alternative oxidase (cf Hoefnagel et al., 1997). In order to avoid this, several groups have 
used haem-deficient strains of  E. coli, which are unable to synthesise the haem found in 
Complex  III.  While  this  was  initially  used  for  the  expression  of  Arabadopsis  thaliana 
(Berthold, 1998 and Berthold et al., 2002), it was later used by Nihei et al (2003) to express 
TAO. The activity of the alternative oxidase, in all cases, allowed the recombinant cells to 
survive, despite lacking a major respiratory complex.
Combined observations of both native and recombinant protein have confirmed that 
the size of the alternative oxidase protein varies depending on the organism in which it is 
expressed (for example, 38kDa in  S. guttatum versus 36kDa in trypanosomes), and it is 
known to associate  with the matrix-facing leaflet  of the inner mitochondrial  membrane 
(Rich and Moore, 1976; Rasmusson et al., 1990). Both native and recombinant protein can 
be  visualized  with  immunoblotting  after  SDS-PAGE  electrophoresis  using  anti-AOX 
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antibodies (Elthon et al., 1989), confirming molecular mass from predictions made on the 
basis of protein sequence information (cf Berthold and Siedow, 1993).
1.3.3 Catalytic cycle and active site of the alternative oxidase
Catalytically, the alternative oxidase is known to reduce oxygen through to water, 
using  reduced quinol  from the Q-pool  as  the hydrogen donor (Rich and Moore,  1976; 
Moore and Siedow, 1991). Whilst the exact catalytic cycle has not been elucidated, it was 
thought that the pathway of electron transfer within the alternative oxidase is dissimilar to 
the electron transfers observed in other cytochrome and electron transport complexes. In 
the latter, the iron clusters at the core of the proteins are reduced and reoxidised by the 
passage of one electron at a time. However, a recently proposed mechanism suggests that 
the electron transfer during the oxidation of quinol and reduction of oxygen catalysed by 
AOX may occur in several steps (Moore et al., 2013), rather than one step as previously 
thought.  As previously  mentioned,  EPR  signals  of  such  characteristic  reduction  and 
reoxidation are absent in the alternative oxidase; instead,  EPR experiments  indicate  the 
presence of an iron-only centre (Berthold et al., 2002; Moore et al., 2008). Whilst initially 
the AOX was thought to be EPR-silent, EPR analysis of recombinant A. thaliana AOX was 
conducted for the first time in parallel mode (rather than perpendicular) by Berthold et al., 
(2002) which  revealed  the presence of a non-haem, non-sulphur  diiron site  in  a  mixed 
valent FeII/FeIII state.  Experimentation using parallel-mode EPR has been subsequently 
repeated  with  recombinant  TAO,  intact  A.  maculatum mitchondria  and  native  AOX 
extracted from A. maculatum mitochondria. Characteristic signals for diiron centres were 
confirmed in all three samples. (Moore et al., 2008).
The signals observed by both Berthold et al., (2002) and Moore et al., (2008) share 
similarities to signals observed in a family of proteins known as the diiron carboxylates. 
This  family  is  a  functionally  diverse  group  containing  a  non-haem,  diiron  centre,  and 
members include methane monooxygenase, ribonucleotide reductase and bacterioferretin. 
All contain four-helix bundles coordinating the diiron centre within the core of the catalytic 
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units (Berthold and Stenmark, 2003). Most of the members of this family are large, multi-
domain proteins unassociated with membranes,  though some smaller members do exist, 
such as ferritin and rubrerythrin (cf Berthold and Siedow, 1993; Nordlund and Eklund, 
1995).  Additionally,  both  the  diiron  carboxlyates  and  the  alternative  oxidase  lack  a 
spectroscopic absorbance above 340nm (Berthold and Siedow, 1993). These experimental 
observations have lead to the inclusion of the alternative oxidase as a member of the diiron 
carboxylate family (Moore et al., 2008).
In order to identify the potential  diiron binding residues of the active site of the 
alternative oxidase,  sequence alignment and comparison of the AOX and the other diiron 
carboxylates was undertaken. Six key iron-binding residues were identified (Nordlund and 
Eklund, 1995), corresponding to known diiron binding motifs (E...ExxH repeated twice). 
The residues are not sequential,  but are spread across the four-helix bundle in both the 
diiron carboxylates  and the alternative  oxidase.  When the proteins are  fully folded,  the 
residues are brought close enough together to form a binding scaffold to ligate the diiron 
centre. The residues are shown below in Table 1.2, and are placed in a model below in 
Figure 1.4.
By way of confirmation, if any one of the six residues are mutated the activity of the 
plant  alternative  oxidase  is  completely  diminished  (Albury  et  al.,  1998;  Albury  et  al., 
2002). This has been confirmed in other alternative oxidase isoforms, such as TAO (Ajayi 
et al., 2002; Nakamura et al., 2005). Furthermore, it is supported by recent findings from 
studies  highlighting  the  necessity  of  iron  to  the  functionality  of  the  protein  in  plants 
(Affourtit and Moore, 2004) and other key organisms (such as Minagawa et al., 1990, using 
Hansenula  anomala,  now  Pichia  anomala).  When inhibitors  of  ferric  iron  are  present, 
activity of the alternative oxidase is inhibited, but when the inhibitor is removed, activity is 
completely restored.
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Residue and number Helix
Glu178 1
Glu217 2
His220 2
Glu268 3
Glu319 4
His322 4
Table 1.2 – A list of the key residues involved in iron binding. Above are the six residues proposed to 
ligate the diiron centre of the alternative oxidase, based on the iron ligation motifs found in other diiron 
carboxylates. Numbering corresponds to S.guttatum.
Figure 1.4 – Multiple alignments of each of the four helices involved in iron binding. The multiple 
alignments above show areas of sequence similarity and the highly conserved iron-binding ligands in several 
diiron carboxylates and the alternative oxidase. AOX – alternative oxidase; MMO – methane 
monooxygenase; RUB – rubrerythrin; BAC – bacterioferritin Key residues are highlighted in red.
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1.3.4 Regulation of alternative oxidase activity
1.3.4.1 Genetics of the alternative oxidase
Genetically, the alternative oxidase protein in plants is the product of a single family 
of genes, ranging from a single gene to six genes encoded in the nuclear DNA (cf Polidoros 
et al., 2009). Transcription of these genes appears to be determined by the role that the 
alternative oxidase plays in the organism of interest – in thermogenic tissues expression is 
significantly  increased when required for pollination,  whereas in  non-thermogenic plant 
tissues, expression is controlled by various abiotic stressors as demonstrated by Clifton et  
al. (2005) and Clifton  et al. (2006). By comparison, the expression of the trypanosomal 
alternative oxidase is controlled developmentally, as it is only expressed during one stage in 
the organism’s life cycle (Chaudhuri et al., 1995).
In plants and fungi, there are two main families of AOX genes, which are associated 
with  either  inducible  stress  response  (Aox1;  cf Clifton  et  al.,  2006)  or  constitutive 
expression (Aox2; Considine  et al., 2002). Thermogenic plants, therefore, tend to contain 
the  latter,  while  non-thermogenic  plants  usually  contain  the  former,  though  this  is  not 
always the case. A recent finding indicates that the thermogenic lily A. maculatum contains 
mRNA from the Aox1 family (Ito et al., 2011), and moreover that the different mRNAs are 
found during different points during the developmental cycle of thermogenesis. Since the 
different mRNAs isolated from A. maculatum are known to give rise to protein isoforms of 
AOX, this may indicate that the isoforms are performing a variety of roles; though the 
nature of each isoform has not been established to date. In plant alternative oxidases, it is 
thought that the nuclear-encoded gene product is transported into the mitochondria  in a 
mature, truncated form (cf Tanudji et al., 1999) after self-folding (Albury et al., 1996).
1.3.4.2 Regulation by changes to the quaternary structure – homodimerisation
Alternative  oxidase  activity  appears  to  be  regulated  post-translationally  by  two 
different mechanisms which occur simultaneously in some tissues. In plants for example, 
activity is thought to be regulated in part by reduction and oxidation of the protein. When 
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the  unit  is  oxidised  and  less  active,  two  monomers  are  covalently  linked  through  an 
intermolecular  disulphide  bond  occurring  between  the  highly  conserved  cysteine  122 
residues  (S.  guttatum numbering;  Rhoads  et  al.,  1998).  When  this  disulphide  bond  is 
reduced, the two monomers become linked non-covalently instead resulting in increased 
activity  (Umbach  and  Siedow,  1993).  In  mitochondrial  tissue  from  several  plants  (S. 
guttatum, Glycine max and Vigna radiata), Umbach and Siedow (1993) noted the presence 
of both the reduced and oxidised forms, indicating that the enzymes are able to switch 
between states – most likely as a result of oxidation and reduction of the quinone pool in 
the membrane which is  known to have an effect on alternative oxidase activity  in vivo 
(Moore and Siedow, 1991). In subsequent studies, it was observed that the activity of the 
alternative oxidase increases up to five times in the reduced state in mitochondrial tissues 
from soybeans (Umbach et al., 1994). Although the exact mechanism by which activity is 
increased is not known, it is possible that the helices are more stable in the active form. In 
addition, since the substrate (quinol) is hydrophobic, it may also be possible that the active 
form  allows  for  greater  membrane  interaction  and  therefore  increased  access  to  the 
substrate.
However, this mechanism of regulation does not appear to be the case in organisms 
such as trypanosomes and fungi, which do not respond in the same way to the reduction 
and oxidation of the quinone pool. This may be due to the lack of a suitable analogous 
cysteine residue in the N-terminal region (Chaudhuri and Hill, 1996 and Fukai et al., 2002; 
Sakajo et al., 1991 respectively) of their alternative oxidase sequence, though they may be 
able  to  form  dimers  through  non-sulphide  interactions  as  indicated  by  the  recent 
trypanosomal crystal structure which is homodimeric in nature.
1.3.4.3 Regulation by pyruvate and other α-keto acids
As previously discussed in Section 1.2, a build up of pyruvate in the mitochondria 
may indicate that the Kreb’s cycle has ceased to function normally, which would have an 
impact  on  electron  transport.  Therefore,  in  organisms  where  the  alternative  oxidase  is 
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expressed in order to overcome the effects of disruption of the Kreb’s cycle or oxidative 
phosphorylation, it was anticipated that pyruvate could play a part in regulation of the AOX 
protein. In addition to enzyme reduction increasing activity in plant tissues as discussed 
above, the activity can also be increased by the addition of pyruvate to non-thermogenic 
recombinant  alternative  oxidase  (Crichton  et  al.,  2005;  Carré  et  al.,  2011).  Pyruvate 
stimulation is also observed in recombinant alternative oxidases, such as  A. thaliana, and 
also thermogenic recombinant alternative oxidases expressed in prokaryotic systems. It is 
thought that the OH group of the pyruvate interacts directly with the alternative oxidase, 
forming a thiohemiacetal species (Rhoads et al., 1998) with the same cysteine involved in 
non-covalent dimerisation, C122. While it was initially suggested that pyruvate increased 
the affinity of the alternative oxidase for its substrate (Umbach  et al., 1994), it was later 
suggested that the formation of the thiohemiacetal in non-thermogenic alternative oxidase 
resulted in a conformational change which lead to increased alternative oxidase activity 
(Hoefnagel  et  al.,  1997),  as  no  increase  in  substrate  affinity  could  be  demonstrated 
kinetically. Stimulation of alternative oxidase activity by other α-keto acids has also been 
observed: AOX activity in both tomato (non-thermogenic) and sacred lotus (thermogenic) 
mitochondria  can be stimulated by succinate,  for example (Holtzapffel  et al.,  2003 and 
Grant et al., 2009 respectively). Similarly, alternative oxidase activity in soybean seedlings 
can be stimulated differentially by succinate,  malate  and pyruvate,  with the former two 
stimulating activity to a lesser extent than the latter (Millar et al., 1993).
By  contrast,  AOX  activity  in  mitochondria  isolated  directly  from  thermogenic 
tissues  (Arum italicum,  Hoefnagel  et  al.,  1997; S.  guttatum,  Crichton  et  al.,  2005;  A. 
maculatum,  Ito  et  al.,  2011)  appears  to  be  insensitive  to  pyruvate,  suggesting  that  the 
enzyme expressed in  these  tissues  is  possibly  fully  stimulated  by endogenous pyruvate 
already bound to the protein, resulting in no observed increase in activity with the addition 
of pyruvate to the medium.
Stimulation  of  alternative  oxidase activity  by pyruvate  – or  indeed other  α-keto 
acids – has not been reported in other species such as fungi and parasites In common with 
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observations regarding reduced and oxidised enzyme forms as discussed previously, the 
organisms which are insensitive to pyruvate lack the conserved cysteine residue (C122) 
which is found in other pyruvate-sensitive alternative oxidases (cf Carré et al., 2011).
1.4 Predicted structural information from protein sequence data
1.4.1 Modelling the alternative oxidase
To date, there is no crystallographic structural data for the plant alternative oxidase. 
Based upon sequence analysis, however, there have been two proposed models of the plant 
alternative oxidase, derived in different ways.
1.4.1.1 The Siedow-Umbach-Moore model
The  SUM  model  was  developed  after  the  discovery  of  highly  conserved  iron-
binding residues  ([E]…[ExxH]x2) in  the  alternative  oxidase  sequence  which  were also 
present in other diirobn carboxylates (Siedow  et al.,  1995) as represented in Figure 1.4 
below. Structural data was available at the time for other members of the diiron carboxylate 
family; namely ribonucleodide reductase R2 (Nordlund and Eklund, 1993) and methane 
monooxygenase (Rosenzweig  et al., 1993). The resemblance between the active site for 
both proteins had been commented on previously (Norlund et al., 1992) and this similarity 
formed the basis for first a model of the alternative oxidase four-helix bundle active site 
(Siedow et al., 1995) and then later the same year, the entire protein (Moore et al., 1995a). 
Emphasis was placed on the highly conserved iron binding residues, and hydrophobicity 
plots indicated that there were transmembrane helices present in addition to a helical bundle 
acting as the diiron binding scaffold. In addition, the crucial cysteine residue involved in 
the formation of the reduced active form (Umbach et al., 1994) was included in the model. 
The model is shown below in Figure 1.5a.
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1.4.1.2 The Andersson-Nordlund Model
A second model of the alternative oxidase was proposed in 1999 by Andersson and 
Nordlund  who  performed  homology  modelling  using  another  diiron  carboxylate,  Δ9-
desaturase,  as a template.  The structure had been solved after the creation of the SUM 
model (Lindqvist  et al., 1996) and Andersson and Nordlund argued that the Δ9-desaturase 
shared more sequence homology with the alternative oxidase in helical regions than the 
other  diiron  carboxylates.  In  addition,  the  AN  model  postulates  that  the  regions  of 
hydrophobicity observed by Moore  et al. (1995a) were not indicative of transmembrane 
helices – rather that the protein was attached to only one leaflet of the membrane through 
two  small  helices  in  a  manner  similar  to  the  attachment  mechanism  observed  in 
prostaglandin H2 synthase-1 (Picot  et al., 1994). Andersson and Nordlund suggested that 
this would allow direct access to the active site for the quinol located within the membrane. 
This model has been recreated for this thesis (as shown below in Figure 1.5b) and is shown 
as a line drawing in Figure 1.5c also.
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Figure 1.5a – The SUM model of the alternative oxidase. Taken from Moore et al., 1995a (reproduced with 
the author’s permission).
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Figure 1.5b – A modified version of the AN model. Iron-binding residues are indicated (right, labelled) 
within the four helix bundle (left, numbers indicate helices 1-4).
Figure 1.5c – The Andersson Nordlund model of the alternative oxidase. The Figure shows a detailed 
representation of the Andersson and Nordlund (1999) model, including modifications by Berthold et al., 
(2000). The Figure is taken from Albury et al., (2009) and reproduced with the author's permission.
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1.4.1.3 Similarities between AOX and other diiron carboxylates
In addition to reported sequence similarity between diiron carboxylates (cf Moore et  
al., 1995a and Andersson and Nordlund, 1999), similarities in biochemical characteristics 
were also noted.  For example,  methane mono-oxygenase (MMO) lacks  a spectroscopic 
signal  above  350nm,  which  is  uncharacteristic  for  iron-containting  proteins;   similarly, 
MMO lacks a characteristic EPR signal found in other iron-containing proteins (Vincent et  
al., 1990; Wilkins 1992; and Lipscomb 1994). It was suggested that while the function of 
the diiron carboxylates  – itself  a  functionally diverse family of proteins  (Nordlund and 
Eklund, 1995) – differs from the function of the alternative oxidase, they could have similar 
structures,  specifically  the  construction  of  the  four-helix  bundle  common  to  all  diiron 
carboxylates, where the helices act as a scaffold, bringing the iron-ligating residues in close 
proximity to form the active site (Andersson and Nordlund, 1999; Berthold et al., 2002).
1.4.1.4 Recent attempts to model the alternative oxidase
Further alignment and investigation of the alternative oxidase sequences found in 
the  UniProt  (www.uniprot.org)  database  has  allowed  modelling  of  both  the  whole 
alternative oxidase protein (AN model, as above and Albury et al., 2009) and small regions 
within the protein of particular biological interest, such as the substrate binding site (Albury 
et al., 2010). In the recent attempts to model the alternative oxidase as part of this thesis, a 
variety of different approaches were taken, such as homology modeling and threading, and 
comparisons of the generated models was conducted using knowledge-based evaluation. 
The limitations  of such techniques  are  well  understood, and the importance  of suitable 
template  choice  and  accurate  alignment  of  template  and  target  sequences  was  not 
overlooked. 
1.4.2 Identification of other key residues
In addition to the six essential residues, other highly conserved residues have been 
identified, and mutated. Areas of particular interest are the substrate and inhibitor binding 
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regions, the oxygen pathway, and identification of any radicals formed close to the active 
site that may donate electrons for the purpose of oxygen reduction. A list of such identified 
residues, their putative roles, and their effect on activity where tested is summarised below 
in Table 1.3.
1.5 Elucidating the structure of the plant alternative oxidase experimentally
1.5.1 Over-expression of recombinant alternative oxidase protein
Of  particular  interest  in  this  project  has  been  over-expression  of  recombinant 
protein,  rather  than  a  focus  on  extraction  of  AOX  from  tissues  where  it  is  natively 
expressed. Extraction of protein from native tissues expressing alternative oxidase has been 
successful, and the choice to pursue expression using a recombinant system was decided 
based on the quantity of protein each extraction would provide. Native extraction, as noted 
by  Moore  and  Siedow (1991)  was  difficult  and  samples  often  lost  activity  soon  after 
solubilisation;  stabilisation of native alternative oxidase (Zhang et al., 1996) was a major 
development in the definition of a purification protocol, and the first highly pure and stable 
AOX protein isolated from native tissue was prepared from A. maculatum tissue (Affourtit 
and Moore, 2004).
Instability  in  AOX  isolated  from  native  sources  is  in  part  due  to  the  protein 
becoming  more  labile  once  released  from  the  mitochondrial  membrane;  the  same 
difficulties  would  be  expected  when  solubilising  recombinant  protein  from  the  vector 
membrane. However due to the greater quantities expressed using a recombinant system, 
less  overall  would  be  lost  to  instability,  and perhaps  having  a  higher  concentration  of 
protein may help to stabilise the protein molecules. Certainly for attempting to crystallise 
the alternative oxidase, large quantities of relatively stable protein would be required, and 
therefore recombinant expression offers an advantage over extraction of protein from native 
tissues. Similarly, tissues expressing alternative oxidase (such as from A. maculatum) are 
only available during certain times of the year, and this would be inhibitory to amassing 
sufficient quantities of protein.
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Residue Effect Role Reference
C172A Slightly reduced 
activity; O2 affinity 
increased
Regulatory cysteine Albury et al., 2002;
Critchton et al., 2010
T179A Slightly reduced 
activity; O2 affinity 
increased
Adjacent to E178; mutant is 
thought to change the 
distance of E178 to the 
diiron centre thus slowing 
down catalytic cycle
Crichton et al., 2010
H261 Not tested; 
expected activity 
loss
Putative quinone-binding
Albury et al., 2010
R262 Not tested; 
expected activity 
loss
Putative quinone-binding
Y253F Reduced activity Possible electron transport 
or quinol-binding
G242 Not tested; 
expected activity 
loss
Conserved, polar residue in 
hydrophobic pocket
N247 Not tested; 
expected activity 
loss
Conserved, polar residue in 
hydrophobic pocket
Table 1.3 – A list of conserved residues and their putative roles and expected effect on activity if 
altered. Residues are grouped according to effect on enzyme activity. Numbers correspond to S. guttatum 
sequence.
Generally speaking, there are well-documented difficulties associated with working 
with recombinant integral membrane proteins (Midgett and Madden, 2007), in particular 
proteins which do not overexpress to a high level. Therefore, there is a requirement for the 
development  of  a  reliable  and  robust  expression  and  purification  protocol  to  allow 
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sufficient quantities of recombinant protein to be produced. Protein that is produced can be 
used for many purposes, such as structural elucidation, kinetic analysis, and assessing the 
impact that mutations have on the overall activity of the protein.
The laboratory of Professor Kita (University of Tokyo) has had much success when 
expressing recombinant TAO protein, mainly due to their use of a haem-deficient  E.coli 
expression strain (FN102), which is discussed in detail in Chapter 4.
1.5.2 Crystallography
To  date,  no  crystallographic  data  is  available  for  the  plant  alternative  oxidase; 
however, the crystal structure of the Trypanosomal alternative oxidase has recently been 
solved to 2.8Å (Shiba  et al., 2013; initial  findings described in Kido  et al.,  2010). The 
structure  was  solved  after  more  than  a  decade  of  trying  to  produce  suitable  crystals. 
Historically, crystallization of membrane proteins has been a difficult task (cf Carpenter et  
al., 2008), and this is reflected in structural databases. For example, in the Protein Data 
Bank (www.rcsb.org/pdb/home/home.do) there over 74,000 protein structures derived from 
X-ray crystallography (as of January 2013), but very few of those structures (~600) are 
membrane proteins. Given that approximately 30% (Bill  et al., 2011) of the proteomes of 
living organisms are comprised of membrane proteins, there is clearly a mismatch in the 
number of membrane proteins known about and those having their structures solved. In part 
the difficulty in crystallising – and indeed purifying – membrane proteins is their apparent 
fragility in the absence of a lipophilic environment. Some proteins appear more stable in 
lower concentrations of the bi-lipid layer (for example Iwata et al., 1995 and Svensson-Ek 
et al., 2002), but this is not the case for most membrane proteins. 
1.5.3 Circular dichroism
In lieu of crystallographic structural data, there are other techniques available that 
will supply information about the structure of a protein of interest.  One such technique, 
circular dichroism (CD), utilises circularly polarised light to distinguish features of protein 
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secondary structure,  such as  α-helices  and β-sheets.  Given the predicted  predominantly 
helical nature of the alternative oxidase, this technique is ideal for matching predictions to 
experimental  observations.  CD  has  been  used  to  some  success  with  other  diiron 
carboxylates, such as ribonucleotide reductase (Stubbe, 2003), which is thought to utilise a 
radical or radicals for electron shuttling in a similar manner to the alternative oxidase; and 
of a much smaller member of the family, rubrerythrin (Wakagi 2003) which is more like 
the plant alternative oxidase in size. There exist a number of different algorithms available 
which allow determination of percentage secondary structure given circular dichroism and 
protein  concentration,  which  are  compared  and evaluated  in  Chapter  5,  along with  the 
correlation  between  predicted  secondary  structure  and  secondary  structure  observed 
experimentally.
Circular dichroism also offers the advantage of investigating protein stability: for 
example how increased temperature or presence and absence of cofactors affects the stages 
of denaturation and disruption of secondary structure.
1.6 Questions remaining in the field of plant alternative oxidase research
In order to consolidate the information presented in this Introduction and shape the 
aims of this project the following questions have been posed and will be readdressed after 
considering the results presented in Chapters 3, 4 and 5.
• Is it possible to over-express recombinant S. guttatum alternative oxidase protein in 
a bacterial system?
• Is it possible to the purify the expressed protein, to provide relatively pure protein?
• Its is possible to crystallise recombinant S. guttatum alternative oxidase?
• Will  recombinant  S.  guttatum alternative  oxidase  share  a  similar  sensitivity  to 
pyruvate as other AOX isoforms?
• What is  the structure of  S. guttatum AOX and is  it  similar to that  of TAO and 
predictions made previously?
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• Does recombinant  S. guttatum expressed in a bacterial system form dimers and if 
so, is it possible to identify the mechanism of dimerisation?
• Is  it  possible  to  replicate  and  expand  upon  previous  attempts  to  model  the 
alternative  oxidase,  taking  into  consideration  the  large  volume  of  new  AOX 
sequences now available in databases?
• How do previous models of the alternative oxidase compare to the newly elucidated 
TAO structure? 
1.7 The Aims of this project
To date, the structure of the plant alternative oxidase has remained elusive. While 
significant progress has been made towards a fuller understanding of the TAO, there is still 
much  to  be  learned  about  the  nature  and  structure  of  the  plant  alternative  oxidase. 
Therefore, the aims of this project were threefold: to overexpress, purify and attempt to 
crystallise the plant alternative oxidase; to use the expressed protein to gain insight about 
the structure-function relationship of the alternative oxidase experimentally; and to carry 
out a comprehensive in silico analysis of the alternative oxidase.
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Chapter 2
Materials and Methods
2.1 Plasmid vectors and Escherichia coli strains
In order to express recombinant alternative oxidase proteins, a library of plasmids 
was created (Dr Mary Albury, University of Sussex as listed below in Table 2.1), using the 
pET15b vector system (Novagen).
Plasmid Organism Creator
SgAOX-pET15b Sauromatum guttatum 
(wild-type)
Albury et al., 2001
pTAO Trypanosoma brucei Fukai et al., 1999
SgAOX-GFP (pET28(a+)-
derived GFP-8His fusion 
vector; Drew et al., 2001)
Sauromatum guttatum with 
green fluorescent protein tag
Dr Momi Iwata (Protein 
Membrane Laboratory, 
Diamond Light 
Source/Imperial College, 
London)
SgAOX-pET15b mutants: 
T179A, C172A, Y253F
S. guttatum Dr Mary Albury (University 
of Sussex)
Table 2.1 – A list of plasmids used and their creators.
The pET15b system offers the advantages of an N-terminal 6-His tag and ampicillin 
resistance, as well expression being controlled by  isopropyl β-D-1-thiogalactopyranoside 
(IPTG) induction.
2.1.1 Preparation of competent E. coli cells
Two strains of  E. coli were frequently used – a C41 (DE3) cell line tailored for 
membrane protein expression, kindly provided by Professor John Walker (University of 
Cambridge; Mirroux and Walker, 1996); and a haem-deficient mutant strain, developed in 
the laboratory of Professor Kita (University of Tokyo, Fukai et al., 2003).
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Both major  cell  strains (C41 and FN102) were made competent  using the same 
protocol, as follows. A streak of frozen, non-competent cell stock was plated out on Luria 
Agar  (LA)  plates  containing  the  necessary  additives  (100μgml-1 ampicillin,  and  then 
50μgml-1 5-amino levulinic acid (ALA, Sigma) and 50μgml-1 kanamycin for FN102 only) 
and the plates were incubated overnight at 37oC. A scrape of cells were used to inoculate 
1ml of Luria Broth (LB, containing ALA if necessary). This was then incubated overnight 
at 37oC with shaking. Following incubation,  the cell  suspension was back-diluted 1:100 
using fresh LB and incubated  at  37oC until  A650 = 0.45-0.55.  The suspension was then 
placed on ice for 5 minutes before centrifugation at 6,000 x  g for 5 minutes at 4oC. The 
resultant  pellet  was  the  resuspended  in  ½  volume  of  ice  cold,  0.1m  CaCl2.  The  cell 
suspension was centrifuged as previously. The resultant pellet was then resuspended in 1:20 
volume of ice cold, 75% 0.1m CaCl2, 25% glycerol. The competent cells were then frozen 
using dry ice, before being stored at -80oC in 200μl aliquots until needed.
2.1.2 Transformation of competent E. coli cells
Both major cells trains were transformed using the same protocol. Frozen cells were 
thawed  out  on  ice,  and  then  100μl  of  cells  were  aliquoted  to  separate  eppendorfs. 
Depending on the plasmid used 0.1 and 1μl of plasmid DNA was then added to the cells to 
be transformed. One tube per plasmid was used as a negative control, and contained only 
cells and no plasmid. The tubes were then mixed gently and placed on ice for 30 minutes. 
Following incubation  on ice,  the cells  were then heat-shocked at  42oC for  90 seconds, 
before  being  placed  back  on  ice  for  5  minutes.  After  chilling  on  ice,  800μl  of  LB 
(containing no additives) was added to each tube, and the tubes were incubated at 37oC for 
1 hour in a water bath. After incubation, the cells were centrifuged at 15,000 x  g for 2 
minutes,  4oC,  and after  centrifugation,  750μl  of  LB was  removed  from each  tube  and 
discarded.  The  remaining  ~150μl  was  used  to  gently  resuspend  the  cell  pellet.  The 
resuspended pellet was spread out on LA plates containing relevant selective antibiotics; 
typically  100μgml-1 ampicillin  for C41 cells  containing the  Sauromatum guttatum AOX 
(SgAOX-pET15b) plasmid and mutants; FN102 containing SgAOX-pET15b and mutants 
required  100μgml-1 ampicillin,  50μgml-1 kanamycin,  and  100μgml-1 ALA;  C41  cells 
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containing the GFP-tagged S. guttatum were supplemented also with 50μgml-1 kanamycin. 
Finally, the plates were then incubated overnight at 37oC.
2.1.3 Preparation of transformed glycerol cell stocks
In order to preserve transformed stocks of cells, glycerol stocks were made using 
cells from a fresh transformation. A loopful of transformed cells was used to inoculate 5ml 
of LB containing necessary additives and the culture was incubated overnight at 37oC with 
shaking. After incubation, sterile glycerol was added to a final concentration of 10% (v/v). 
The glycerol-cell mixture was then aliquoted into appropriate volumes before freezing in 
dry ice, then stored at -80oC. 
2.1.4 Isolation of plasmid DNA
Plasmid  DNA  was  prepared  using  a  Qiagen  Midi  kit  (Qiagen)  following  the 
manufacturer’s instructions. No changes were made to the protocol. Final purified plasmids 
were resuspended in distilled water and stored at -20oC until required. Prior to freezing, 
samples of purified plasmid were electrophoresed on an agarose gel (0.8%, Melford) at 75 
volts (Biorad Powerpac 200) for 1-2 hours. The gels were cast containing ethidium bromide 
dye (Sigma), and fluorescence UV light was captured using a charge-coupled device.
2.2 Protein expression and membrane isolation
The recombinant protein expressed in both  E. coli strains was associated with the 
bacterial  membrane,  so  membranes  were  harvested  in  order  to  isolate  the  recombinant 
protein.
2.2.1 Expression and membrane isolation from C41
The method of expressing recombinant alternative oxidase using the C41  E. coli 
was  based  upon  a  protocol  from Berthold  et  al. (2002)  with  some minor  adaptations. 
Rationale for protocol changes are described more fully in Chapter 4.
A single colony of transformed cells (as described above in Section 2.1.2) was used 
to inoculate an LB starter culture (20ml broth per 1L of main culture) containing the strain-
specific  additives  (typically  100μgml-1 ampicillin,  0.2% glucose,  0.125% FeSO4),  which 
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was the incubated at 37oC overnight with shaking. Following incubation, the whole cell 
suspension  was  used  to  inoculate  the  main  culture  (LB,  100μgml-1 ampicillin,  0.2% 
glucose, 0.125% FeSO4). The main culture was then incubated at 30oC for 4 hours. After 
incubation, the culture flasks were transferred to a pre-cooled 18oC incubator, and left to 
acclimatise for one hour with shaking. Following the one-hour acclimatisation, the cells 
were induced using a final concentration of 25-100μM IPTG, and then incubated for 18 
hours at 18oC. After 18 hours, the cell culture was centrifuged at 8,000 x g for 6 minutes 
using a JA-10 rotor in a Beckman JX centrifuge in order to separate the cells from the 
broth. After centrifugation, the cell pellets were resuspended using 50mM TRIS-HCl, pH 
7.5, 10mM pyruvate. An approximate ratio of 20ml TRIS:1g of wet pellet was used for the 
resuspension. The resuspended cell solution was then supplemented with 100mM PMSF in 
order to reduce protease activity before homogenisation using a glass homogeniser. The 
cells were then lysed, using either the French Press (two passes at 10k psi; SLM Aminco 
FA-078 with a FA-032 cell) or sonication (coarse probe at 14 microns, 30 seconds per ml  
of  cell  suspension).  Following  lysis,  the  cell  debris  was  removed  by  centrifugation  at 
20,000 x g (Beckman JX centrifuge, JA-20 rotor) for 15 minutes. The centrifugation step 
was repeated if the pellets were very loose at the end of the first spin. The supernatant was 
retained and ultracentrifuged at  200,000 x  g for 2 hours in order to pellet  the bacterial 
membranes  (Beckman  Avanti  XP  centrifuge,  70Ti  or  70.1Ti  rotor).  After 
ultracentrifugation, the supernatant was discarded (though a sample was usually retained 
for testing the efficiency of lysis), and the pellets resuspended in 50mM TRIS-HCl, pH 7.5, 
10mM pyruvate (with additives  if  required)  before homogenisation.  Membrane samples 
were then snap-frozen in liquid nitrogen before storage at -80oC.
2.2.2 Expression and harvest – FN102
The protocol for expression of recombinant alternative oxidase is based on Fukai et  
al., 2003 with several adaptations. The rationale for the adaptations is described in Chapter 
4.
A single colony of transformed cells was used to streak LA, 100μgml -1 ampicillin, 
50μgml-1 kanamycin and 100μgml-1 ALA. The plate was then incubated for 12 hours at 
37oC. After incubation, a single bacterial colony was used to inoculate an LB starter culture 
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(10ml broth per 1L of main culture)  supplemented with 100μgml -1 ampicillin,  50μgml-1 
kanamycin and 100μgml-1 ALA. The starter culture was then incubated at 37oC for 4-6 
hours. Following incubation, the starter culture was centrifuged at 5,000 x g for 5 minutes 
in order to remove the ALA from the broth. The resultant cell pellets were resuspended in 
LB containing no additives, and the centrifugation/resuspension step was repeated twice 
more. The OD650 of the final resuspended pellet was taken (LKB Pharmacia 4050 Ultrospec 
II), and enough cell suspension was added to each main culture flask to make the OD 650 = 
0.01.  The  main  culture  broth  (S-broth)  contained  the  following  reagents  (gL-1):  10g 
bacteriological  peptone  (Oxoid),  5g yeast  extract  (Melford),  5g casamino acid  (Oxoid), 
10.4g  di-potassium  hydrogen  orthophosphate  (Fisher),  3g  potassium  di-hydrogen 
orthophosphate  (Fisher),  0.74g  trisodium  citrate  (Sigma),  2.5g  ammonium  sulphate 
(Sigma), 0.05g magnesium sulphate (Sigma),  0.025g iron sulphate (Sigma),  0.025g iron 
chloride (Sigma), 0.1g carbenicillin (Sigma/Melford) and 2g glucose (Sigma). The last five 
reagents were added after autoclaving, and the glucose was autoclaved separately.
After  inoculation  of  the  main  culture,  the  flasks  were  incubated  at  30oC  with 
shaking,  and the OD650 was monitored.  When OD650 reached 0.1,  the main culture was 
induced  using  between  25-100μM IPTG.  Following  induction,  the  main  cultures  were 
incubated at 30oC for 8-14 hours (to allow for cultures expressing less active alternative 
oxidase  protein  to  grow  sufficiently).  After  incubation,  the  cells  were  pelleted  by 
centrifugation at 8,000 x g for 6 minutes. The resultant cell pellets were then resuspended 
in 50mM TRIS-HCl, pH 7.5, 10mM pyruvate (with 20% sucrose if performing a sucrose 
gradient to isolate inner membrane), and supplemented with 100mM PMSF and a Roche 
Complete Protease inhibitor cocktail  tablet  (1 tablet  per 50ml cell  suspension) and then 
homogenised. After homogenisation, the cells were lysed using either the French Press (two 
passes at 10k psi; as above in Section 2.2.1) or sonication (coarse probe at 14 microns, 30 
seconds per ml of cell suspension; as above in Section 2.2.1). The cell debris was then 
removed by centrifugation  at  20,000 x  g (Beckman JX centrifuge,  JA-20 rotor)  for 15 
minutes. The centrifugation step was repeated if the pellets were very loose at the end of 
the first spin.
To prepare the bacterial membrane, the supernatant was ultracentrifuged at 200,000 
x g for 1 hour at 4oC (Beckman Avanti XP centrifuge, 70Ti or 70.1Ti rotor). To prepare the 
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inner membrane fraction, the supernatant was laid over an equal volume of TRIS-HCl, pH 
7.5, 10mM pyruvate, 40% sucrose (provided that the cell pellets had been resuspended with 
TRIS containing  20% sucrose),  and ultracentrifuged at  200,000 x  g for  1 hour  at  4oC. 
Following the first ultracentrifugation step, the middle layer (often slightly yellow in hue) 
was extracted, and mixed with an excess of 50mM TRIS-HCl, pH 7.5, 40% sucrose, and 
ultracentrifuged once more at 200,000 x g for 1 hour at 4oC. The pellets obtained were then 
resuspended  in  50mM  TRIS-HCl,  pH  7.5  (with  20%  sucrose  if  isolating  the  inner 
membrane) before homogenisation.  Following homogenisation,  membrane samples were 
snap-frozen using liquid nitrogen, before storage at -80oC.
2.3 Membrane solubilisation and purification
In order to free the expressed recombinant alternative oxidase from the membrane, a 
solubilisation  step  is  necessary.  Separating  the  membrane  from the  protein  is  required 
before purification can be carried out.
2.3.1 Membrane solubilisation
Frozen membrane samples (prepared as described above) were thawed out on ice. 
For small-scale solubilisation (for condition screening), an equal volume of solubilisation 
buffer (Table 2.2) was added in a dropwise manner to the membrane sample. The buffer 
and membrane were mixed gently before incubation on ice for 30-60 minutes. For larger-
scale solubilisation (for preparatory purposes), approximately 8mg (for inner membrane) or 
6mg (for whole membrane) of protein was used per 1ml of solubilisation buffer (Table 2.2). 
The buffer was added to the membrane in a dropwise fashion. The mixture was then left 
stirring on ice for 30-60 minutes. After incubation on ice, the membrane-buffer solution 
was ultracentrifuged at 200,000 x  g (Beckman TL-100 Ultracentrifuge with a TLA100.3 
rotor) for 30-60 minutes at 4oC. The supernatant (soluble fraction) was removed for further 
purification, and the pellet (insoluble fraction) was resuspended in 50mM TRIS-HCl, pH 
7.5 and retained to assess the efficiency of solubilisation.
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Optional additive Rationale
50-300mM NaCl Recommended additive for downstream affinity purification; 
limits non-specific interactions with the metal ions of the affinity 
resin
1-5mM DTT Can be used to keep the sample under reducing conditions, and 
limits formation of dimers
10mM pyruvate In the case of the S. guttatum recombinant protein, pyruvate 
(max. concentration 10mM) appears to stabilise the protein. 
20/40% (w/v) 
sucrose
Required when isolating inner membranes through sucrose-
gradient ultracentrifugation.
1% (w/v) DDM In solubilisation trials this proved to be the best detergent and 
concentration for the S. guttatum alternative oxidases.
1.4% (w/v) OG Recommended detergent and concentration for recombinant TAO 
proteins; can be used in conjunction with DDM for S. guttatum 
recombinant proteins. During early detergent screening, it was 
noted that OG repeatedly reduced recombinant AOX activity and 
as such OG was not screened to the same extent as DDM.
5-20% (v/v) glycerol Appears to stabilise the recombinant protein once it has been 
removed from the membrane; should be incorporated into the 
solubilisation buffer.
Table 2.2 – A list of optional additives. The optional additives listed above may be used to supplement the 
standard 50mM TRIS-HCl, pH 7.5 buffer for solubilisation and membrane isolation.
2.3.2 Further purification
The recombinant alternative oxidase proteins were 6-His tagged in order to purify 
using  affinity  chromatography.  Two main  types  of  affinity  resin were used;  His-Select 
nickel affinity resin (Sigma) and His-Select cobalt affinity resin (Sigma). Table 2.3 below 
lists equilibration, wash and elution buffers used during the purification process.
The soluble fraction (prepared as detailed above in Section 2.2) was retained on ice 
while  the  affinity  resin  was  equilibrated.  Both  types  of  resin  (cobalt  and nickel)  were 
equilibrated  by  first  removing  the  storage  slurry,  then  using  5x  resin  bed  volume  of 
equilibration buffer either at room temperature (batch method) or at 4oC (column method). 
After equilibration,  the solubilised membrane sample was applied to the resin. In batch 
purification (small scale), this was typically ~600μl of solubilised membrane sample on a 
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50-100μl resin bed volume. For column (large scale) purification, up to 15ml of solubilised 
membrane sample was used on a bed volume of 3-6ml. The solubilised membrane sample 
was allowed to bind by gentle mixing for 1 hour at 4oC (batch method) or simply gravity 
flow (column method) at  4oC. The resultant flow-through after a low-speed spin (batch 
method) or gravity flow (column method) was retained and labelled as the flow-through 
fraction.
Following binding of the sample to the resin, the resin was then washed in stages 
using 5-10x the resin bed volume of wash buffer (see Table 2.3 below). In each case, the 
flow-through was retained and labelled as the wash fraction. After washing, the protein was 
eluted  from  the  resin  using  elution  buffer.  In  total,  2-3  (batch)  or  5-20  (column) 
applications of 5x the resin bed volume were applied, and the separate flow-throughs were 
retained as the elution fractions. During elution using the column method, the imidazole 
concentration was gradually increased.
Buffer Optional additive Rationale
Equilibration 
buffer and wash 
buffer
Glycerol (5-20%) Keeps the protein stable once solubilised.
100mM MgSO4 Appears to keep the protein stable and active 
during purification
Detergent (0.5% 
DDM, 0.5% OG)
Keeps the protein soluble during purification
Elution buffer 20-250mM 
Imidazole
For elution purposes; disrupts the binding 
between the 6His-tag and metal ions.
Table 2.3 – optional additives for purification buffers (50mM TRIS-HCl, pH 7.5, 10mM pyruvate).
2.4 Visualisation of recombinant protein
2.4.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
In order to visually assess the quality of prepared samples, and to gauge purity of 
purified recombinant protein, SDS PAGE was used (Laemmli, 1970).
Gels were cast using the BioRad Mini-Protean system (10cm x 8cm x 1mm gels) 
using the buffers listed below in Table 2.4a. Final acrylamide concentration was achieved 
using the matrix shown in Table 2.4b. The resolving reagents were mixed gently in a side-
arm  conical  flask,  and  de-gassed  if  necessary  before  pouring.  The  resolving  gel  was 
allowed  to  polymerise  for  30  minutes,  whilst  overlayed  with  butan-saturated  water  to 
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prevent drying out. After setting, the stacking gel was applied along with a well-comb. The 
stacking  gel  was  allowed  to  polymerise  for  20  minutes  before  the  apparatus  was 
disassembled.
The protein samples were then mixed with 2x loading dye (Table 2.4a) at a 1:1 
ratio, vortexed, and heated at 90oC for 6 minutes. The dye-sample mixture was then loaded 
into  the  sample  wells  along  with  a  rainbow  marker  (Amersham  FullRange  Rainbow 
Markers) and the electrophoretic rig was submerged in 1x SDS-running buffer (Table 2.4a). 
A current was then applied to the system for approximately 1 hour, 150 volts, or until the 
dye front reached the bottom of the rig at which point the rig was disassembled and the gels 
were  rinsed  briefly  in  distilled  water  before  either  Western  blotting  or  staining  using 
GelCode Blue (Thermo Scientific) following the manufacturer’s instructions. Stained gels 
were destained with distilled water overnight before being dried (BioRad 583 Gel Dryer).
Buffer Reagents Comments
TRIS buffer for resolving 
gel
1.5M TRIS-HCl, pH 8.8
TRIS buffer for stacking gel 0.5M TRIS-HCl, pH 6.8
Loading dye (2x) 0.1M TRIS-HCl, pH 6.8, 
10mM EDTA, 2% (w/v) 
SDS, 5% (w/v) glycerol, 
0.05% (w/v) bromophenol 
blue
No β-mercaptoethanol 
used. Can be 
supplemented with up to 
5mM DTT if reducing 
conditions are required.
SDS Running (tank) buffer 
(10x)
0.25M TRIS, 1.92M glycine, 
0.03M SDS.
10x stock diluted when 
required to 1x with 
distilled water.
Table 2.4a – Buffers required for SDS PAGE.
2.4.2 Western blotting
In order to better  visualise the bands containing recombinant  alternative oxidase 
protein  on  SDS PAGE gels,  it  was  often  necessary  to  perform Western  blotting  using 
primary antibodies raised against S. guttatum alternative oxidase (Elthon et al., 1989).
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SDS PAGE gels were run as described above (Section 2.4.1), and rinsed briefly in 
distilled water.  The gels were then transferred to a small  amount of chilled 1x transfer 
buffer (see Table 2.5 below). Meanwhile, an 8x10cm nitrocellulose filter (pore size of
Final % acrylamide – resolving gel
Reagent 7.5% 10% 12% 15%
30% 
polyacrylamide
7.5ml 10ml 12ml 15ml
Resolving buffer 7.5ml 7.5ml 7.5ml 7.5ml
10% SDS 300μl 300μl 300μl 300μl
10% APS 300μl 300μl 300μl 300μl
TEMED 20μl 20μl 20μl 20μl
dH2O 14.38ml 11.88ml 9.88ml 6.88ml
Total 30ml 30ml 30ml 30ml
Stacking gel – 5% acrylamide
30% 
polyacrylamide
1.6ml
Stacking buffer 2.5ml
10% SDS 100μl
10% APS 100μl
TEMED 10μl
dH2O 5.7ml
Total 10ml
Table 2.4b – Final acrylamide concentration matrix.
0.45nm, Protran, Whatman) was also equilibrated in 1x transfer buffer, along with blotting 
paper and sponges of the same size.  A blotting cassette was assembled (see Figure 2.1 
below) and placed into the transfer rig along with two ice packs. The blotting tank was then 
filled with the remainder of the chilled 1x transfer buffer. A current (typically 100V for 1 
hour with stirring) was applied to the rig, during which time the temperature of the tank 
was monitored. If temperature of the buffer in the tank rose above 30oC, fresh chilled 1x 
transfer buffer was added to the tank, and the ice packs were replaced in order to prevent 
damage to the nitrocellulose membrane.
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Following transfer, the nitrocellulose membrane was washed briefly in 1x TBST 
(Table 2.5) and then submersed in block solution (Table 2.5) and allowed to equilibrate 
with gentle shaking for 15 minutes. After equilibration, primary anti-AOX antibody was 
added  to  the  block  solution  containing  the  nitrocellulose  to  a  dilution  of  1:5000.  The 
solution and membrane were then incubated at room temperature with gentle shaking for 1 
hour.  After  incubation,  the  membrane  was  washed  using  1x  TBST  briefly  six  times, 
followed by 6x 5 minute washes with shaking. Following washing, a fresh 20ml aliquot of 
block solution was added to the membrane along with the secondary antibody (rabbit anti-
mouse with a HRP conjugate, Dako BioProducts at a 1:20,000 dilution). The membrane 
and block were then incubated for a further hour at room temperature with gentle shaking. 
Following  the  incubation,  the  membrane  was  washed  as  described  previously.  After 
washing,  the  membrane  was  placed  in  1x  blot  rinse  (Table  2.5)  for  15  minutes.  The 
membrane was then gently blotted dry using blotting paper and transferred to a piece of 
Saranwrap for exposure to the Enhanced Chemiluminescence reagents (Amersham ECL 
Detection Kit, GE Healthcare) at a ratio of 1:1 for solutions 2 and 1, for 3 minutes and 1 
minute respectively.
The membrane was then blotted dry once more before being covered in a single 
layer of Saranwrap and placed in an extremity cassette (DuPont Ultravision). After securing 
the membrane in place in the cassette,  a single piece of x-ray film (Fujifilm Super RX 
Medical X-ray film) was placed on top of the wrapped membrane and exposed for between 
10 seconds and 1 hour. The exposed films were then developed using a (Konika SRX-
101A) auto-rad developer and the positions of the protein markers were noted immediately 
after developing.
2.4.3 Sample preparation – acetone precipitation
Cold  (-20oC)  acetone  was  added  to  the  sample  in  a  ratio  of  4:1  and  mixed 
thoroughly,  following which the sample  was incubated  at  -20oC for  1 hour.  Following 
incubation, the sample was centrifuged at 13,000 x g for 10 minutes (Eppendorf Centrifuge 
5415R). After centrifugation, the acetone was carefully aspirated from the pellet, and the 
pellet  was  left  to  air-dry  for  30-40  minutes,  to  avoid  over-drying  of  the  pellet.  The 
driedpellet was then resuspended in 2x loading dye and heated for 6 minutes at 90oC before 
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being loaded onto an SDS PAGE gel, and electrophoresed as described in Section 2.4.1 
above.
Buffer Reagents Comments
Transfer buffer, 
10x
1.92M glycine, 13mM TRIS, 
pH 7.2
1x working solution made using 8 
parts cold distilled water, 1 part 
methanol, 1 part 10x TB stock
TBST, 10x 140mM NaCl, 20mM TRIS, 
pH 7.6, 0.1% (v/v) Tween-
20
Block solution 2% (w/v) Marvel milk 
powder, 3% (w/v) BSA in 1x 
TBST
Blot rinse, 10x 10mM TRIS, 5mM ETDA, 
pH 7.2
Table 2.5 – Western blotting buffers.
Figure 2.1 – A diagrammatic representation of the transfer cassette. Orientation of the components of the 
transfer cassette are shown relative to one another. The arrow indicates the direction of the current.
Cassette – anode 
Sponge pad 
Sponge pad 
Blotting paper 
Gel
Blotting paper 
Nitrocellulose
Cassette – 
cathode 
t
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2.5 Protein Assays
A variety of assays were used to assess the protein concentration and activity of 
prepared samples.
2.5.1 Protein estimation assays
Both of the following methods were used to ascertain protein concentration in any 
samples prepared; the method used is indicated in the results sections of each Chapter as 
appropriate. 
2.5.1.1 BCA protein concentration estimation method
Protein concentration was estimated using a Pierce BCA protein assay kit (Thermo 
Scientific, adapted from Smith et al., 1985), following the manufacturer’s instructions. No 
changes  were  made  to  the  protocol,  which  is  summarised  as  follows.  For  samples 
containing substances likely to affect the estimation assay, an acetone precipitation step 
was required, and was carried out as described above in Section 2.4.3. 100μl of diluted (or 
resuspended) sample (1:20, 1:50 or 1:100 to dH2O), standard was added to 100μl of 5% 
SDS in 0.1M NaOH. Samples were prepared in triplicate and standards (BSA at 0.1, 0.2, 
0.4, 0.6, 0.8 and 1mgml-1) in duplicate. Blanks (containing water) were also prepared in 
duplicate.  1ml of BCA working reagent  (50:1 of solutions  A:B from the kit)  was then 
added to each tube before vortexing. The samples were then incubated for 30 minutes at 
37oC. After incubation,  the absorbance at 562nm of each standard and sample was then 
measured  spectrophotometrically;  the  absorbance  of  the  standards  was  used  to  plot  a 
standard  curve  from  which  the  concentration  of  the  unknown  samples  could  be 
extrapolated.
2.5.1.2 Lowry protein concentration estimation method
This  alternative  method  for  estimating  protein  concentration  was used  whilst  in 
Professor Kita’s laboratory, at the University of Tokyo and is based on Lowry et al. (1951).
Several  different  BSA concentration  standards  were  prepared  in  distilled  water. 
Samples of protein of unknown concentration were then prepared in two different dilutions 
(either  1:250,  1:100 or  1:50)  with  a  dilution  of  1:50  being used for  low concentration 
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samples. Each of the standards and protein samples had a total volume of 500μl. A 1:1:100 
solution was then made of 2% copper (II) sulphate (pentahydrate), 4:% potassium sodium 
tartrate and 4% sodium carbonate (dissolved in 0.2M sodium hydroxide and 2% sodium 
dodecyl  sulphate)  respectively.  500μl  of  this  solution  was  then  added  to  each  of  the 
standards and protein samples, following which 50μl of phenol reagent (Wako) was added. 
Each tube was vortexed immediately after the phenol reagent was added.
The standards and protein samples were then left at 37oC for 30 minutes before the 
absorbance of each solution was monitored at 700nm using a spectrophotometer (Shimadzu 
UV-1201).
2.5.2 Spectrophotometric activity assay
Activity assays were required to assess the functional capability of the expressed 
recombinant protein, using a variety of substrates. In each case, a 10mm quartz (Hellma, 
Suprasil) cuvette was used.
Using  a  Cary  400  UV  spectrophotometer1 (Varian)  connected  to  the  Varian 
spectrophotometer computer suite (CaryWin UV) a scanning wavelength baseline (Scan) 
was taken to ensure that the sample cuvette and assay buffer (Table 2.6a) did not absorb 
significantly  at  the  wavelength  used  to  monitor  substrate  depletion/product  formation. 
Using the Kinetics program, a single wavelength was monitored (Table 2.6b) throughout 
the duration of the assay. To begin with, only buffer was placed in the cuvette, followed by 
sample once a flat line was observed. Following addition of sample, substrate was added to 
initiate the reaction. Additions were made quickly and accurately, allowing the stir-bar to 
complete the mixing of any substances added to the cuvette. Initial rates were monitored 
and the reaction was allowed to progress sufficiently before addition of inhibitors or other 
solutions where appropriate (Table 2.6b). Data collected from each assay was imported into 
an Excel spreadsheet for further analysis. In order to calculate substrate consumption, the 
following calculation  was used,  where  ε = molar  extinction  coefficient  of  the  oxidised 
substrate.
1 When at University of Tokyo, Shimadzu UV-3000 was used
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Equation 1
Buffer Composition
50mM TRIS 50mM TRIS-HCl, pH 7.5, 10mM pyruvate
Yeast Medium A 0.3M mannitol, 1mM MgCl2, 5mM K2HPO4, 10mM KCl, 20mM 
MOPS, pH 7.2 (with KOH)
Table 2.6a – Buffers used for spectrophotometric assays.
Additive Rationale Comments
Q1H2 (ubiquinol-1) Substrate Working concentration 150μM, ε 
= 15,000 M-1 cm-1 at 278nm
DQH2 (duroquinol) Substrate Working concentration 250μM, ε 
= 2,150 M-1 cm-1 at 283nm
DUQH2 
(decylubiquinol)
Substrate Working concentration 200μM, ε 
= 4140 M-1cm-1 at 289nm 
OGS (octyl-
gallate)
Inhibitor of the alternative 
oxidase
Working concentration 1μM
AA (antimycin A) Inhibitor of the bc1 complex Working concentration 4μM
AF (ascofuronone) Inhibitor of the alternative 
oxidase (cf Minagawa et al., 
1996)
Variable working concentration 
used to determine effect of 
concentration on inhibition
Pyruvate Apparent stabilising effect on 
recombinant S. guttatum 
alternative oxidase; boosts 
activity
Working concentration up to 
10mM. Added to either the assay 
medium or during membrane 
harvest
Table 2.6b – Substrates, inhibitors and stabilisers compatible with spectrophotometric assays. In the 
case of decylubiquinol, the extinction coefficient is taken from Rich (1984).
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2.5.3 Substrate reduction protocol
The quinol family of substrates required for alternative oxidase activity must be in 
the reduced state.  They were reduced in-house,  using the following protocol  (based on 
Rich, 1981).
Three aliquots of sodium dithionite (Sigma) were prepared by dissolving sodium 
dithionite  in  50ml  of  distilled  water;  the  quantity  of  sodium  dithionite  required  is  in 
proportion to the quantity of oxidised substrate used (typically four times as much sodium 
dithionite as substrate). Oxidised substrate (i.e. 0.25g of duroquinone or 10mg of quinone) 
was dissolved in 50ml diethyl ether, resulting in a transparent yellow-orange solution. The 
substrate solution and one aliquot of sodium dithionite were mixed vigorously in a glass 
separating  funnel  for  3  minutes  in  order  to  allow the  dithionite  to  begin  reducing  the 
substrate.  After  mixing,  the  solution  was  allowed  to  separate  into  the  aqueous  phase 
(containing the water and spent dithionite) and ether phase (containing the partially reduced 
substrate) and the aqueous phase was carefully discarded to avoid excessive loss of the 
ether phase. A second sodium dithionite aliquot was added to the ether phase remaining in 
the separating funnel; this was mixed for 3 minutes, allowed to separate into the aqueous 
and ether phases, before the aqueous phase was discarded. This was repeated once more 
using the remaining aliquot of sodium dithionite.
Following the final discarding of the aqueous phase, the funnel and substrate were 
washed twice using 100ml of saturated sodium chloride (to remove any excess water from 
the ether phase) and again the aqueous phase was discarded. The ether phase was then 
removed from the separating funnel, and passed through a second funnel lined with filter 
paper containing 30g of anhydrous sodium sulphate powder (to remove any traces of water) 
and collected in a glass beaker. Either a conical funnel or a Büchner funnel and vacuum 
pump can be used.
A  microlance  needle  was  used  to  make  a  single  hole  in  the  caps  of  several 
eppendorf tubes. The filtered ether phase was then transferred to the eppendorf tubes in 1ml 
aliquots.  The tubes were then placed in a heated gyratory evaporator (Savant Speedvac 
SC110)  on  low heat  (approximately  30oC)  until  the  ether  phase  had  been  evaporated, 
leaving behind a small white residue in each tube (reduced substrate). Each individual tube 
44
was then sealed using Parafilm M (Alcan) and placed in a light-tight dessicator at room 
temperature until required.
In order to prepare the reduced substrate for spectrophotometric activity assays, the 
substrate were resuspended gently in 1ml of acidified ethanol (10mM hydrochloric acid), 
and  the  concentration  was  determined  spectrophotometrically  using  the  extinction 
coefficient of the substrate in ethanol at a specific wavelength (see Table 2.6b).
The  resuspended  reduced  substrate  was  then  stored  at  -80oC  after  use.  The 
resuspended substrate remained stable for a maximum of 3 months when stored at -80oC. 
The substrate  concentration  was  verified  before  each subsequent  use by measuring  the 
absorbance of the substrate at the substrate-specific wavelength (as detailed in Table 2.6b) 
and dividing this value by the extinction coefficient (also detailed in Table 2.6b) and the 
pathlength of the cuvette (which was always 1cm).
2.6 Crystallography
Purified  recombinant  protein  was  used  for  crystallographic  screening.  Prior  to 
screening, a pre-crystallisation test (PCT) was carried out to establish whether the protein 
sample was within the optimal concentration and purity range. The PCT kit used for all  
tests was supplied by Molecular Dimensions. After carrying out the PCT and adjusting the 
protein concentration if necessary, screens were set up as follows.
2.6.1 Initial screening – hanging drop method
Initial  screening  was  carried  out  in  the  laboratory  of  Dr.  Darren  Thompson, 
University of Sussex. Protein and screen solutions were kept at 4oC throughout the process 
of setting up the screen. The hanging drop method was used in the initial screening process, 
with  24-well  plates  (Molecular  Dimensions)  and  plastic  coverslips  (Molecular 
Dimensions). Each well was lightly hand-greased using silicon grease (DuPont). Following 
greasing, 600-1000μl of screen solution was added to the bottom of each well. See Table 
2.6.1 for kits used. 1μl of screen solution was taken from each well, and tip-mixed with 1μl  
of protein sample on a coverslip. The coverslip was then inverted and placed on top of the 
relevant  well  immediately,  forming  an  air-tight  seal  with  the  grease.  Once  filled,  the 
plate(s)  were  stored  at  4oC  or  room  temperature  and  viewed  under  a  standard  light 
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microscope  every  3-4  days  for  30-60  days  after  the  screen  was  set  up.  Formation  of 
precipitation, microcrystals and larger crystals were recorded and photographed.
2.6.1.1 Seeding and refinement
After conditions producing microcrystals were identified using the initial screening 
kits, further refinement was carried out along with seeding trials. The conditions (detailed 
in the product information) were adapted by adjusting pH, precipitant concentration, and 
salt molarity. Stock solutions of all the components were made, and mixed to create a non-
Kit (manufacturer) Description
MemStart (Molecular 
Dimensions), 48 conditions
Sparse-matrix kit developed for membrane proteins
MemSys (Molecular Dimensions) 
48 conditions
Developed from the most successful conditions from 
MemStart
MemGold (Molecular 
Dimensions) 48 conditions
Non-sparse matrix based on the most successful 
conditions from MemStart and MemSys
Protein Screen I (Molecular 
Dimensions) 50 conditions
Sparse-matrix, general protein crystallography 
screen
Protein Screen II (Molecular 
Dimensions) 48 conditions
Sparse-matrix, general protein crystallography 
screen
Table 2.7 – Crystallographic screening kits used.
-sparse matrix. Depending on the complexity of the conditions required, either 24 or 96-
well  plates  were  used.  Screens  were  then  set  up  in  duplicate  as  previously  described 
(hanging drop method), or using the sitting drop method (described below in Section 2.6.3). 
In both cases,  the crystals  from the relevant  successful screen were crushed and mixed 
using a fine gauge acupuncture needle and then streaked through a drop of protein-solution 
mix in order to initiate seeding. Plates were then sealed  and one plate was incubated at 4 oC 
and the other at room temperature. The plates were monitored every 3-4 days for 30-60 
days after being set up. 
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2.6.2 Sitting drop method 
In addition to the hanging drop method, the sitting drop method was utilised when 
working  in  the  laboratories  of  Professor  So  Iwata  (Membrane  Protein  Laboratory  – 
Imperial College, London and Diamond Synchrotron facility, Didcot) and Professor Kita 
(Graduate School of Medicine, University of Tokyo).
The protein sample and screen conditions were kept at 4oC whilst being prepared. In 
contrast to the hanging drop method, 96-well sitting drop plates (Fisher) were used. Due to 
the reduced well size, 100μl of screen solution was placed into each well. 0.5μl of screen 
solution was then placed into the small vapour shelf at the top of the well. To this, 0.5μl of 
protein  sample  was  added,  and  mixed  gently  using  the  pipette  tip.  To  seal  the  plate, 
shireseal  was  applied.  Once  sealed,  the  plates  were  again  incubated  at  either  room 
temperature or 4oC and monitored every 3-4 days for 30-60 days after being set up. 
During screening trials at the Diamond Synchrotron facility, a Cartesian robot was 
used to aid the setting up of several 96-well sitting drop plates (Innovadyne). In this case 
the well volume used was 80μl, but the sitting drop volumes were 100nl of protein mixed 
with 100nl of screen solution. The process was automated.
2.7 Circular Dichroism
Circular dichroism (CD) was used to assess the secondary structure of recombinant 
alternative  oxidase.  CD  experiments  were  carried  out  using  a  Jasco  J715 
spectrophotometer,  connected to Jasco Spectra Manager software suite and fitted with a 
Jasco  Peltier-type  temperature  regulation  system  in  the  laboratory  of  Dr.  Ewan  Main 
(University of Sussex).
2.7.1 Sample preparation using polyethylene glycol (PEG) precipitation
Protein samples for CD experiments were prepared by first precipitating the sample 
using PEG. A stock solution of 50% (w/v) PEG-6000 (Sigma) was added dropwise to the 
protein sample, and gently mixed after each addition until the solution became opaque. The 
sample was then centrifuged at 13,000 x g for 30 minutes at 4oC. The supernatant was 
removed  and  retained.  The  pellet  was  allowed  to  air  dry  for  10-30  minutes  at  room 
temperature,  before storage  at  -80oC until  required.  In  order  to  test  the  efficacy  of  the 
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precipitation, the supernatant was assayed using the techniques described above in Section 
2.5.2;  if  there  was  significant  activity  measured,  the  precipitation  was  repeated  by 
recombining the supernatant and the pellet, and then the dropwise addition of 50% PEG 
6000 (Sigma). The solution was then centrifuged at 13,000 x g for 30 minutes at 4oC. The 
supernatant was retained and re-assayed. This process was repeated until no activity was 
observed in the supernatant.
2.7.2 Monitoring secondary structure – multiple wavelength scan
Dried and frozen pellets (as described above) were thawed on ice, and resuspended 
to an appropriate volume with the relevant buffer. Typically, using a 1mm cuvette, 250μl of 
dH2O containing 0.04% DDM was used to resuspend a single pellet. The buffer alone was 
then added to the cuvette, and a baseline reading (scanning from 300-180nm) was taken to 
ensure no excessive absorption was observed in this range. The same settings for scanning 
were applied to the baseline as to the experimental scans, described below.
The resuspended pellet was then transferred to a clean cuvette (Hellma, Suprasil, 
1mm), and absorbance across wavelengths of 300-180nm was recorded with a wavelength 
pitch of 0.1nm. Scans were performed in triplicate and an average taken. Data was then 
imported into a Gnumeric spreadsheet for further analysis.
2.7.3 Temperature melt CD
Initial multiple wavelength scanning CD indicated that the alternative oxidase was 
mainly  alpha  helical  in  structure.  In  order  to  assess  how  stable  the  α-helices  were, 
temperature  melt  experiments  were  performed.  As  detailed  in  Section  2.7.2,  PEG 
precipitated protein was resuspended in the relevant buffer, and placed into a clean cuvette. 
Absorbance was measured at 222nm and temperature increments of 1oC from 10-90oC or 
decrements of 1oC between 90-10oC..  Data was exported as a Gnumeric spreadsheet for 
further analysis.
2.8 In silico modelling of the alternative oxidase
A variety of in silico analyses were performed and these are described in detail in 
Chapter 3. Below in Table 2.8 the algorithms used are listed, along with the function of the 
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algorithm  or  program.  The  algorithms  were  either  accessible  via  a  web  interface,  or 
downloaded  and  run  from  either  a  Windows  or  Linux  (Ubuntu)  machine.  Image 
manipulation  throughout  the project  was performed with the GNU Image Manipulation 
Program (GIMP; http://www.gimp.org/) and LibreOffice Draw.
Software Function
AutoDock Protein/molecule docking software
BioSerf Automated ab initio homology modelling
CFSSP Chou and Fasman (1974) secondary structure prediction 
algorithm
ClustalW Multiple sequence alignment
DeepView Molecular visualisation software
Dichroweb Analysis of circular dichroism data
GOR Garnier-Osguthorpe-Robinson (1978) secondary structure 
prediction algorithm
Hex Protein/molecule docking software
HHPred Protein homology detection and structure prediction
JPred3 Protein secondary structure prediction
NJPlot Phylogenetic tree drawing software
PHYLIP Phylogenetic tree drawing software
Phyre2 Protein threading server
PROFphd Protein tertiary structure prediction
PROSITE Curated database of protein domains, families and functional sites
PSIPRED 3.0 Protein tertiary structure prediction
PyMOL Molecular visualisation software
RaptorX Protein threading server
SeaView Multiple alignment viewer and editor
SwissModel Homology modelling server
Treeview Phylogenetic tree viewing software
VMD Visual Molecular Dynamics; a Molecular visualisation software
Table 2.8 - Software used during the in silico analysis of the S. guttatum alternative oxidase. For 
references, see Chapter 3.
The numbering of residues referred to in this thesis is taken from the  S. guttatum 
alternative  oxidase protein (UniProt  accession number P22185) unless otherwise stated. 
The other main sequence used in the in silico modelling of the alternative oxidase was the 
Trypanosomal  alternative  oxidase  (TAO;  UniProt  accession  number  Q26710,  from 
Trypanosoma brucei brucei). Lists of all sequences used can be found in Appendix 1. The 
accession numbers  of  any crystal  structures  used (accessed via  the Protein  Data  Bank, 
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PDB) are listed in the body of the text. At the time of submission, the crystal structure of 
the TAO had been recently submitted to the PDB (PDB code 3VV9, Shiba  et al., 2013). 
However, the structures themselves were not accessed via the PDB, but came directly from 
the research  laboratory  or  Professor Kita  at  the University  of Tokyo some time before 
publication. 
50
Chapter 3
Modelling the alternative oxidase
3.1 The value of bioinformatics
In the  absence  of  structural  data,  in  silico analysis  of  protein  sequence  may be 
performed. With careful selection of algorithms and informed interpretation of their output, 
meaningful  and  empirically  evaluated  predictions  are  possible  –  from the  inference  of 
evolutionary  relationships  (McDonald  and Vanlerberghe,  2006),  to  predicted  secondary 
structure  (Moore  and  Siedow,  1991)  and  models  generated  where  homologous  protein 
structure exists (Andersson and Nordlund, 1999). Models of either structure or sequence 
relationship  may  then  be  used  to  generate  hypotheses  about  the  structure-function 
relationship of a protein, the family to which it belongs, and the evolutionary relationship it 
may share with other protein families (Gomes et al., 2001; Berthold and Stenmark, 2003).
The scope of this Chapter is to revisit previous in silico alternative oxidase analysis, 
and reassess alignments, phylogeny and models in light of new sequence and structure data. 
For the first time, molecular docking has been attempted, with positive results.
3.1.1 Sequence analysis
The first AOX sequence to be published was that of  S. guttatum in 1991 (Rhoads 
and McIntosh, 1991). A filtered2 Basic Local Alignment Search Tool (BLAST, Altschul et  
al.,  1990)  search  of  the  UniProt  Knowledgebase  (http://www.uniprot.org;  Uniprot 
Consortim,  2012)  using  the  S.  guttatum sequence  (UniProt  accession  number  P22185) 
reveals  607  sequences  with  similarities  ranging  from 90% down  to  25%.  Of  the  607 
sequences, only 33 have been reviewed and annotated manually. 89% of the 607 sequences 
are eukaryotic in origin, and the remaining 11% are found in prokaryotic genomes.
2  An E value cut-off of 1 was applied
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Previous sequence analysis of alternative oxidase sequences (Moore et al., 1995a) 
led to the identification of highly conserved residues across both plant and fungal species 
and  earlier  (Moore  and  Siedow,  1991)  use  of  the  Garnier-Osguthorpe-Robson  (GOR; 
Garnier et  al., 1978) algorithm predicted a primarily helical protein (51%) with 10%  β-
sheet,  16%  β-turn  and  the  remaining  23%  attributed  to  random  coil.  However, 
bioinformatic  analysis  of  the  alternative  oxidase  sequences  alone  did  not  provide 
information beyond predicted secondary structure elements, such as metal binding motifs – 
information which was incredibly important, as the cofactor required for alternative oxidase 
activity was not known at the time (Moore and Siedow, 1991). Only after the inclusion of 
sequences  from another  family  of  proteins,  the  diiron  carboxylates,  did  multiple  local 
alignment analysis reveal the presence of several iron binding motifs universally conserved 
within  the  alternative  oxidase  sequences  (cf Siedow  et  al.,  1995;  Moore  et  al.,  1995a; 
Andersson and Nordlund, 1999) and ultimately the classification of the alternative oxidase 
as a non-haem, diiron protein (Siedow et al., 1995; Moore  et al., 1995a; Berthold  et al., 
2002).
3.1.2 Phylogeny
Structure-specific phylogenetic analysis of the alternative oxidase with respect to 
the diiron carboxylates suggested that the alternative oxidase and the diiron carboxylate 
family have a common ancestor, most likely a primitive oxygen reductase (Gomes et al., 
2001).  Further  phylogenetic  analyses  were  conducted  without  the  inclusion  of  diiron 
carboxylate  sequences;  instead,  sequences  from plastid  terminal  oxidases  (PTOX) were 
used in the analysis. PTOX proteins, a family of terminal oxidases expressed in plastid 
organelles such as chloroplasts, are thought to play an essential role in the desaturation of 
carotenoids (Carol  et al., 1999; Josse  et al., 2000; Carol and Kuntz, 2001). Furthermore, 
when expressed in E.coli membranes, PTOX confers the same cyanide-resistant respiration 
observed in tissues expressing alternative  oxidase which is  inhibited by addition of the 
AOX-inhibitor octyl-gallate (Josse et al., 2000). Sequence similarity between the AOX and 
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PTOX families is very low (25%; Josse et al., 2000) despite some similarities in function 
(as  terminal  oxidases)  and  catalytic  mechanisms  (quinol:oxygen  oxidoreductases). 
However,  the  iron-binding  motifs  identified  in  both  the  diiron  carboxylates  and  the 
alternative oxidase are retained in PTOX, suggesting similarity in structure (Carol  et al., 
1999).
Several analyses suggest that AOX and PTOX have a common ancestor of bacterial 
origin,  but  that  they  entered  into  eukaryotic  taxa  through  different  routes  shortly  after 
divergence.  The  alternative  oxidase  entered  into  the  eukaryotic  lineage  through  the 
endosymbiotic relationship between proteobacteria,  which resulted in the creation of the 
mitochondria;  conversely,  the  PTOX  entered  into  the  plant  lineage  through  the 
endosymbiotic relationship between cyanobacteria, resulting in the creation of organelles 
like  the  chloroplast  (Finnegan  et  al.,  2003;  McDonald  and  Vanlerberghe,  2006). 
Phylogenetic analysis of AOX sequences from protozoa, including apicomplexan parasites 
such  as  T.  brucei and  C.  parvum suggests  that  the  parasitic  alternative  oxidases  are 
descended from the eukaryotic  mitochondrial  alternative oxidases (Roberts  et al.,  2004; 
Williams et al., 2010).
A  particularly  popular  and  adaptable  program  for  generating  both  multiple 
alignments and phylogenetic trees is ClustalX (Thompson et al., 1994), which allows the 
user to stipulate which scoring matrices to use for alignments and tree-building. This is 
particularly useful when analysing distantly related sequences, where certain matrices (such 
as  BLOSUM50  and  BLOSUM40)  are  specifically  designed  to  accurately  align  more 
distantly related sequences (Henikoff and Henikoff, 1993).
3.1.3 Previous models of the alternative oxidase
There have been two previous attempts to model the alternative oxidase. In 1995 
Moore  et al. proposed a model in which the active site was located at the centre of four 
small helices, with two transmembrane helices anchoring the molecule to the membrane 
(Figure 1.5a). The second model, generated by Andersson and Nordlund (1999) and later 
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refined by Berthold et al. (2002), proposed instead a four helix bundle acting as a scaffold 
to the active site; by contrast the attachment to the membrane was not via transmembrane 
helices but by a shorter helix laying parallel to the lipid layer rather than perpendicular to it 
(Figure 1.5b). The second model is accepted as the most accurate to date. The two models 
were  derived  using  different  methods.  In  the  former,  information  from hydrophobicity 
plots, sequence alignment and identification of known iron-binding motifs were combined 
in  a  knowledge-based  approach  to  model  the  AOX  without  a  template.  In  the  latter, 
homology modelling was used instead, with model evaluation based on existing knowledge 
of the protein.  In between the publication of the first  model  and the conception  of the 
second, more sequences were made available of both alternative oxidase proteins and diiron 
carboxylates, on which the second model was based.
3.1.4 In silico approaches to modelling proteins with unknown structure
When attempting to predict or model the structure of a protein of novel or unknown 
structure,  there  are  several  approaches  that  can  be  taken.  Ideally,  as  many  as  possible 
should be pursued and the results  compared in order to select the most accurate model 
based on both statistical analysis and whether the model compares favourably to existing 
experimental data. Of particular relevance to this project are knowledge-based approaches 
(such as secondary structure prediction), homology modelling and threading.
3.1.4.1 Prediction of secondary structure
Prediction  of  secondary  structure  from sequence  data  was  first  explored  in  the 
1960s.  For example,  Guzzo (1965) noted the recurrence of certain  amino acid residues 
(namely proline, gluatmic acid, aspartic acid and histidine) within structurally-characterised 
helical regions of myoglobin and alpha- and beta-haemoglobin. It was suggested that the 
occurrence of these residues in sequence data may be useful in predicting the nature of 
local secondary structure from a protein sequence (such as where the helices begin and end, 
for example). A notable early example which both expanded upon and improved Guzzo’s 
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work, whilst taking into account critical analysis from Prothero (1966), was the prediction 
of alpha-helical regions within proteins (cf Kotelchuck and Scheraga, 1969). Additionally, 
the prediction method incorporated early theoretical work from Zimm and Bragg (1959) 
regarding the physical transition that polypeptides undergo when shifting from random coil 
structures to alpha-helical structures and the implication of this theory to the formation of 
secondary structure. The linking of the Zimm-Bragg coil-helix transition theory to specific 
amino acids  involved in structure determination was a very important  step towards the 
modern structure prediction algorithms in use today.
Early  secondary  structure  algorithms  created  by  Chou  and  Fasman  (1974)  and 
Garnier et al. (1978) utilised the quantified propensity for each amino acid to be involved in 
any  given  secondary  structure  element,  although  the  calculation  was  implemented 
differently in both algorithms. As the number of structures in databases have increased, 
along with  computing  power,  prediction  algorithms  have  evolved and improved.  Some 
more recent approaches to the prediction of secondary structure such as PSI-PRED (Jones, 
1999; Buchan et al., 2010) and PHD (Rost and Sander, 1993) utilise feed-forward artificial 
neural networks to refine results and improve accuracy. Others, such as the PredictProtein 
(Rost et al., 2004) and Jpred3 (Cuff et al., 1998; Cole et al., 2008) servers apply multiple 
algorithms to the sequence of interest,  after aggregating information from structural and 
sequence databases based on sequence similarity. Reported accuracy of modern algorithms 
varies (see Section 3.1.4.4 below); for novel proteins and those which are underrepresented 
in the database however, accuracy may be lower than expected compared to proteins where 
many homologous sequences and structures are known and defined.
3.1.4.2 Homology modelling
Building a three-dimensional model of a protein of unknown structure is beyond the 
scope of secondary structure prediction algorithms. In order to generate a coordinate map 
for the atoms in a protein, protein structures with sequences of acceptable similarity can be 
used as templates  in  the process of homology modelling.  This  concept  is  based on the 
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recognition  that  whilst  protein  sequences  from a  common  ancestor  mutate  and  evolve 
differently, structure often remains conserved (Chothia and Lesk, 1986; Martí-Renom  et  
al., 2000). A comprehensive comparison of how much sequence similarity is required to 
guarantee identical structures in any two given sequences (Sander and Schneider, 1991) 
revealed  that  the  similarity  threshold  was  length-dependent,  with  longer  sequences 
requiring less similarity than shorter sequences. The resulting Sander-Schneider threshold 
states  that  at  least  25%  identically  aligned  residues  must  exist  across  sequences  80+ 
residues in length in order to confidently state that the fold (tertiary structure) will be the 
same.
Therefore,  the  first  stage  of  homology  modelling  is  the  selection  of  a  suitable 
template  sequence with greater  than 25% similarity  to the target  sequence of unknown 
structure.  This  can  be  undertaken  by  the  user  through  manually-evaluated  multiple 
sequence alignments performed with programs such as ClustalX (Jeanmougin et al., 1998) 
using sequences identified after execution of a BLAST search (or similar) and retrieved 
from  databases  such  as  UniProt  or  GenBank  (http://www.ncbi.nlm.nih.gov/genbank/). 
Ideally,  the sequence with the lowest E value and highest  similarity  should be chosen, 
although  modelling  one  protein  on  several  similar  proteins  provides  the  user  with  the 
opportunity to  select  the most  accurate  model.  Alternatively,  a template  can be chosen 
using web-based interfaces such as SwissModel (http://swissmodel.expasy.org/; Schwede 
et  al.,  2003)  and  HOMA (http://www-nmr.cabm.rutgers.edu/HOMA/;  Srinivasan  et  al., 
1993),  which perform the multiple  alignment  and sequence-retrieval  automatically  with 
minimal user input.
After suitable template sequences have been chosen, models can be built. During 
this  process,  the atoms of the residues in  the target  sequence are overlaid,  segment  by 
segment, onto the atoms of the template structures, to create a set of Cartesian coordinates 
for  the  target  sequence.  Areas  with  particularly  low  similarity  to  the  template  or  few 
structural templates, such as loop regions, require careful consideration when modelling. 
Programs such as MODELLER (Sali  and Blundell,  1993), for example,  use libraries  of 
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known loop sequences and structures to select the most appropriate loop structure, taking 
account  of  the  spatial  constraints  of  both  the  surrounding  structure  and  the  loops 
themselves.
Following its generation, the model must be evaluated. In order to evaluate a model, 
the  energy  required  for  the  protein  to  exist  in  that  particular  conformation  must  be 
calculated  and  compared  to  other  possible  conformations.  Model  accuracy  may  be 
determined statistically;  for example the ProSA algorithm (accessible via a web server, 
ProSA-web:  https://prosa.services.came.sbg.ac.at/prosa.php; Wiederstein and Sippl, 2007) 
provides a measure of structure or model quality given its atomic coordinates, in the form 
of  a  standard  deviation-derived  z-score.  In  order  to  generate  a  z-score,  the  algorithm 
calculates  an approximation  of the potential  mean force (PMF) for a protein given the 
distance between all pairs of Cα atoms (Sippl, 1990). The z-score in this case essentially 
represents  the  deviation  of  the  energy  distribution  for  the  uploaded  protein  from  the 
theoretical energy distribution of the same protein were it in a random conformation (Sippl, 
1993). The z-score for the uploaded protein can then be compared to z-scores calculated for 
all current protein structures in the PDB (Wiederstein and Sippl, 2007), thus allowing the 
user to assess whether the z-score of the uploaded protein is within an acceptable range of 
z-scores for other proteins of known structure and similar size.
3.1.4.3 Threading
Protein threading is  an alternative approach to homology modelling  in instances 
where less than 25% sequence similarity exists between the target and template sequence. 
Based on  fold-recognition,  threading  algorithms  initially  construct  multiple  alignments, 
comparing  the  sequence  of  unknown  structure  to  those  in  the  databases  with  known 
structure.  The sequence of unknown structure is  then threaded onto existing  structures, 
residue by residue, often with iterative refinement. The added advantage of threading over 
homology  modelling  is  that  multiple  structures  are  compared,  as  opposed  to  single 
templates  chosen  by  the  user  in  homology  modelling.  Examples  of  popular  threading 
57
algorithms include Phyre2 (Kelley and Sternberg, 2009), RaptorX (Peng and Xu, 2011; 
Källberg  et al., 2012) and HHPred (Söding, 2005; Söding  et al., 2005), all of which are 
available freely via online servers (see Section 3.2.4 below for URLs). The resulting model 
may be evaluated using the same software as for homology models, such as ProSA-web.
3.1.4.4 Limitations and evaluation of structure prediction and protein modelling
Whilst predicting secondary and tertiary structure is a useful tool when investigating 
a protein of unknown structure, the techniques used are not without limitations (Wallner 
and Elofsson, 2005; Ginalski, 2006). The number of sequences available in databases has 
increased  significantly  in  the  last  decade  due  to  improvements  in  DNA  and  protein 
sequencing, but some classes of protein remain under-represented. As such, training sets for 
automated  multi-template  secondary  structure  predictions  (PHD  and  PSI-PRED,  for 
example) are likely to biased towards classes of proteins which are well-represented in the 
databases. Similarly,  with homology and threading modelling techniques,  novel proteins 
with no close relatives are unlikely to be modelled accurately. This limitation is particularly 
relevant to proteins such as the alternative oxidase, where only the structures of distant 
relatives are available. The only solved structure in the alternative oxidase family is that of 
TAO  (PDB  code  3VV9,  Shiba  et  al.,  2013).  In  order  to  encourage  improvements  in 
prediction and modelling reliability and accuracy, projects such as the Critical Assessment 
of Techniques for Protein Structure Prediction (CASP,  http://predictioncenter.org/; Moult 
et al., 1995) allow for the overall performance of different approaches to be established. 
This  information  is  particularly  useful  for  those  carrying  out  structure  prediction  and 
modelling,  as  it  highlights  the  limitations  of  the  techniques  and  allows  for  objective 
appraisal of predicted structures and generated models.
3.1.5 Docking
Molecular  docking is  the  process  by which the  likelihood of  a  receptor  (R,  i.e. 
protein)  and  ligand  (L,  i.e.  substrate)  forming  an  energetically  stable  –  and  therefore 
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favourable – interaction is determined. In addition to calculating the probability of a ligand-
receptor  interaction,  cautious  interpretation  of  the  results  of  a  docking  algorithm  may 
suggest the strength of the interaction. The extent to which the ligand and receptors change 
conformation in order to achieve the overall best fit is known as the ‘induced fit’ model. 
While molecular docking is particularly useful in the field of rational drug discovery, in this 
project it is a useful tool to assess predicted substrate-binding sites.
There are two main methods by which calculations pertaining to receptor-ligand 
interactions  may be performed;  shape complementarity  or by simulation of the docking 
process. In the former, the proposed binding surface of the receptor is given informational 
descriptors  based  on  the  solvent-accessible  surface  area  (ASA).  The  ASA  is  given  in 
Angstroms squared (Å2) and derived using information and algorithms first developed in 
the 1960s and 1970s (cf Bondi, 1964; Lee and Richards, 1971; Shrake and Rupley, 1973) 
which used experimentally obtained crystallographic data to determine the van der Waals 
radii  and  therefore  surface  area  of  residues  and  atoms  within  proteins.  Following 
calculation of ASA, the ligand is given descriptors based on its similarity to the receptor 
molecule when both molecules are rigid (Shoichet et al., 1991; Shoichet and Kuntz, 1991; 
Helmer-Citterich and Tramontano, 1994). This approach requires assumptions to be made 
about the molecules; namely that they are in a fixed and rigid state, and that the van der 
Waals radii/surfaces are accurate from predictions. Therefore, whilst the output from these 
docking predictions can be obtained with relative speed, they may not accurately reflect the 
changes in conformation that take place during the process of ligand-receptor interaction, as 
both molecules adopt minimal-energy conformations to allow an energetically favourable 
interaction that will not immediately decay.
The second approach is that of simulating the interaction process, starting with the 
ligand and receptor separated by a physical distance. A finite number of changes are then 
made to the conformation and physical proximity of the ligand and the receptor; after each 
such  change  (or  move),  the  energy  in  the  system (i.e.  between  the  two  molecules)  is 
calculated. When the combination with the tightest fit and lowest energy is observed, then 
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the  state  of  induced  fit  has  been  achieved.  As  a  result,  this  process  is  far  more  time 
consuming, since a very large energy landscape consisting of many possible conformations 
needs  to  be  calculated  and matched.  There  are  many thousands of  degrees  of  freedom 
generated when both receptor and ligand are flexible, which requires far more computing 
power to solve than docking simulations where both molecules are rigid. Many docking 
programs  are  available  as  web-based  interfaces,  such  as  Hex  (http://hexserver.loria.fr/; 
Macindoe  et  al.,  2010)  and  GRAMM-X 
(http://vakser.bioinformatics.ku.edu/resources/gramm/grammx; Tovchigrechko and Vakser, 
2006) as well as plug-ins for molecular visualisation programs such as AutoDock (Morris 
et al., 2009) which can be used with PyMOL.
3.2 Methodology
3.2.1 Sequence analysis
All protein sequences were taken from the UniProtKB database. Suitable candidates 
for alignment of the alternative oxidase family were selected using a BLAST search based 
upon  the  S.  guttatum alternative  oxidase  protein  sequence  (UniProt  accession  number 
P22185). FASTA protein Sequences were then retrieved via the UniProt server interface. 
Alignments  were  performed  using  ClustalX  (Thompson  et  al.,  1994)  and  evaluated 
manually. When aligning the diiron carboxylate sequences to the  S. guttatum alternative 
oxidase, the alignment was performed manually. The alignment files (in *.aln format) were 
viewed and edited using either Clustal X or SeaView (Gouy et al., 2010).
3.2.2 Phylogeny
Alignments produced and refined using ClustalX were converted into bootstrapped 
phylogenetic tree files (in *.phb format), using the neighbour joining method. Trees were 
viewed  in  NJ  Plot  (Perrière  and  Gouy,  1996)  and  PHYLIP  via  the  Mobyle  server, 
http://www.mobyle.pasteur.fr/ (Felsenstein,  1989).  In  order  to  construct  a  reliable 
phylogenetic  tree, sequences with sufficiently  high sequence homology were indentified 
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using a  BLAST search.  In the interest  of maintaining  a  balance  between plants,  fungi, 
parasites and prokaryotes a limit of 10 was placed on the number of sequences used from 
any given phyla.
3.2.3 Homology modelling
Homology modelling was carried out using the Swiss-MODEL modelling server 
(http://swissmodel.expasy.org/).  All  features  were  used,  including  automated  mode  and 
template identification. The S. guttatum amino acid sequence (P22185) was modified by the 
removal  of residues 1-63, which are not present  in the final  expressed protein.  Models 
based directly on Δ9-desaturase (P22337; 1OQ4; chain A) and TAO (Q26710; 3VV9; Shiba 
et al., 2013) and structures were generated in alignment mode after manual alignment of 
sequences in SeaView. 
3.2.4 Threading
Threading was carried out using the programs and servers listed below in Table 3.1, 
using a truncated S. guttatum sequence lacking residues 1-63 as described above. The user-
defined parameters are stated where they differ from default parameters.
3.2.5 Model evaluation
Models were evaluated quantitatively using the ProSA-web server (Wiederstein and 
Sippl, 2007), from uploaded *.pdb files.
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Program/server User-defined parameters
Phyre2 (Kelley and Stenberg, 2009)
www.sbg.bio.ic.ac.uk/phyre2/
Intensive mode
RaptorX (Peng and Xu, 2011; Källberg et al., 
2012)
http://raptorx.uchicago.edu/
Multi-template refinement
BioSerf, including GenThreader (Jones, 1999) and 
MODELLER (Sali and Blundell, 1993)
http://bioinf.cs.ucl.ac.uk/bio_serf/public_job/
None available
HHPred (Söding, 2005; Söding et al., 2005)
http://toolkit.tuebingen.mpg.de/hhpred
Current and “on hold” PDB libraries
Table 3.1 – Threading software used, with parameters changed from default.
3.2.6 Docking
Docking of a ubiquinone-1 molecule to the alternative oxidase homology model 
based on TAO was completed using the Hex server (Macindoe et al., 2010) and AutoDock 
as a PyMOL plugin (Morris et al., 2009). Few user-defined parameters were available via 
the  Hex  server,  so  all  but  the  correlation  type  (which  was  changed  to  “shape  and 
electrostatic”)  were  left  on  their  default  settings.  The  AutoDock  grid  was  adjusted  to 
contain the whole monomeric protein.
3.2.7 Generating a dimeric AOX model containing a diiron active site
Using the same method as described in Section 3.2.3 above, a second homology 
model of S. guttatum AOX based on TAO was generated using the coordinates of the chain 
forming the second monomer (chain A) in the dimeric  TAO crystal  structure.  The two 
homology  models  were  then  merged  into  a  single  PDB file.  In  a  similar  manner,  the 
coordinates for the four iron ions (two per monomer) were taken from the TAO PDB file 
and merged with the dimer PDB file. To assess the validity of both the dimer PDB and 
iron-containing models, each model was aligned to the TAO crystal structure.
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3.2.8 Building a membrane-AOX model
The  dimeric  homology  model  of  S.  gutattum based  on  the  TAO  template  (as 
described above in Sections 3.2.3 and 3.2.7) was solvated using the solvate command in 
Visual  Molecular  Dynamics  (VMD;  Humphrey  et  al.,  1996).  Water  molecules  were 
removed above the Z plane where the membrane was to be placed. A membrane patch was 
built using the membrane modelling script in VMD and the dimer model was placed into 
the  membrane  according  to  the  solvation  limits  generated  previously  to  produce  a 
membrane-AOX model. Finally, using the beta-field command in VMD, lipid molecules 
within 0.6Å of the protein were marked and removed from the model.  The model  was 
solvated once more and any water molecules which appeared between the membrane and 
the protein were removed.
3.2.9 Visualisation
All molecular visualisation was performed using DeepView (Version 4.1; Guex and 
Peitsch, 1997) and PyMOL (Version 1.4.1, Schrödinger, LLC). 
3.3 Results
3.3.1 Sequence analysis
A multiple alignment was constructed using all 606 sequences identified during an 
automated BLAST search using the  S. guttatum AOX sequence (excluding any E values 
above 1) against the UniProt database. A truncated version is shown overleaf in Figure 3.1.
3.3.2 Phylogeny
Phylogenetic trees were constructed from manually reviewed multiple alignments 
and assessed for accuracy based on the closeness with which species clades were formed. 
An example bootstrapped tree is shown below in Figure 3.2.
1 4 5 632
343141
Figure 3.1 – A multiple sequence alignment of alternative oxidase sequences. This Figure shows a truncated multiple alignment of alternative oxidase sequences. UniProt Accession numbers are given along with species names 
(see Appendix 1 for a list of all sequences used). TP = thermogenic plant, NP = non-thermogenic plant, A = amoebae, F = fungi, PB = proteobacteria, Helices are indicated by numbered cylinders, based on the S. guttatum 
alternative oxidase homology model using TAO as a template. Red arrows indicate the four highly conserved iron-binding Glu residues (178, 217, 268 and 319) and blue arrows indicate the 2 highly conserved His residues (220 
and 322) which form the secondary iron ligation sphere. The region highlighted by the blue bracket indicates the previously identified His-Arg pair involved in quinone-binding and the residues highlighted by the green bracket 
indicates the three-residue region thought to be responsible for determining pyruvate-sensitivitiy (cf Crichton et al., 2005; Ito et al., 2011). The yellow diamonds indicate the potential dimer interface residues as identified in 
Section 5.3.3 and listed in Table 5.8.
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3.3.3 Homology modelling
Two homology models were successfully produced;  one based directly on the Δ9-
desaturase structure (1OQ4) and one based on the recently-solved TAO crystal structure 
(Shiba et al., 2013). Both models are illustrated in Figures 3.3a and 3.3b respectively. PDB 
coordinate files for both models can be found on the compact disc in the back of this thesis  
in  the  “Homology  Models”  directory;  the  homology  model  of  S.  guttatum alternative 
oxidase using TAO as a template is named “HM1.pdb” and the homology model of  S. 
guttatum alternative oxidase based on Δ9-desaturase is named “HM2.pdb”. For each model 
z-scores as determined by ProSA-web are shown below in Table 3.2, along with QMEAN4 
scores generated by the Swiss-MODEL server. The z-scores for both models are within 
range of z-scores for other  proteins  of similar  length and known structure (see Section 
3.1.4.2). Two graphical representation of this agreement (as provided by the ProSA-web 
analysis output) can be found in Appendix 1 for reference.
An overlay of the homology model based on Δ9-desaturase and the homology model 
based  on  TAO  is  shown  below  in  Figure  3.4a,  and  both  homology  models  and  their 
respective templates are shown below in Figure 3.4b.
The  distance  between  the  6  iron-binding  residues  (Glu178,  217,  268,  319  and 
His220, 322) was measured in both homology models and is shown below in Table 3.3 
below.
Model template z-score QMEAN4 score
Δ9-desaturase (chain A) -1.41 0.14
TAO (chain B) -3.93 0.25
Table 3.2 – Quantitative analysis of two S. guttatum homology models. This Table demonstrates the z-
score (ProSA-web) and QMEAN4 score (Swiss-MODEL) for each homology model.
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Figure 3.2 – Phylogenetic tree of several AOX sequences. This Figure shows a small bootstrapped, 
unrooted phylogenetic tree generated by ClastalX (neighbour joining method). Clades are indicated with 
square brackets, with the exception of N.nucifera, which is a thermogenic plant (marked with an asterisk).
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Figure 3.3a – Homology model of S. guttatum alternative oxidase using Δ9-desaturase (1OQ4) as a 
template. Helices previously predicted to be membrane-associated (cf Andersson and Nordlund, 1999) are 
shown in the grey box in the top image.
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Figure 3.3b – Homology model of S. guttatum alternative oxidase using TAO as a template. Helices 
predicted to be membrane-associated are shown in the grey box in the top image.
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Figure 3.4a – An overlay of the homology models based on Δ9-desaturase (grey) and TAO (rainbow).
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Figure 3.4b – A comparison of each template used to generate homology models of S. guttatum AOX 
and the homology model created. This Figure shows: A – Δ9-desaturase (1OQ4 chain A); B – the S. 
guttatum homology model based on Δ9-desaturase; C – TAO (chain B); and D – the S. guttatum homology 
model based on TAO. All orientations show the length-ways view through the four-helix bundle coordinating 
the diiron active site (red spheres in A and C).
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Residue pairs Distance in Å between residue pairs
Δ9-desaturase-based TAO-based TAO structure
E178 → E217 3.4 2.7 3.6
E178 → H220 3.6 3.0 3.0
E178 → E268 8.0 6.7 7.3
E178 → E319 4.5 4.9 3.8
E178 → H322 7.8 7.7 8.1
E217 → H220 3.4 3.3 4.3
E217 → E268 3.8 4.0 3.7
E217 → E319 4.6 3.1 4.1
E217 → H322 5.8 4.8 3.1
H220 → E268 3.4 7.7 6.6
H220 → E319 4.6 4.0 2.6
H220 → H322 7.3 5.4 5.3
E268 → E319 5.6 3.4 3.4
E268 → H322 4.8 6.4 3.2
E319 → H322 4.8 5.7 5.1
Fe → Fe - 3.1 3.1
Table 3.3 – A comparison of residue-to-residue distances in the two S. guttatum homology models and 
the TAO structure. This Table lists the distances between the 6 iron-binding residues (Glu178, 217, 268, 319 
and His220, 322) and iron ions in both the Δ9-desaturase-based and TAO-based homology models alongside 
the same distances observed in the TAO structure (PDB code 3VV9, Shiba et al., 2013).
3.3.3.1 Generation of a dimeric AOX model containing diiron centres
Alignment and overlay of the generated dimeric AOX model (containing one diiron 
centre per monomer, see Section 3.2.7) with the dimeric TAO template was absolute, with 
no deviations between the structures. The dimeric S. guttatum AOX model is shown below 
in Figure 3.5. A PyMOL session file can be found on the CD in the back of this thesis 
containing this generated structure (“Dimer.pse”).
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3.3.3.2 Generation of a membrane-AOX model
The dimeric membrane-AOX model is shown below in Table 3.6a. The protein lies 
approximately 14Å into a single leaflet of the membrane. Figure 3.6b shows the surface of 
the  dimeric  homology  model  with  hydrophobic  residues  highlighted  in  red  (left)  and 
aromatic residues identified as possibly membrane-interacting are shown in green (right); 
these Figures were generated in an effort to define how deep into the membrane the protein 
should be placed. The aromatic residues shown in Figure 3.6b are listed in Table 3.4 and 
may  be  responsible  for  membrane-binding  in  S.  guttatum alternative  oxidase.  PyMOL 
session files can be found on the CD in the back of this thesis containing the dimeric  S. 
guttatum alternative oxidase protein in a membrane patch (“Membrane.pse”).
Residue number
W160
F165
F166
W232
Y233
F259
Table 3.4 – A list of the aromatic residues predicted to interact with the membrane in S. guttatum AOX. 
The residues correspond to the model shown above in Figure 3.6b.
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Figure 3.5 – A representation of the dimeric S. guttatum homology model. The iron ions of the diiron 
centres are shown in red.
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Table 3.6a – The dimeric S. guttatum homology model embedded in a membrane patch. Phsopholipids 
are shown here in grey with water molecules at the membrane surface shown in red. The iron ions of the 
active site are shown as red spheres.
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Figure 3.6b – A surface representation of the S. guttatum dimeric homology model. Hydrophobic 
residues are shown in red (left) and aromatic residues are shown in green (right). The dashed white line 
indicates the proposed placement of the protein in the membrane with C and M indicating the cytosol and 
membrane sides respectively. The bottom two images represent the portion of the protein embedded in the 
membrane as viewed from inside the membrane. The orientations of the models shown here are the same as 
those shown in Figure 3.5.
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3.3.4 Threading
Results from each threading algorithm are shown below in Table 3.5.
Program/server Templates identified
Phyre2 Identified 73 putative templates; two 
consensus models built
RaptorX Identified 39 putative templates
BioSerf/GenThreader/MODELLER Unable to identify suitable template
HHPred Unable to identify suitable template
Table 3.5 – A list of models generated from each threading algorithm.
3.3.4.1 Threading – RaptorX and Phyre2
RaptorX identified 39 possible templates on which S. guttatum was then modelled. 
None  of  the  models  produced replicated  the  necessary  physical  proximity  of  the  iron-
binding residues (Glu178, 217, 268, 319 and His220, 322; approximate ideal proximity was 
based on Table 3.3 above).  Phyre2 identified 73 templates  on which  S. guttatum AOX 
could be modelled and subsequently two consensus models were produced. In one model, 
the aforementioned  iron-binding residues  were  not  proximal  to  one another,  but  in  the 
second model (shown in Figure 3.7 below) 5 of the 6 residues were proximal (based on 
Table 3.3) with Glu178 more than 10Å away from all but one of the other 5 residues.
3.3.5 Docking
Use  of  the  AutoDock PyMOL plugin  resulted  in  the  generation  of  10  possible 
substrate-protein interaction conformations, with free energy states between -6.33kcal/mol 
and -4.23kcal/mol. The docking grid encompassed the whole monomeric homology model 
(Figure 3.3b), but all ten substrate-protein interactions were predicted to occur in the space 
between helices one and four. The two positions closest to the active site are shown in 
Figure 3.8 below in green (left, -5.38kcal/mol free energy on binding and 9.2Å from the 
iron centre) and yellow (right, -4.88kcal/mol free energy on binding and 7.7Å from the iron 
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centre).  The highest-scoring position (-6.33kcal/mol  free energy on binding)  lies  12.3Å 
from the iron centre.
A possible substrate-binding site (Figure 3.9, left) has been suggested as a result of 
docking, found between the membrane-associated helices one and four. A PyMOL session 
file (“Cavities.pse”) can be found on the CD at the back of this thesis.
Figure 3.7 – A representation of the consensus model generated by Phyre2.
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Figure 3.8 – A diagrammatic representation of the potential docking of ubiquinol-1 in S. guttatum AOX 
by AutoDock. The two docked molecules (in green, left and yellow, right) represent the two positions closest 
to the diiron catalytic centre (9.2Å and 7.7Å respectively). The six iron-binding residues (Table 3.3) are 
shown in blue with the diirons shown in red.
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Figure 3.9 – A diagrammatic comparison of two possible substrate binding sites. One possible substrate-
binding cavity identified through docking with Autodock (left, in magenta) is compared to the inhibitor-
binding site identified by Shiba et al. (2013; right, in blue).
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3.4 Discussion
3.4.1 Multiple alignment and phylogenetic analysis
In  agreement  with  previous  findings  cf Moore  et  al.,  1995  and  more  recently 
Williams  et al., 2010), there is a large amount of conservation observed across proposed 
helical regions when large numbers of alternative oxidase sequences are aligned (Figure 
3.1). The 6 iron-binding residues (Glu178, Glu217, His 220, Glu268, Glu319 and His322) 
are wholly conserved in all  alternative oxidase sequences to date. Sequence variation is 
observed outside of the helical regions, whilst residues directly up- and down-stream of the 
6 iron-binding residues appear to be mostly conserved. Interestingly, there is a high level of 
variation  in  the  region  previously  identified  as  responsible  for  determining  pyruvate 
sensitivity which is in agreement with previous findings (Crichton et al., 2005; Carré et al., 
2011; Ito et al., 2011). 
When 100 of the aligned sequences with greater  than 60% similarity  were used 
(distributed as evenly as possible between plant, fungi, bacterial and protists) to create a 
bootstrapped phylogenetic tree, many of the species did not form consistent clades. This 
suggests that there were errors in the initial  iterations of tree construction, perhaps as a 
result of a relatively low similarity threshold applied across a large number of sequences. 
By gradually reducing the number of sequences, trees with more appropriate clade patterns 
could be generated, such as the bootstrapped tree shown above in Figure 3.2. Interpretation 
of the tree suggests that the modern thermogenic plants found in Australasia (S. renifoli and 
N. nucifera) diverged from the common ancestor less recently than the European araceae 
(A. conicinna,  A. maculatum and  D. vulgaris), with the  S. guttatum, native to Asia and 
Africa diverging after the Australasian species, but before the European species. However, 
in  contradiction  with  previous  phylogenetic  analyses  of  alternative  oxidase  sequences 
Roberts  et al.,  2004; Williams  et al.,  2010), it  appears that the AOX proteins found in 
protist parasites (Trypanosoma and Cryptosporidium species) may be more closely related 
to prokaryotic AOX proteins than to plant AOX proteins; moreover, the fungal and parasite 
sequences  are  more  distantly  related  to  the  proteobacterial  sequences  than  the  plant 
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sequences are to the proteobacterial sequences. Because the sequences were selected for 
similarity  and  familiarity,  it  is  accepted  that  there  is  inherent  bias  and  therefore 
interpretations are made with caution.
3.4.2 Homology modelling vs. threading
Several  models  were  produced  using  both  homology  modelling  and  threading. 
Empirically, the z-scores for the two homology models (Table 3.2, Figures 3.3a and 3.3b) 
are within an acceptable range (Appendix 1) and the arrangement of the six iron-binding 
residues  in  three  dimensions  is  consistent  with previously  proposed alternative  oxidase 
iron-binding models (Table 3.3).  By contrast,  the QMEAN4 scores (Table 3.2) are low 
(0.14 for the homology model based on  Δ9-desaturase  and 0.25 for the homology model 
based on TAO) on a scale where 0 is indicative of a poor model, and 1 is indicative of a  
very good model. However, low QMEAN4 scores are not unusual for membrane proteins, 
which are under-represented in the databases used as training sets for algorithms such as 
SwissMODEL  (Benkert  et  al.,  2011).  Furthermore,  accurate  calculation  of  energy 
distribution in membrane protein models is difficult when the molecules of the membrane 
are not  included in the dataset,  so comparison to  the energy distribution  of  other  non-
membrane-associated protein models of a similar sequence length is not favourable.
A manual assessment of the models shows no disallowed backbone conformations. 
Empirically and heuristically, the homology model based on the TAO structure must be 
selected as the most accurate model, as there is the greatest degree of sequence similarity 
between the target and the template (40%). Models generated using threading techniques 
were of poorer quality,  as none managed to satisfy the proximity required of the iron-
binding residue positions relative to one another in the final structure. This is likely to be 
due to  poor  template  identification.  Even using  a  scoring matrix  such as  BLOSUM40, 
which is particularly useful for aligning distantly related sequences, did not lead to any 
templates on which an accurate model could be based. This is a result of poor sequence 
similarity between the alternative oxidase and the most closely related family, the diiron 
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carboxylates  (<30%).  The  accepted  iron-binding  motifs,  (ExnExxH)2,  are  distributed 
throughout the entire sequence and even with iterative alignment the motifs from several 
diiron carboxylate sequences are not aligned with those in the alternative oxidase sequence 
using  a  BLOSUM40 scoring  matrix.  At  the  time  of  writing,  the  TAO structure  is  not 
available through any of the databases that the threading software discussed herein search, 
so it is not possible to definitively state whether inclusion of the structure would improve 
the results  of the threading.  However,  given that the similarity  of the two sequences is 
above  the  25%  Sander-Schneider  threshold,  there  is  a  reasonable  probability  that  the 
threading process would be improved significantly.
3.4.3 Validity, variations and value of the Δ9-desaturase and TAO homology models
Whilst modelling the alternative oxidase on Δ9-desaturase is inherently inaccurate 
due to the low sequence similarity, it was the best model available at the time – especially 
taking into account the even greater degree of dissimilarity between the alternative oxidase 
and the other diiron carboxylates (10-20% similarity). This model was used extensively to 
construct crude representations of both the active site and other important regions such as 
the quinone binding pocket (cf Albury et al., 2009). The limitations of the model based on 
Δ9-desaturase were accepted; namely the lack of appropriate membrane associated helices 
and the low accuracy in the loop regions, where the template-target sequence similarity was 
<1%. Nevertheless, when used with a caveat of empirical limitation, it was a useful tool for 
physical visualisation of theoretical concepts such as the impact of residue mutation in a 
three-dimensional space. When the TAO structure was made available before publication, 
the quality of the working alternative oxidase model improved, especially when modelling 
virtual mutations and proposing a physical mechanism for the alternative oxidase catalytic 
cycle  (Moore  et  al.,  2013)  –  which  may then  be presented  with an  increased  level  of 
confidence.
As illustrated in Figure 3.4a above, there is one important difference between the 
homology model based on the Δ9-desaturase and TAO templates; the presence of two  extra 
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helices in the TAO-based model. All previous models of the alternative oxidase predicted 
the presence of four longer helices, with one helix approximately half the length of the 
others, which was thought to anchor the protein in the membrane in a manner similar to that 
of prostaglandin H2-synthase (Andersson and Nordlund, 1999). The extra helices present in 
the TAO structure, lie below the main four-helix bundle and do not constrain the active site, 
nor contain any of the iron-binding residues; as such, the previous prediction of a diiron 
active site coordinated by a four-helix bundle is accurate. The role of the extra helices has 
not been verified experimentally, although distribution of several aromatic residues (Table 
3.4) would indicate that helices 1 and 4 are serving as an anchor to keep the alternative 
oxidase  within  the  membrane.  For  reference,  an  overlay  of  the  model  based  on  Δ9-
desaturase and the model based on TAO are illustrated in Figure 3.4a. While the main areas 
of overlay deviation occur in the unstructured loop regions, the placement of the helices 
relative to one another is also somewhat dissimilar. Furthermore, the distances between the 
iron-binding residues for each homology model (Table 3.3) could perhaps indicate that the 
diiron centre observed in the diiron carboxylate family is not identical to the diiron centre 
of the alternative oxidase family. This is perhaps some novel evidence that the alternative 
oxidase, initially placed in the diiron carboxylate family (cf Berthold et al., 2002) may not 
belong fully to that family. In fact, the alternative oxidase family has recently recognised 
officially as a family in its own right (EC 1.10.3.11).
It is worth noting that despite previous predictions that the alternative oxidase may 
have β-sheet or turn secondary structure elements (cf Moore and Siedow, 1991, and Table 
5.8, Chapter 5), the TAO crystal structure does not have any β secondary structure elements 
at  all.  Since alpha helices  are  well  represented in the databases from which propensity 
scoring tables are generated (Chou and Fasman, 1974; Garnier et al., 1978), this is not the 
reason why the  predictions  have  been somewhat  inaccurate  in  the  past.  The degree  of 
variability in secondary structure predictions in Table 5.8 may indicate that the alternative 
oxidase  secondary  structures  potentially  contain  residue  sequences  that  are  somewhat 
atypical compared to other residue-structure correlations.
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3.4.4 Membrane-AOX model
In the membrane-AOX model (Figure 5.6) generated using VMD and PyMOL, the 
protein  has  been  placed  approximately  14Å into  the  membrane.  This differs  from the 
membrane-TAO model proposed by Shiba et al. (2013), in which the protein is placed 8Å 
into the membrane. Given the relatively even distribution of hydrophobic residues toward 
the  solvent  accessible  surface  of  both  TAO  and  the  homology  model  of  S.  guttatum 
alternative oxidase based on TAO, there is no clear indication from these residues where 
the protein should sit in the membrane. However, there is a very hydrophobic, surface-
accessible cavity in TAO – in which an ascofuranone-derivative molecule has been co-
crystallised in each of the four chains presented in the crystal structure – approximately 7Å 
above the membrane-solvent boundary. This cavity, which is also present in the TAO-based 
S.  guttatum homology  model  (Figure  3.9,  right),  could  potentially  allow  a  quinol-
homologue substrate to pass into it, would therefore perhaps be more likely found closer to 
the  membrane-solvent  interface,  rather  than  some  7Å  above  it.  In  light  of  this,  the 
membrane-AOX model developed as part of this project has been heuristically modelled to 
allow the solvent-accessible entrance to the cavity to be placed inside the membrane, rather 
than outside.
3.4.5 Docking
In addition  to  the hydrophobic  cavity  identified  in  the TAO crystal  structure,  a 
second possible substrate binding region has been identified (Figure 3.9) through molecular 
docking.  It  was  possible  to  model  the  interaction  between  the  alternative  oxidase  and 
ubiquinol in this proposed binding pocket. The simulated docking outcomes with the lowest 
energy scores (as illustrated above in Figure 5.6) all place the ubiquinone-1 molecule with 
the  quinone  ring  in  approximately  the  same  orientation  (parallel  to  the  membrane), 
suggesting perhaps that the substrate may be aligned as such in vivo. It is accepted that the 
accuracy of docking algorithms may decrease in the case of the alternative oxidase, as the 
binding site is likely to be embedded within the membrane  in vivo, but is partly solvent-
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exposed in the homology model. Therefore, calculated physical interactions (particularly 
electrostatic  and  hydrophobic  interactions)  may  not  be  as  realistically  calculated  as 
required. Bearing this limitation in mind, the outcome of the docking experiments is of 
interest  and would be useful for further refining the exact  substrate-residue interactions 
which take place in the substrate binding pocket.
Interestingly,  the  newly  identified  substrate  binding  pockets  do  not  appear  to 
incorporate any of the proposed quinone-binding motifs as suggested previously, such as 
the  HR  pair  (H261,  R262)  and  the  quinone-binding  triad  element  (LxxxHxxT, 
corresponding  to  L137,  H141  and  T144;  Fisher  and  Rich,  2000).  In  the  TAO-based 
homology model, the HR pair is greater than 5Å away from both of the proposed substrate 
binding  pockets,  and  the  triad  element  (L137,  H141  and  T144)  are  located  in  an 
unstructured  region,  the  position  of  which  varies  between  chains  in  the  TAO  crystal 
structure.  In light  of this,  the inclusion of the alternative  oxidase in  group of quinone-
binding proteins possessing the HR pair and triad element may need to be reconsidered.
3.4.6 Concluding remarks
It  has  been  possible  to  model  the  S.  guttatum alternative  oxidase  on  both  the 
distantly-related, diiron carboxylate Δ9-desaturase, and the more closely related member of 
the  alternative  oxidase  family,  TAO.  Whilst  using  TAO  as  a  template  for  homology 
modelling undoubtedly produces the most accurate outcome, the homology model based on 
Δ9-desaturase provided a useful tool in the absence of a more accurate model. In light of the 
two newly-identified  potential  substrate-binding  sites,  investigation  of  the  key residues 
within these sites should be carried out using mutagenesis studies to further elucidate the 
structure-function  relationship  of  these  regions.  The  presence  of  a  four-helix  bundle 
providing a scaffold from which iron-binding can take place had been previously predicted, 
and therefore remains an essential part of the model, whilst the presence of two membrane-
associated – and possibly substrate-associated – helices would suggest that the nature of the 
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membrane-protein  interaction  is  key  to  the  structure  and  function  of  the  S.  guttatum 
alternative oxidase.
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Chapter 4
Expression and purification of the alternative oxidase
4.1 Background
The aim of this part of the project was to define a protocol for the over-expression, 
solubilisation  and  purification  of  recombinant  S.  guttatum alternative  oxidase  in  a 
prokaryotic expression system. 
Alternative  oxidase  protein  has  been  extracted  from native  tissues  (cf Huq and 
Palmer, 1978; Berthold and Siedow, 1993; Affourtit and Moore, 2004), but the instability 
and short lifespan of the protein following liberation from the mitochondrial membrane (cf 
Moore and Siedow, 1991) limits the experimental scope of using protein isolated from such 
tissues.  Therefore,  in  order  to  conduct  experiments  where  stable,  long-lived  protein  is 
required, it has been necessary to implement the provision of alternative sources of AOX 
protein, specifically through recombinant protein expression. Previous attempts to express 
recombinant  alternative  oxidase  have  used  both  eukaryotic  (Albury  et  al.,  1996)  and 
prokaryotic (cf Kumar and Söll, 1992; Berthold et al., 2002; Kido et al., 2010) expression 
systems, in the form of Schizosaccharomyces pombe and E. coli respectively. The S. pombe 
expression  system  has  been  used  successfully  as  a  strain  for  production  of  mutated 
alternative oxidase proteins (Crichton  et al., 2010) in addition to wild-type  S. guttatum. 
This eukaryotic system is ideal for this expression to monitor activity, as the AOX protein 
product  is  targeted  to  the  inner  mitochondrial  membrane  and  expressed  functionally 
alongside the traditional respiratory chain complexes.
Whilst  the  S.  guttatum alternative  oxidase  has  been expressed  successfully  in  a 
eukaryotic  system,  extensive  expression  in  a  prokaryotic  host  has  not  been  previously 
attempted. Other AOX isoforms such as A. thaliana and T. brucei (cf Berthold, 1998; Fukai 
et  al.,  1999  respectively) have  been  expressed  in  prokaryotic  hosts  however  and  the 
86
protocols described have formed the basis for expression of S. guttatum AOX in specialist 
E. coli strains as described in this Chapter.
In order  to  ensure  a  reproducible  S.  guttatum recombinant  protein  yield  can  be 
achieved  using  a  prokaryotic  expression  system,  the  previously  described  expression 
protocols (Berthold, 1998; Fukai et al., 1999; Nihei et al., 2003) have been adapted where 
necessary to account for isoform-specific differences in protein behaviour. Furthermore, it 
was necessary to define solubilisation and purification protocols for the production of  S. 
guttatum recombinant alternative oxidase – which had not been attempted before.
4.1.1 Considerations for designing an expression and purification protocol
4.1.1.1 Expression strains – C41 and FN102
As  previously  stated,  a  protocol  for  expression  of  recombinant  S.  guttatum 
alternative oxidase in yeast has been successfully defined (Albury et al., 1996). However, 
the system was not designed to produce protein which can be readily purified. As a result,  
an additional system may be used to complement this eukaryotic system; namely the use of 
the gram-negative bacterium E. coli. Simple genetics and a short doubling time mean this is 
an ideal candidate for protein expression (cf. Russo, 2003; Terpe, 2006). Furthermore, if the 
recombinant alternative oxidase is targeted to the bacterial cytoplasmic membrane, it may 
be  separated  from  the  contents  of  the  cell  with  careful  application  of  cell  lysis, 
solubilisation and finally purification.
Expression  of  recombinant  protein  using  prokaryotic  systems  has  been  a  long-
established  method  for  the  bulk  production  of  proteins  of  interest  for  either  medical, 
industrial  or  research  purposes.  Much  of  the  early  development  of  this  technique  was 
carried out using  E. coli (cf. Cohen  et al., 1972; Morrow et al., 1974) and following the 
advancement of such protocols and techniques, there exists today a plethora of well-tested 
and  well-documented  prokaryotic  expression  systems  for  use  in  protein  expression 
experiments, such as for the over-expression of AOX. Some E. coli strains are particularly 
well-suited to expressing different classes of protein and for this project two strains were 
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chosen – one strain modified for the general over-expression of membrane proteins (C41), 
and the other a haem-deficient mutant strain (FN102) with fewer respiratory complexes 
than other E. coli strains.
Historically,  over-expression  of  membrane  proteins  in  standard  BL21  (DE3)/T7 
RNA  polymerase  systems  has  resulted  in  cell  death  due  to  over-expression,  causing 
undesirable effects such as membrane degradation (Dong  et al., 1995; Grisshammer and 
Tate, 1995). Similarly, over-expression of globular proteins has been linked to expression-
related toxicity (Studier et al., 1990; George et al., 1994) in the same system. Work carried 
out by Miroux and Walker (1996) aimed to identify E. coli strains which were capable of 
over-expressing membrane and globular proteins, without succumbing to the toxic effects 
associated  with  over-expression.  Through  numerous  rounds  of  over-expression  of  the 
membrane-spanning  oxoglutarate-malate  carrier  protein  in  BL21  (DE3),  Miroux  and 
Walker (1996) were able to isolate surviving cells, which they named C41, that were able 
to grow to high densities and express significant quantities of protein as inclusion bodies. 
Further rounds of over-expression of other membrane-bound proteins in the newly-selected 
C41 strain  indicated  that  the  strain  was capable  of  over-expressing  membrane proteins 
(such as the F1F0 subunit of ATPase, Arechaga et al., 2000) without falling prey to the toxic 
effects observed in the other BL21 (DE3) cell lines.
A second  E. coli strain known as FN102 was also chosen for this project, but for 
different  reasons.  When  expressing  recombinant  AOX  in  either  yeast  (S.  pombe,  as 
previously  described)  or  bacteria,  the  protein  is  targeted  to  the  membrane  and  is 
incorporated  as  a  functional  (unless  mutated;  see  Chapter  5)  protein.  As  a  result,  the 
recombinant protein works in tandem with the respiratory chain present in the organism – 
and this can be problematic when attempting to ascertain the proportion of activity of the 
cells that is a direct result of the alternative oxidase. Whilst a suitable solution has been 
developed in yeast systems (such as the use of complex-specific inhibitors during activity 
assays, Albury  et al., 1996), in bacterial systems (where more respiratory complexes are 
present naturally), the issue is compounded. However, the development of several strains 
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lacking the ability to synthesise haem A – and therefore to synthesise fully functioning 
cytochrome  c  oxidase (COX) proteins – have offered a solution to this  particular  issue 
(Avissar and Beale, 1989; Kumar and Söll, 1992). Furthermore, when AOX is functionally 
expressed  in  haem-deficient  strains,  it  'rescues'  the  strain,  acting  as  the  final  electron 
acceptor and allowing respiration to continue. Therefore, with no COX activity present, the 
proportion of alternative oxidase activity should be easier to quantify, which has proved 
advantageous to parts of this project. Additionally, haem-deficient strains have been used 
successfully  previously  to  express  alternative  oxidase  proteins  (cf   Berthold,  1998; 
Chaudhuri et al., 1998; Fukai et al., 2003) of both plant and parasite origin.
For  these  reasons,  the  FN102  strain  (as  provided  by  Professor  Kita,  Tokyo 
University)  was  used  alongside  the  C41  strain  in  order  to  provide  two  prokaryotic 
expression systems, both used in conjunction with a modified pET15b plasmid (Dr Mary 
Albury,  as  described  in  Chapter  2).  For  the  ease  of  downstream  purification  of  the 
recombinant AOX a six-histidine tag was encoded at the N-terminal of the recombinant 
gene sequence inserted into the pET15b vector. The plasmid also encoded for ampicillin 
resistance,  for  the  purposes  of  transformant  selection  and  competition  reduction.  The 
mitochondrial leader sequence had been removed for expression in E. coli, leaving only the 
mature protein encoded, which was thought to be inserted into the bacterial membranes as 
though it  were mitochondrial  in nature.  The pET15b plasmid allowed for protein over-
expression  through  the  T7  promoter  mechanism (Studier  and Moffatt,  1986),  and  also 
controllable protein expression through the lac operon system (cf. Jacob and Monod, 1961 
and Hanson et al., 1998) using IPTG as a lactose homologue.
4.1.1.2 Growth conditions
It is generally accepted that E. coli cultures grow optimally at around 37oC, which 
corresponds to efficient enzyme functionality. E. coli are relatively hardy however and may 
also be grown at temperatures below 37oC if required. For example, growing at 30oC slows 
growth during the exponential phase and prevents premature entry into the stationary phase, 
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whilst growing at 18oC after induction slows the exponential growth to a greater extent, but 
also  reduces  protein  aggregation  and  increases  protein  solubility  (cf. Sørensen  and 
Mortensen, 2005).
The  media  required  for  growth  of  transformed  C41  and  FN102  cells  is  strain-
specific.  For  C41,  standard  Miller  Luria  Broth  supplemented  with  the  plasmid-specific 
selective antibiotic ampicillin (100μg/ml), 0.2% glucose as an additional carbon source and 
0.125%  iron  sulphate  was  recommended  (Berthold,  1998).  As  shown  previously,  the 
availability of iron during protein expression is essential for the formation of functionally 
active alternative oxidase protein (cf Affourtit et al., 2004). By contrast, a sodium chloride-
free tryptone-peptone buffered growth media was recommended for successful growth of 
transformed  FN102  cells  (Nihei  et  al.,  2003,  see  Chapter  2,  Section  2.2.2  for  exact 
composition). Other supplements added include two iron sources (iron sulphate and iron 
chloride) to ensure sufficient iron for inclusion into the recombinant alternative oxidase 
protein; and magnesium sulphate, which had previously been identified as important for 
maintaining AOX stability (Nihei et al., 2003). In this case, the plasmid-specific selective 
antibiotic carbenicillin was used in place of ampicillin with no noted negative effects on 
growth efficiency (Nihei et al., 2003). Additionally, all agar plates and starter cultures for 
the growth of FN102 cells required the addition of ALA to enable the synthesis of haem-
complexes  prior  to  the  expression  of  alternative  oxidase.  A critical  step  in  the  growth 
protocol for the FN102 strain is the removal (by centrifugation) of the ALA from the starter 
culture prior to inoculation of the main culture medium (Nihei et al., 2003).
For both the C41 and FN102 strains, identifying an optimal IPTG concentration is 
vital (Hansen et al., 1998; Kilikian et al., 2000), as this directly limits or optimises protein 
expression. Previous expression protocols (Berthold, 1998; Chaudhuri et al., 1998; Fukai et  
al.,  2003;  Nihei  et  al.,  2003)  stipulate  varying IPTG concentrations  for  different  AOX 
isoforms, ranging from 25μM-100μM.
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4.1.1.3 Membrane harvest and lysis
Whilst for both FN102 and C41 strains the recommended centrifugation speed for 
pelleting the bacterial cells after the growth was 8,000 x  g (Berthold 1998; Fukai  et al., 
1999; Fukai  et al., 2003), the technique for lysis varies. Berthold (1998) and Fukai  et al. 
(2003) performed lysis using a French Press, whilst Fukai  et al. (1999) performed lysis 
using  sonication.  When  lysing  transformed  cells  with  recombinant  alternative  oxidase 
targeted to the cytoplasmic membrane, it is particularly important that the cell membranes 
should be broken into smaller sections, but not eradicated entirely in order to avoid AOX 
inactivation through premature removal of the lipophilic membrane environment required 
for protein stability.
4.1.2 Factors affecting solubilisation and purification
The extraction of intrinsic proteins from the membrane requires disruption of the 
lipid layer and this is most often achieved using detergents. In  the  case  of  the  alternative 
oxidase, the association with the membrane is thought to be monotopic (Rich and Moore, 
1976), with aromatic residues (see Chapter 5, Section 5.3.3) potentially playing a role in 
anchoring the protein to the membrane.
Previously,  n-octyl-β-D-glucoside  (OG;  Nihei  et  al.,  2003)  and  deoxybigCHAP 
(Affourtit and Moore, 2004) have been used to liberate recombinant TAO and native  A. 
maculatum from  E.  coli and  mitochondrial  membranes  respectively.  However,  as  S.  
guttatum alternative  oxidase  had  not  been  previously  solubilised  from  bacterial  host 
membranes,  alternative detergents  and combinations  thereof were tested experimentally. 
Stronger  detergents  were  considered  with  caution;  sodium dodecyl  sulphate  (SDS),  for 
example, would potentially lead to protein aggregation and denaturation. By comparison, 
milder  non-ionic  detergents  such  as  n-Dodecyl  β-D-Maltopyranoside  (DDM)  and 
detergents in the polyoxyethylene series are capable of disrupting membranes with limited 
damage  to  proteins  and  have  previously  been  used  to  solubilise  the  membrane-bound 
respiratory enzyme cytochrome c oxidase (Rosevear et al., 1980). Similarly, the non-ionic 
91
and  mild  detergent  OG  has  previously  been  successfully  used  to  solubilise  functional 
membrane-bound respiratory complexes from native tissues (Baron and Thompson, 1975) 
as well as functionally-active recombinant TAO (Nihei et al., 2003). However, other milder 
detergents  shorter  chain  polyoxylethylene  detergents  (C8E4 or  C8E5)  can  often  be  more 
inactivating  to  some  recombinant  proteins  than  DDM  and  other  polyoxylethylene 
detergents with chains of intermediate length (C12-C14) (Maire et al., 2000).
For the purposes of solubilisation, it is essential to ensure that the final detergent 
concentration  is  equal  to  or  slightly  greater  than  the  detergents  critical  micelle 
concentration  (CMC),  as  this  permits  the  detergent  molecules  to  form  micelles.  This 
process  facilitates  the  disruption  of  the  membrane  as  well  as  providing a  hydrophobic 
environment in which the liberated recombinant protein may be sequestered, thus reducing 
the risk of losing protein conformation (i.e. the exposure of a membrane-bound protein to a 
hydrophilic  environment)  and  therefore  function.  The  CMCs  of  most  commonly  used 
detergents are well characterised (cf Maire et al., 2000). Maintaining the concentration of 
the  chosen  detergent  at  or  just  above  its  CMC  during  solubilisation  is  advised,  but 
following solubilisation the detergent concentration may be decreased to limit micelle size 
in order to allow for the detergent to be removed downstream.
Following solubilisation of native  A. maculatum alternative oxidase (cf Hoefnagel 
et  al.  1997;  Affourtit  and  Moore,  2004)  and  recombinant  TAO  (Nihei  et  al.,  2003) 
continued presence  of  detergent  in  suspension and purification  buffers  was required  to 
retain protein activity. The requirement for detergent post-solubilisation is not uncommon 
for membrane proteins and given the relatively small mass of the alternative oxidase, it is 
not unreasonable to expect that the solubilised recombinant protein will be localised within 
the detergent micelles formed during solubilisation. Additionally,  the alternative oxidase 
substrates are hydrophobic in nature (cf Hoefnagel et al., 1997) and would be sequestered 
to the core of the protein where the active site is found. As a result, it may be that the AOX 
not only requires a hydrophobic local environment but also close association with lipophilic 
structures such as membrane and detergent micelles. An additional lipophilic substance, 
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glycerol, has previously been added to solubilisation and purification buffers of the TAO 
(Nihei et al., 2003) and is thought to help retain protein activity by limiting conformational 
flexibility (cf Sousa, 1995).
Another additive which had been previously identified as essential for recombinant 
TAO  stability  post-solubilisation  is  magnesium  sulphate  (Nihei  et  al.,  2003).  The 
requirement for Mg2+ ions in other membrane-bound proteins (such as ATPase,  cf Cohen 
and  Thompson,  1975)  has  been  documented,  although  the  exact  nature  of  protein 
stabilisation by Mg2+ ions is not known. One possible interaction that may be particularly 
relevant to the alternative oxidase is the adsorption of the Mg2+ ions onto any negatively 
charged, solvent-accessible side chains (specifically charged amide groups), thus reducing 
excessive interaction of these side chains with water (cf Collins, 2006).
Crucially, the importance of the addition of pyruvate to buffers used for natively-
expressed AOX (Carré et  al.,  2011)  and recombinant  plant  alternative  oxidase proteins 
would indicate that the presence of pyruvate in solubilsation and purification buffers may 
be essential for recombinant alternative oxidase stability. Whilst the exact mechanism by 
which pyruvate stabilises the alternative oxidase in unknown, it has been suggested that the 
pyruvate may interact with the cysteine-122 residue (cf Carré et al., 2011), which according 
to recent modelling (see Chapters 3 and 5) would most likely be solvent-facing.  In the 
previously defined purification protocol for TAO (Nihei  et al.,  2003), pyruvate was not 
added to any of the extraction,  solubilisation or purification buffers due to the apparent 
insensitivity  of  TAO  to  pyruvate  (Chaudhuri  et  al.,  2005).  Therefore,  the  addition  of 
pyruvate to extraction, solubilisation and purification buffers should be considered specific 
to  the  extraction  of  recombinant  plant  alternative  oxidases  and  potentially  other  AOX 
isoforms from species which show pyruvate sensitivity.
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4.2 Methodology
Transformation,  bacterial  growth,  cell  harvest,  membrane  solubilisation  and 
recombinant alternative oxidase protein purification was carried out as detailed in Chapter 
2, with experimental variations described below.
4.2.1 Expression strains
Modified  pET15b  plasmids  containing  the  wild-type  (S.  guttatum)  gene  (as 
described in Chapter 2) were transformed into C41 and FN102 cells using the previously 
defined heat shock method (Chapter 2, Section 2.1.2) and grown for a maximum of 12 
hours at 37oC on the appropriate LA plates.
4.2.2 Strain-specific growth conditions, membrane harvest and cell lysis
C41
Transformed C41 cells were grown as described in Chapter 2, Section 2.2.1 with no 
modifications after initial determination of optimal IPTG concentration (minimum 25μM, 
maximum 100μM). Re-suspension of the cell pellets after growth (harvest) was performed 
in 50mM TRIS-HCl, pH7.4 in both the presence and absence of sodium chloride (minimum 
50mM, maximum 300mM), DTT (minimum 1mM, maximum 5mM) and 10mM pyruvate.
FN102
Transformed FN102 cells were grown as described in Chapter 2, Section 2.2.2 after 
initial experimentation with starter culture growth times (minimum 2 hours, maximum 8 
hours), main culture growth times following induction (minimum 4 hours, maximum 16 
hours)  and  varying  IPTG  concentration  (minimum  25μM,  maximum  100μM).  Re-
suspension of cell pellets after growth (harvest) was performed in 50mM TRIS-HCl, pH7.4 
in  both  the  presence  and  absence  of  pyruvate  (minimum  1mM,  maximum  100mM). 
Isolation of both crude membrane and inner membrane was investigated, based on Kido et  
al. (2010). To determine the effect of ALA on growth, starter cultures were grown in the 
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presence and absence of ALA, and in one case ALA was not removed prior to main culture  
inoculation using the starter culture.
4.2.3 Solubilisation
Several detergents were investigated (see Table 4.10 below) using the basic method 
as  described  in  Chapter  2,  Section  2.3.1.  Solubilisation  time  (minimum  30  minutes, 
maximum  60  minutes)  and  centrifugation  time  (minimum  30  minutes,  maximum  60 
minutes)  were  varied  to  determine  optimal  conditions.  Centrifugation  speed  was  kept 
constant. 
4.2.4 Purification
To  determine  the  effect  of  detergent  and  glycerol  concentration,  various 
concentrations were investigated as follows: DDM – minimum 0.5%, maximum 1%; OG – 
minimum  0.5%,  maximum  1.4%;  C12E8 (octaethylene  glycol  monododecyl  ether)  – 
minimum 0.5%, maximum 1%; glycerol – minimum 2.5%, maximum 20%. Similarly, to 
determine the effect of the presence or absence of 200mM magnesium sulphate, 200mM 
iron  sulphate,  150mM  zinc  sulphate  and  10mM  pyruvate  these  reagents  were  either 
included in the purification buffers, or omitted. Small-scale purifications (to test the effect 
of detergent, glycerol or salt concentration for example) were carried out using the batch 
method,  whilst  larger-scale  preparative  purification  was  carried  out  using  the 
column/gravity flow method (Chapter 2, Section 2.3.2).
4.2.5 Protein activity assays
In order to maintain reproducibility, all activity assays were carried out using the 
spectrophotometric (see Chapter 2, Section 2.5.2) method. A number of substrates were 
used (duroquinol, ubiquinol-1 and decylubiquinol) depending on availability. The substrate 
used  to  obtain  the  results  shown  below  in  Section  4.3  is  indicated  in  each  Table 
information.
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4.2.6 Visualisation of recombinant alternative oxidase
SDS PAGE and Western blotting analysis was carried out exactly as described in 
Chapter 2, Section 2.4.
4.3 Results
Specific and total activity shown in the Tables in this Section are those of wild-type 
recombinant protein and have been ascertained using ubiquinol-1 as substrate and the BCA 
method of protein estimation (see Chapter 2, Section 2.5.1.1) from a single preparation 
unless otherwise stated. The results of over-expression of the various mutants is discussed 
in Chapter 5; this Chapter is mainly concerned with the over-expression of wild-type (S. 
guttatum) alternative oxidase.
4.3.1 Factors affecting expression
4.3.1.1 Expression strains
It was possible to express active recombinant alternative oxidases from both the 
C41 and FN102 strains, as shown below in Table 4.1:
Strain Average specific activity of 
membrane (μmols/min/mg)
Average protein produced 
from 5L grow-up (mg)
C41 0.5 (0.05) 60 (13.8)
FN102 1 (0.1) 20 (2.2)
Table 4.1 – Average specific activity and total wild-type recombinant protein produced per strain. This 
Table shows activity produced following the Berthold (1998) protocol; 35mM duroquinol substrate. Averages 
were taken over 5 preparations and standard deviation is shown in brackets.
96
4.3.1.2 Growth conditions, membrane harvest and cell lysis
4.3.1.2.1 C41
Two methods were used to  grow C41 cells  expressing recombinant  S. guttatum 
based on methods by Berthold (1998) and Fukai  et al.  (1999), the results of which are 
summarised in Table 4.2 below.
Method Average specific activity 
(μmol/min/mg)
Average total protein (mg)
Berthold, 1998 0.5 (0.05) 60 (13.8)
Fukai et al., 1999 0.1 (0.03) 8 (1.5)
Table 4.2 – Average protein activity of membrane-bound recombinant S. guttatum AOX. This table 
shows average protein activity of the membrane-bound recombinant S. guttatum AOX and total protein as 
grown using the two previously described methods using 35mM DQH2 as substrate. Averages were taken 
over 5 preparations and standard deviation is shown in brackets.
The Berthold (1998) growth method required little refinement. The growth curves 
in Figure 4.1 show optical density across a number of preparations, which demonstrates the 
reproducibility of the growth protocol.
The  only  change  from the  Berthold  growth  protocol  was  a  deviation  from the 
recommended  incubation  temperature  post-induction  due  to  difficulties  controlling  the 
temperature of the incubators. When the ambient temperature in the laboratory was high 
(i.e. in summer), the cooling system on the incubator was unable to chill the flasks to the 
required temperature of 18oC. The consistently achievable temperature was between 19oC 
and 20oC, which is under the 21oC temperature threshold recommended for incubation of 
proteins  prone  to  aggregation  or  insolubility  (cf. Baneyx,  1999).  Activity  and  protein 
concentration from preparations carried out over the winter period (where 18oC was easily 
achieved) and summer period were compared to ensure that the increase of 2oC did not 
negatively  impact  protein  expression  or  protein  activity.  Two  membrane  preparations 
carried out during summer months (exhibiting specific activities of 0.42μmol/min/mg and
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Figure 4.1 Growth curves from five separate cultures using the Berthold (1998) growth method. Cells 
were induced at 5 hours post-inoculation.
0.48μmol/min/mg and total protein of 52mg and 55mg respectively) were comparable to 
two membrane preparations  carried  out  during winter  months  (where specific  activities 
were  0.46  and  0.51  μmol/min/mg  and  total  protein  of  55mg  and  55mg  respectively). 
Average  total  activity  for  the  summer  preparations  was  25μmol/min,  and average  total 
activity for the winter preparations was 27μmol/min.
Final  IPTG concentrations  of  25,  50,  75 and 100μM were investigated  and the 
results are shown below in Table 4.3.
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IPTG 
Concentration 
(μM)
Total protein in 
membrane 
fraction (mg)
Specific activity of 
membrane 
fraction(μmols/min/mg)
Total activity of 
membrane fraction 
(μmols/min)
25 25 0.12 3.00
50 22 0.08 1.76
75 23 0.07 1.61
100 19 0.03 0.57
Table 4.3 – The effect of IPTG concentration on cell protein concentration and activity of recombinant 
S. guttatum AOX expressed in C41. 35mM duroquinol was used as substrate..
4.3.1.2.2 FN102
As predicted, there was a difference in growth times for FN102 cells expressing 
recombinant  S.  guttatum  alternative  oxidase  and  published  figures  for  FN102  cells 
expressing TAO (Fukai  et al., 2003). Whilst the overnight (12-hour) plate colonies grew 
satisfactorily (typically 10-50 small colonies per plate), the starter cultures inoculated from 
the  plate  colonies  consistently  took  >5  hours  to  reach  optimal  optical  density  for 
inoculation into the main culture media (optical density of 0.1 at 650nm). Similarly, once 
the main culture had been inoculated to an optical density of 0.01, the cultures required 
several  hours  (minimum of  2,  maximum of  8)  to  reach  an  optical  density  of  0.1  and 
therefore induction density. Growth after induction of FN102 was not as rapid as observed 
in the C41 strain (see Figure 4.1), although it was not significantly reduced. This is shown 
below in Figure 4.2.
Figures 4.3a and 4.3b below illustrate the effect that the inclusion and subsequent 
removal  or  non-removal  of  ALA  has  on  the  growth  curves  for  FN102  cells.  In  this 
experiment  ALA was added at  the beginning of the starter  culture step and then either 
removed or left in the media prior to inoculation of a larger volume of media. In addition, 
the cultures were either induced (+ IPTG condition) or not induced (- IPTG condition) to 
see whether this had a noticeable effect on growth in the presence and absence of ALA.
99
Figure 4.2 – The growth of three cultures of FN102 cells transformed with S. guttatum AOX-containing 
plasmids. Cells were induced at ▼ and harvested at .▽
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Figure 4.3a – The effect of ALA on growth curves. Comparison of growth curves where ALA was either 
removed or left in the main culture medium and the effect of subsequent addition or non-addition of IPTG. 
Induction times of the +IPTG conditions where ALA was not removed and where ALA was removed are 
indicated by  and ▼ respectively,▽
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Figure 4.3b - The effect of the presence and absence of ALA in the starter culture on subsequent 
growth curves. This Figure illustrates the effect of adding no ALA to the starter culture compared to adding 
ALA to the starter culture and subsequent addition or non-addition of IPTG. Induction times for the +IPTG 
condition where ALA was removed and ALA was not present are indicated by ▼ and  respectively.▽
Activity  measurements  were  taken  from the  samples  shown  above  (membrane-
bound  recombinant  AOX  only)  after  harvest  (optical  density  at  harvest  not  shown  in 
Figures 4.3a and 4.3b) and are shown in Table 4.4 below. Final IPTG concentrations of 25, 
50, 75 and 100μM were investigated and the results are shown below in Table 4.5.
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Condition Specific activity 
(μmols/min/mg)
Total activity 
(μmols/min)
Total protein 
(mg)
+  ALA,  no  removal,  + 
IPTG
0.72 7.92 11
+ ALA, no removal, - IPTG 0.002 0.024 12
+ ALA, removal, + IPTG 1.10 14.3 13
+ ALA, removal, - IPTG 0.001 0.012 12
- ALA, + IPTG 0.11 0.88 8
- ALA, - IPTG 0.00 0.00 7
Table 4.4 – The effect of ALA on activity of membrane-bound recombinant AOX. This Table shows the 
effect on activity of membranes isolated from FN102 cells +/- ALA, +/- ALA removal, and +/- IPTG (200ml 
cultures).
IPTG 
Concentration 
(μM)
Total protein in 
membrane 
fraction (mg)
Specific activity of 
membrane 
fraction(μmols/min/mg)
Total activity of 
membrane fraction 
(μmols/min)
25 12 0.03 0.36
50 8 0.11 0.89
75 6 0.07 0.47
100 4 0.12 0.49
Table 4.5 – The effect of IPTG on activity of membrane-bound recombinant AOX. This Table shows the 
effect of IPTG concentration on total and specific activity of subsequent membrane fraction of recombinant S.  
guttatum alternative oxidase in FN102 cells. 35mM duroquinol was used as substrate.
4.3.2 Factors affecting solubilisation and purification
4.3.2.1 Factors affecting solubilisation
In  order  to  solubilise  the  membrane  fraction,  and  release  the  recombinant  S.  
guttatum AOX from the lipid layer, it  was necessary to establish the localisation of the 
protein within the cell  matter.  This was achieved using Western blotting in conjunction 
with activity assays of the relevant fractions. The results are summarised below in Table 4.6 
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and Figure 4.4.  Data shown is  taken from single preparations  of both C41 and FN102 
strains typical of other preparations.
Fraction Specific activity (μmol/min/mg) Total activity (μmol/min)
Membrane C41 0.48 26
Supernatant C41 0.001 0.035
Membrane FN102 0.9 18
Supernatant FN102 0.002 0.014
Table 4.6 – Activity distribution in membrane and supernatant fractions from membrane harvest.
The detergents  tested  and the  corresponding activities  (all  taken from the  same 
preparation of membrane-bound recombinant  S. guttatum AOX expressed in FN102) are 
shown below in Table 4.7, comparing activity in the soluble (supernatant) and insoluble 
(pellet) fractions. The accompanying SDS PAGE gel in Figure 4.5 shows the effect of the 
detergents in Table 4.7 on sample composition.
DDM was further tested in varying concentrations, with differing incubation and 
centrifugation run times and speeds. The results are summarised below in Tables 4.8a and 
4.8b. A Western blot showing the soluble and insoluble fraction following solubilisation 
with 1% DDM is shown below in Figure 4.6.
                                                     Specific activity (µmol/min/mg)
Detergent Soluble fraction Insoluble fraction
1% DDM 0.128 0.041
1% DDM, 200mM NaCl 0.246 0.076
1% DDM, 20mM MgSO4 0.062 0.053
0.1% TRITON X-100 0.040 0.052
1.4% OG 0.020 0.533
0.1% DeoxyBigCHAP 0.087 0.071
3% Digitonin 0.274 0.267
0.1% Tween-20 0 0
Table 4.7- The effect of detergent on activity post membrane solubilisation. All measurements refer to a 
single preparation of membrane-bound S. guttatum AOX expressed in FN102, using the Lowry (1951) 
estimation method.
104
Figure 4.4 – Presence of recombinant AOX during each stage of harvest on SGS-PAGE gel and 
Western blot. In this Figure, an SDS-PAGE gel (top) and Western blot (bottom) show the presence of the 
recombinant S. guttatum alternative oxidase in the membrane (1) and supernatant (8) fractions during and 
following membrane harvest: recombinant protein present in the unlysed culture (4); re-suspended cell pellet 
following initial centrifugation (6); lysed cells (sonication); (5); and top (2) and bottom (3) ultracentrifuge 
fractions. (-) indicates a gap between lanes 6 and 7. Samples shown are recombinant S. guttatum alternative 
oxidase expressed in C41, using the Berthold (1998) growth and harvest protocol. All lanes contain 15μg of 
protein. The dark bands present at approximately 76kDa are most likely dimeric recombinant S. guttatum 
alternative oxidase protein.
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Figure 4.5 – SDS-PAGE gel of solubilisation of recombinant membrane-bound AOX by various 
detergents. This Figure of an SDS PAGE gel shows the resultant soluble (SN) and insoluble (PPT) fractions 
following solubilisation with detergents. Lanes: Mr. Marker 1. Membrane; 2. SN Tween-20; 3. PPT Tween-
20; 4. SN  TritonX-100; 5. PPT TritonX-100; 6. SN DeoxyBigChap; 7. PPT DeoxyBigChap; 8. SN 
Digitonin;9. PPT Digitonin. All lanes contain protein from the same preparation of membrane-bound 
recombinant S. guttatum AOX expressed in FN102 Concentration of detergents listed reflects those in Table 
4.7 above.
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Final % of DDM (w/v) Specific activity (µmol/min/mg)
0 0.023
0.75 0.018
1 0.531
1.5 0.130
2 0.274
Table 4.8a – The effect of final DDM concentrations on specific activity. Activities shown correspond to 
solubilisation with DDM on membrane samples from the same membrane preparation (recombinant S.  
guttatum AOX expressed in C41). 35mM duroquinol was used as substrate.
Conditions Activity (µmol/min/mg)
Incubation time 
(mins)
Spin time (mins) Soluble fraction Insoluble fraction
<30 <30 0.001 0.02
30 <30 0.002 0.019
30 60 0.489 0.001
60 30 0.102 0.007
60 60 0.106 0.002
Table 4.8b – The effect of incubation and spin time on activity of solubilised membrane. This Table 
shows the effect of incubation time and centrifugation spin time on activity of recombinant S. guttatum AOX-
containing membrane sample expressed in C41 and solubilised with 1% (w/v) DDM. 35mM duroquinol was 
used as substrate.
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Figure 4.6 – Westen blot showing the soluble (S) and insoluble (IS) fractions after solubilisation with 
1% DDM. Sample corresponds to the data shown in Table 4.8a. The dark band present above the 38kDa 
marker is most likely dimeric recombinant S. guttatum alternative oxidase protein.
4.3.2.2 Buffers and additives
Several  metal-based  buffer  additives  were  tested  in  order  to  either  stabilise  the 
recombinant protein or otherwise maintain activity during solubilisation and purification. 
The additives investigated are detailed in Table 4.9 below, illustrating the effect of each 
additive in the solubilisation buffer.
Specific activity (μmols/min/mg)
Additive + -
100mM MgSO4 0.498 0.520
200mM ZnSO4 0.001 0.520
150mM FeSO4 0.031 0.520
Table 4.9 – Effect of metal sulphates on specific activity of solubilised recombinant S. guttatum AOX. 
This Table details the effect on specific activity of solubilised protein by the addition of various metal-based 
additives to the purification and assay buffers. Data corresponds to solubilised recombinant S. guttatum AOX 
expressed in C41 from a single membrane preparation. 35mM duroquinol was used as substrate.
The effect of glycerol concentration on alternative oxidase activity is shown below 
in Table 4.10.
4.3.2.3 Purification
A number of conditions were tested when purifying recombinant protein and the 
most  effective  is  summarised  below in Figure  4.7.  A purification  table  (Table  4.11)  is 
shown below. SDS PAGE and Western blots showing the membrane, flow-through, wash 
and eluate fractions using the protocol shown in Figure 4.7 is shown below in Figure 4.8, 
along with an early attempt at purification for comparison.
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% 
Glycerol
Specific Activity 
(μmol/min/mg)
Total Activity 
(μmol/min)
Total Protein (mg)
Membrane 1.43 49.3 34
20 0.32 7.04 22
10 0.31 7.13 23
7.5 0.30 5.7 19
5 0.31 7.13 23
Membrane 1.00 30 30
2.5 0.24 4.32 18
1 0.25 4.75 19
0 0.17 3.74 22
Table 4.10 – The effect of final glycerol concentration on activity of solubilised membrane samples. This 
Table shows the effetc of glycerol concentration on solubilised recombinant S. guttatum AOX expressed in 
FN102 compared to the membrane fractions from which they were solubilised. Samples were solubilised 
using 50mM TRIS pH 7.5, 100mM MgSO4, 10mM pyruvate, 1% DDM and 35mM duroquinol was used as 
substrate.
Fraction Specific activity 
(μmols/min/mg)
Total activity 
(μmols/min)
Total 
protein 
(mg)
Purification 
factor
% 
recovery
Membrane 0.91 29.7 32.5 - -
Soluble 0.93 29.5 31.5 1 99
Pooled 
eluate
20.6 14.6 0.71 22.6 49
Table 4.11 – Purification table for recombinant S. guttatum AOX expressed in FN102. This purification 
table shows activities observed when following the purification protocol as given below in Figure 4.5. 
Purification factor refers to the factor increase of specific activity compared to the specific activity of the 
membrane. % recovery refers to the percentage of total activity compared to the total activity of the 
membrane faction. Activities shown here correspond to samples on SDS-PAGE gel and Western shown 
below in Figure 4.8.
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Figure 4.7 – Purifcation workflow. This Figure summarises the final buffer combinations used during the 
stages of purification for recombinant S. guttatum AOX expressed in FN102.
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Figure 4.8 – SDS-PAGE gel and Western blots of purified recombinant S. guttatum AOX expressed in 
FN102. A: Western blot showing early attempts at purification (FT flow-through, W wash, E eluate) 
compared to later attempts (B and C) using the protocol shown above in Figure 4.6. Samples shown in parts B 
and C correspond to activities listed in Table 4.11 (Mr = marker). The dark bands present between the 76kDa 
and 52kDa markers are most likely dimeric recombinant S. guttatum alternative oxidase protein.
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4.3.2.4 The effect of pyruvate on activity
Membrane-bound S. guttatum alternative oxidase expressed in FN102 was assayed 
in the absence and presence of pyruvate. Table 4.12a demonstrates the difference in activity 
observed in the absence of pryuvate and the presence of 10mM pyruvate in either the assay 
buffer, the extraction buffer, or both. 150mM Q1H2 was used as the substrate, and inhibition 
of at least 95% by 100nM ascofuranone was demonstrated in each assay.
Protein
(mg/ml)
Total protein
(mg)
Specific activity 
(μmols/min/mg)
Total activity 
(μmols/min)
Membrane (-) 3.5 5.6 0.5 2.7
Membrane (+A) 3.5 5.6 0.6 3.2
Membrane (+E) 1.9 1.9 2.1 4.0
Membrane (+AE) 1.9 1.9 3.0 5.7
Table 4.12a – The effect of pyruvate on recombinant S. guttatum AOX expressed in FN102. This Table 
demonstrates the effect on activity of the absence of pyruvate (-), 10mM pyruvate added to the assay buffer 
(+A), 10mM pyruvate added to the extraction buffer (+E) and 10mM pyruvate added to both extraction and 
assay buffers (+AE).
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Table 4.12b below shows the effect of differing the pyruvate concentration in the 
assay buffer only. The membrane sample assayed had a concentration of 3.5mg ml -1  and a 
total protein of 5.6mg.
The  effect  of  adding  10mM pyruvate  to  the  assay  buffer  alone  when  assaying 
various purification fractions was also monitored and the results are shown below in Table 
4.13.
Figure 4.9 below shows the absorbance at 278nm of recombinant membrane-bound 
S. guttatum alternative oxidase in the presence of 150μM Q1H2 substrate.
Pyruvate added (mM) Specific activity
(μmols/min/ mg)
Total activity
(μmols/min)
0 0.5 2.7
1 0.4 2.1
10 0.6 3.2
15 0.6 3.2
20 0.4 2.4
25 0.5 2.7
50 0.4 2.1
Table 4.12b – The effect of pyruvate concentration on activity of recombinant S. guttatum AOX 
expressed in FN102. The Table demonstrates the effect on specific and total activities when adding pyruvate 
to the assay buffer. Protein concentration was estimated using the Lowry (1951) method.
Specific activity 
(μmols/min/mg)
Total activity 
(μmols/min)
Fraction Total protein (mg) - + - +
Membrane 5.6-, 1.9+ 0.5 2.1 2.7 4.0
Soluble 0.44-, 0.26+ 0.02 3.8 0.01 1.0
Eluate 0.02-, 0.01+ 0.12 4.2 0.024 0.042
Table 4.13 – The effect of pyruvate on activity during each stage of purification. This Table shows the 
effect of adding 10mM pyruvate to the assay buffer alone when assaying various fractions of recombinant S. 
guttatum AOX protein expressed in FN102. Protein concentration was estimated using the Lowry (1951) 
method.
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Figure 4.9 – Spectrophotometric trace of the specific activities of recombinant S. guttatum AOX protein 
samples expressed in FN102. This trace shows specific activity (the numbers above each absorbance slope 
represents specific activity in μmols/min/mg) for several recombinant S. guttatum alternative oxidase 
fractions: A membrane isolated in the absence of pyruvate with no pyruvate added to the assay buffer (Table 
4.12a); B membrane isolated in the absence of pyruvate with 10mM pyruvate added to the assay buffer (Table 
4.12a); C membrane isolated in the presence of 10mM pyruvate with 10mM pyruvate also present in the assay 
buffer (Table 4.12a).
4.3.2.5 Downstream processing
In  order  to  concentrate  the  purified  protein  several  methods  were  tested  as 
summarised below in Tables 4.14a and 4.14b.
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Method Result
Dialysis All activity lost, protein precipitated
Ammonium sulphate 
precipitation
Some of the protein activity retained, although trace (NH4)2SO4 
was undesirable for downstream protocols and negatively 
impacted on protein life-span
PEG precipitation Most of the protein activity retained, and PEG easy to remove via 
centrifugation. See Table 4.13b below
Ultrafiltration 
(centrifuge method)
Protein consistently precipitated on filter, and significant protein 
amount and activity lost
Centrifugation Results obtained were inconsistent, varying from good activity 
retention to total activity loss
Table 4.14a – Concentration methods used. This Table lists the various concentration methods used, and 
general results obtained.
Further to the results shown above in Table 4.14a, it  was necessary to ascertain 
whether PEG had an inhibitory effect on the activity of the recombinant protein and several 
precipitations were carried out. Typical results are shown in Table 4.14b, and Figure 4.10 
below.
Fraction Total protein (mg) Specific activity 
(μmols/min/mg)
Total activity 
(μmols/min)
Eluate 1.2 0.04 0.058
PEG SN 1.1 0.002 0.003
PEG PPT 0.1 0.122 0.012
Table 4.14b – The effect of PEG precipitation on the activity of purified recombinant S. gtuttaum AOX 
expressed in FN102. SN refers to supernatant and PPT refers to the pellet left following ultracentrifugation.
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Figure 4.10 – Western blot of PEG precipitated purified recombinant S. guttatum AOX expressed in 
FN102. This Western Blot shows the presence of recombinant alternative oxidase in the PEG precipitation 
pellet (PPT) and absence in the PEG precipitation supernatant (SN). Sample shown corresponds to the activity 
shown above in Table 4.14b. The dark bands present above the 76kDa and between the 78kDa and 52kDa 
markers are most likely dimeric recombinant S. guttatum alternative oxidase protein.
4.3.2.6  Quantification,  visualisation  and  activity  monitoring  of  recombinant  alternative 
oxidase
Two methods were used to estimate alternative oxidase concentration, namely the 
BCA and Lowry methods. In order to identify any differences in sensitivity, the protein 
content of an active membrane sample (FN102) was estimated on the same day using the 
two methods.  In this  case,  the Lowry gave an estimation approximately one-fifth (8mg 
protein total) of that given by the BCA (42mg protein total). In addition when carrying out 
the  BCA  estimation  method,  control  protein  estimations  were  performed  using  buffer 
containing  no protein,  but  treated  in  the  same manner  as  experimental  samples.  These 
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estimations gave readings of approximately 0.001 at 562nm (0.002 max, 0.000 min). By 
comparison, the lowest BSA concentration standard, corresponding to 0.1mg/ml protein, 
had a typical absorbance of 0.202 (±0.021). To further ensure that protein estimation was 
accurate, any samples where absorbance was below 0.010 were repeated.
Figure 4.11 – Possible location of recombinant S. guttatum AOX expressed in FN102 on an SDS-PAGE 
gel and Western blot. This Figure shows the probable recombinant S. guttatum AOX band on an SDS PAGE 
gel and corresponding Western blot, as indicated by the arrows. Also observed is the double band often seen 
when running recombinant S. guttatum AOX on SDS PAGE gels. Lanes: 1 – markers; 2 – Western blot 
corresponding to lane 3; 3 – membrane-bound recombinant S. guttatum AOX; 4 – supernatant from 
membrane isolation. The dark bands present between the 76kDa and 52kDa markers are most likely dimeric 
recombinant S. guttatum alternative oxidase protein.
When conducting activity assays, ubiquinol-1 was the preferred substrate, although 
not in constant supply as it was donated by Professor Kita (University of Tokyo). Initially, 
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duroquinol and decylubiquinol were used in activity assays, but lower activity was recorded 
using these substrates for the same sample, as shown below in Table 4.15.
On  each  of  the  Western  blots  presented  in  this  Chapter  a  higher-weight  AOX 
species can be seen, typically between the 52kDa and 76kDa markers and above the 76kDa 
marker. This is thought to be a dimeric recombinant  S. guttatum AOX which is present 
unless the protein was placed under reducing conditions.
Substrate Average Specific activity 
(μmols/min/mg)
Total activity 
(μmols/min)
Ubiquinol-1 0.90 (0.11) 18.0
Duroquinol 0.51 (0.05) 10.2
Decylubiquinol 0.35 (0.13) 7.0
Table 4.15 – The effect on activity of recombinant S. guttatum AOX protein of three substrates. This 
Table shows the specific and total activity observed in one sample using three different substrates. The sample 
was taken from recombinant S. guttatum alternative oxidase expressed in FN102 in the membrane-bound 
form, containing 20mg total protein. Standard deviation is indicated in the specific activity column.
4.4 Discussion
4.4.1 Strains and growth conditions
It has been possible to successfully express and harvest protein from two  E. coli 
expression strains, C41 and FN102 (Table 4.1).
4.4.1.1 C41
Following the Berthold (1998) growth and harvest method for the C41 strain, little 
refinement  of  the  original  protocol  was  required  to  produce  consistent  quantities  of 
recombinant protein (Table 4.1) targeted to the cytoplasmic membrane (Figure 4.6). The 
optimal concentration of IPTG required for induction of C41 cells expressing recombinant 
S. guttatum was ascertained (25μM, Table 4.3), resulting in consistent protein concentration 
and specific activity.  Furthermore,  growth of the main culture post-inoculation and pre-
induction  (4  hours  at  30oC and  1  hour  at  18oC)  appears  consistent  over  a  number  of 
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preparations (Figure 4.1). After evaluation of the data shown in Table 4.4, the Berthold 
(1998) method was selected for all further growth of C41 cultures. The method as defined 
by  Fukai  et  al.  (1999)  was  not  used  since  it  consistently  produced  lower  protein 
concentration and specific activity than the protein produced by C41 cells expressed using 
the Berthold (1998) method.
4.4.1.2 FN102
The  previously  defined  protocol  for  over-expression  and  membrane  harvest  of 
FN102  cells  expressing  recombinant  TAO  (Nihei  et  al.,  2003)  has  been  successfully 
adapted to express recombinant  S. guttatum AOX (Table 4.1). Use of  50μM of IPTG to 
induce FN102 cells expressing recombinant  S. guttatum alternative oxidase appears to be 
optimal, giving the highest total activity and sufficient protein content (Table 4.5).
In agreement with previous findings (Chaudhuri et al., 1998; Nihei et al., 2003) the 
addition of ALA to agar plates and starter culture is required for FN102 growth. A lack of 
ALA results in significantly decreased cell  growth and subsequent activity  as shown in 
Figure 4.3b and Table 4.4. Retaining ALA in the media leads to increased growth rate, but 
halves the recombinant AOX activity indicating that whilst the cells are able to express the 
haem-COX proteins and subsequently the recombinant alternative oxidase after induction, 
expression of the recombinant AOX while the other COX proteins are present is shown to 
be  decreased.  This  is  demonstrated  by  reduced  AOX specific  activity  observed  in  the 
membrane  fraction  where  ALA was  not  removed  compared  to  the  membrane  fraction 
where the ALA was removed, whilst the total protein concentration remains similar in both 
conditions (Table 4.4). The reason for this is unclear; it could be assumed that following 
induction, growth of the FN102 cells without ALA removal should increase more than that 
of  the  cells  where  the  ALA had been removed  given the  additional  oxidative  role  the 
recombinant  protein  is  performing.  However,  as  this  is  not  directly  linked  to  energy 
production,  there  may  be  additional  factors  acting  on  the  cells  that  would  explain  the 
observed protein behaviour. For example, when the ATP supply is likely to be steady and 
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adequate where membrane redox potentials are close to normal for E. coli (i.e. when ALA 
is  present  and  not  removed),  then  the  activity  of  the  recombinant  protein  is  reduced, 
although  it  is  unclear  how  this  may  occur.  Crucially,  in  FN102  cells  expressing 
recombinant  S. guttatum AOX, the time taken to reach the required optical density of 0.1 
(at 650nm) after inoculation appears to be longer and more variable than the times given for 
FN102  cells  expressing  recombinant  TAO  (between  2  and  8  hours  for  S.  guttatum 
compared to between 2 and 4 hours for TAO, Nihei et  al.,  2003).  Since expression of 
recombinant  AOX in both this  project and the previously published work (Nihei  et al., 
2003)  is  under  the  tight  control  of  the  T7  promoter,  with  cells  grown in  lactose-free, 
glucose-containing media prior to induction, this difference in pre-induction growth cannot 
be  attributed  to  isoform-specific  differences  in  alternative  oxidase  protein  activity. 
However, the variation in time taken for FN102 cells expressing recombinant  S. guttatum 
alternative  oxidase  may  be  explained  by  naturally  fluctuating  levels  of  COX  protein 
production  in  the  presence  of  ALA;  COX activity  may  decrease  after  periods  of  high 
turnover or remain relatively stable after periods of moderate turnover. The former would 
produce ATP more rapidly, but levels would also be depleted more rapidly. The variation in 
time taken to reach inducible optical density results in a less-predictable growth protocol 
than is observed with C41 cells expressing recombinant  S. guttatum AOX. Therefore, the 
growth of FN102 cells post-inoculation requires very careful monitoring of optical density.
4.4.1.3 Cell lysis
Two methods of cell lysis were used during this project – sonication and the French 
Press.  Membrane samples  prepared  from the  same growth,  where  half  the  resuspended 
harvested cells  were sonicated and the remaining half  lysed using the French Press, no 
significant  difference  in  specific  activity  was  observed  (C41  cells  when  sonicated: 
0.48μmols/min/mg, compared to the French Press: 0.52μmols/min/mg; FN102 cells when 
sonicated:  0.89μmols/min/mg,  compared  to  the  French  Press:  0.90μmols/min/mg). 
Regarding the practicality of each method, there is a preference for the French Press when 
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the  volume  of  re-suspended  harvested  cells  is  >50mls  and  sonication  for  volumes  of 
<50mls. The French Press also offers more opportunity to visually assess the lysate for 
signs of effective lysis (i.e. clarification of the sample leaving the cell) and therefore repeat 
the lysing process should it appear that lysis has not been effective. However, care must be 
taken  when  using  both  sonication  and  the  French  Press  as  methods  of  lysis  of  cells 
expressing recombinant alternative oxidase, as excessive damage to the membrane during 
lysis may result in inactivation of the recombinant protein.
4.4.2 Solubilisation
It has been possible to ascertain a solubilisation protocol for the effective liberation 
of active recombinant  S. guttatum alternative oxidase resulting in 99% recovery of total 
acitivity from the membrane fraction (Table 4.11). The protocol consists of the drop-wise 
addition of solubilisation buffer to the membrane fraction (50mM TRIS-HCl, pH 7.5, 1% 
(w/v) DDM, 10mM pyruvate, 100mM MgSO4, 5% (v/v) glycerol), followed by 30 minutes 
incubation with gentle stirring at 4oC and ultracentrifugation at 200,000 x g for 30 minutes 
at 4oC. After ultracentrifugation, the soluble fraction consistently contains the recombinant 
alternative oxidase, as verified by activity (Table 4.8b) and Western blotting (Figure 4.6). 
Previous  attempts  to  solubilise  recombinant  TAO  (Nihei  et  al.,  2003)  stipulate  the 
requirement for 1.4% (w/v) OG, 20% (v/v) glycerol and 100mM MgSO4; as such, the DDM 
and pyruvate are specific requirements for the solubilisation of the S. guttatum alternative 
oxidase.  Given the similarity  between  S. guttatum alternative oxidase and TAO, it  was 
unexpected that OG should be so ineffective at liberating recombinant  S. guttatum AOX 
protein from the membrane (Table 4.7). Whilst  both DDM and OG are mild, non-ionic 
detergents, DDM has a larger head-group and longer alkyl chain than OG and therefore 
DDM forms larger micelles than OG (cf Baron and Thomson, 1975; Rosevear et al., 1980; 
Maire et al., 2000). These differences could suggest that TAO and S. guttatum alternative 
oxidase  may  have  different  requirements  for  lipophilic/hydrophobic  association 
contributing to overall protein stability. However, as OG is known to decrease activity in 
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some proteins (Maire et al., 2000) continued use of DDM for solubilisation is preferable. 
The 1% (w/v) DDM (equivalent to 0.2mM) concentration used for the solubilisation of the 
S. guttatum alternative oxidase is greater than the CMC of DDM (0.17mM; cf Maire et al., 
2000), which would allow for the formation of micelles. It is probable that the recombinant 
alternative  oxidase  molecules  are  at  least  partially  enveloped  by  the  DDM  micelles; 
however,  the  exact  extent  of  this  interaction  is  not  known.  If  required,  the  number  of 
protein  molecules  per  micelle  could  be  further  elucidated  using  analytical 
ultracentrifugation (cf Reynolds and Tanford, 1976).
Furthermore, if the recombinant protein molecules are partially embedded within 
the detergent micelles, this may increase the potential effect of the Mg2+ ions present in the 
buffer;  if  less  protein  surface  area  is  solvent-accessible  (i.e.  buried  in  the  detergent 
micelles),  any Mg2+ ions  binding to  negatively  charged groups  will  reduce  the  protein 
solvent-accessible surface area to an even greater extent. Addition of other sulphate salts 
(zinc and iron sulphate, Table 4.9) does not appear to stabilise recombinant  S. guttatum 
alternative oxidase to the same extent as magnesium sulphate, indicating that it may be the 
magnesium ions rather than the sulphate ions which are stabilising the protein. However, 
magnesium sulphate alone does not increase activity, so it should be used in combination 
with DDM, pyruvate and glycerol for optimum effect.
4.4.3 Purification
A protocol has been defined within this project for the purification of recombinant 
S. guttatum alternative oxidase, resulting in 22-fold increase in specific activity from the 
membrane-bound  fraction  to  the  purified  fraction  and  49%  recovery  of  total  activity 
between the same fractions (Table 4.11). Using 1ml of nickel or cobalt affinity resin per 
15mg  of  recombinant  protein,  at  least  three  applications  of  4x  the  bed  volume  of 
equilibration buffer (50mM TRIS-HCl, pH 7.5, 10mM pyruvate, 0.5% (w/v) DDM, 0.5% 
(w/v) OG, 100mM MgSO4, 5% (v/v) glycerol) should be used to equilibrate the affinity 
resin. The soluble fraction should be allowed to bind to the resin for no longer than 15 
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minutes at 4oC and following collection of the flow-through, the resin should be washed 
twice with 5x the  bed volume of wash buffer  (as per  the equilibration  buffer,  with an 
additional 25mM imidazole). A final elution buffer (as per the equilibration buffer, with 
250mM imidazole) 3x the bed volume may be applied as a single step elution for volumes 
<4ml, or as a multiple step gradient (25mM-250mM imidazole) elution for volumes >4ml.
This protocol differs from the previously defined protocol for the purification of 
recombinant  TAO  (Nihei  et  al.,  2003),  which  does  not  stipulate  the  requirement  for 
pyruvate  or  a  DDM-OG combination.  As  discussed  previously,  the  optimum detergent 
appears to be isoform-specific; however, any detergent added after solubilisation is unlikely 
to be forming new micelles, as the concentrations required (0.5% (w/v) of both DDM and 
OG) are below their respective CMCs. The additional detergent may simply be beneficial 
through the encouragement of the perpetuation of existing detergent-protein micelles by 
ensuring any detergent molecules lost from the micelles may be readily replaced.
4.4.4  General  factors  affecting  the  over-expression,  solubilisation  and  purification  of 
recombinant S. guttatum alternative oxidase
4.4.4.1 The effect of pyruvate on recombinant S. guttatum alternative oxidase
By adding pyruvate – which would be abundant in the cell cytoplasm if Kreb's had 
been halted – to membrane-bound recombinant S. guttatum alternative oxidase, activity can 
be increased (Tables 4.12a and 4.13). If the pyruvate is added to the assay buffer alone, the 
increase  is  a  relatively  small  1.2-fold,  however  when  adding  pyruvate  to  the  protein 
membrane  extraction  buffer,  a  4-fold  increase  in  activity  is  observed.  Furthermore,  if 
pyruvate  is  added  to  both  the  membrane  extraction  buffer  and  the  assay  medium,  the 
activity is increased 6-fold. This is generally consistent with previous findings, namely that 
the addition of pyruvate to native alternative oxidase extracted from thermogenic tissue 
increases the alternative oxidase activity (Carré  et al., 2011). This is the first time it has 
been demonstrated with recombinant  S. guttatum AOX expressed in  E. coli.  There is  a 
cautious acceptance that the stimulation by pyruvate of thermogenic alternative oxidase 
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isoforms occurs independently of expression system. However,  whether this  increase in 
activity is as a result of a conformational change remains untested, and the data presented in 
this thesis cannot confirm this suggestion.
Interestingly, before pyruvate was routinely added to the extraction and purification 
buffers, no inhibition of activity was observed, which is somewhat in contradiction with 
previously reported findings that an absence of pyruvate leads to the inactivation of the 
alternative oxidase (Carré  et al.,  2011). It may be that the concentration of endogenous 
pyruvate present in the E. coli cells prior to membrane extraction was sufficient to maintain 
activity, especially if the pyruvate is bound to the protein (as opposed to being free in the 
lysate)  and  did  not  dissociate  during  the  process  of  extraction,  solubilisation  and 
purification. Similarly, lower than expected rates of activity in early purified recombinant 
S.  guttatum AOX  samples  may  have  been  in  part  due  to  depleting  pyruvate  levels. 
However, this does imply that at least some of the pyruvate was potentially still bound to 
the protein as activity was low, rather than absent (Tables 4.12a and 4.13). This supports 
the suggestion that the pyruvate molecules interact directly – through more than simply 
transient association – with the alternative oxidase protein.
4.4.4.2 Recombinant protein quantification
Accurate  quantification of recombinant  alternative oxidase in the membrane and 
soluble fractions has been a consistent frustration during the course of this project. Since 
the protein estimation accounts for the total protein concentration rather than recombinant 
protein concentration only, the estimated protein concentrations used to calculate specific 
activity  were  artificially  inflated.  As  a  result,  the  specific  activites  reported  for  the 
membrane and soluble fractions are likely to be lower than the actual activity. This has not 
been considered in previous attempts to assay recombinant alternative oxidase (cf Berthold, 
1998; Chaudhuri et al., 1998; Fukai et al., 1999; Nihei et al., 2003).
An  alternative  method  of  recombinant  protein  quantification  was  considered; 
expression of GFP-tagged alternative oxidase was attempted,  but the attempts  were not 
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successful  and  were  not  taken  forward.  Additionally,  quantification  through  coomassie 
intensity  was attempted,  although difficulty  in  accurately  identifying  bands on an SDS 
PAGE gel  that  corresponded solely  to  recombinant  AOX made  this  method  unreliable 
(Figure 4.11) and was not taken forward. One possible method for accurately quantifying 
protein  concentration  is  the  use  of  quantitative  Western  blotting  using  flourescence 
labelling (Bergendahl et al., 2003).
4.4.4.3 Downstream processing – protein concentration
As indicated in Table 4.14a, a number of techniques were investigated in order to 
identify the most effect method to concentrate purified protein samples. Of the methods 
investigated PEG precipitation proved to be the most effective, resulting in the retention of 
activity  in  the  pelleted  fraction  post-centrifugation  (Table  4.14b)  and  demonstrable 
localisation of the recombinant alternative oxidase to the same fraction (Figure 4.10). The 
pelleted fraction containing the concentrated recombinant alternative oxidase could also be 
readily frozen and stored at -80oC until required, with virtually no activity loss observed 
over  12  months  of  storage. The  other  methods  investigated  (ammonium  sulphate 
precipitation,  ultrafiltration,  dialysis  and  high-speed  centrifugation)  resulted  in  an 
unacceptable, irreversible loss of protein activity and so were not used. 
4.4.4.4 Substrate preference
As shown in Table 4.15, a higher rate of specific activity is observed when ubiqinol-
1  is  used  as  a  substrate  compared  to  duroquinol  and  decylubiquinol  in  the 
spectrophotometric activity assays. This is in agreement with previous findings (Hoefnagel 
et al., 1997), but does indicate that when ubiquinol-1 is not available, either duroquinol or 
decylubiquinol may be used.
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4.4.5 Isoform-specific differences in alternative oxidase protein activity
There are  significant  differences  between the specific  activity  of the three  main 
recombinant  S. guttatum alternative oxidase fractions (membrane-bound, solubilised and 
purified, Table 4.11) and the specific activity of other alternative oxidase isoforms, both 
native  and  recombinant  (summarised  in  Tables  4.16a  and  4.16b  below).  Particularly 
noteworthy comparisons are recombinant TAO and native A. maculatum (Kido et al., 2010 
and Affourtit and Moore, 2004 respectively), both of which reported specific activity values 
for a membrane-bound, solubilised and purified alternative oxidase isoform. For both  A. 
maculatum and  TAO,  the  specific  activities  observed  in  all  fractions  are  considerably 
greater  than  those  observed  in  the  equivalent  fractions  of  recombinant  S.  guttatum 
alternative oxidase. The higher activity exhibited by TAO may be an indication of the high 
turnover observed  in  vivo; during the blood-stream stage of the trypanosome life  cycle 
when  the  organism  produces  ATP  through  glycolysis  only,  the  TAO  acts  as  the  sole 
terminal oxidase turning over rapidly to reoxidise NADH to ensure glycolysis is sustained 
(Clarkson  et al., 1989; Chaudhuri  et al., 1995; Minagawa  et al., 1996). The TAO is not 
subject to regulation,  so given sufficient provision of substrate and a suitably lipophilic 
environment, the enzyme should function at maximum capacity both in vivo and in vitro. 
Moreover,  TAO  has  a  truncated  N-terminal  region  compared  to  S.  guttatum and  A. 
maculatum and this region has previously been identified as important in regulation of the 
activity  of  many  alternative  oxidase  isoforms  (Crichton et  al.,  2005;  Ito  et  al.,  2011). 
However, the high turnover rate of the TAO cannot account for the considerably greater 
protein concentration  observed during all  stages of expression and purification  of TAO 
compared to  that  of  recombinant  S.  guttatum alternative  oxidase.  As the  expression  of 
recombinant alternative oxidase is controlled by the same promoter for both  S. guttatum 
and TAO, the greater quantity of protein produced in FN102 cells expressing TAO may 
perhaps indicate that either TAO requires less cellular energy to synthesise than S. guttatum 
or  that  S.  guttatum recombinant  protein  is  subject  to  degredation  at  some  point  after 
synthesis. There is some evidence of S. guttatum presence in the non-membrane portion of 
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the cell lysate (Figure 4.4, lane 8) and furthermore there was no AOX activity observed in 
this fraction when assayed, suggesting degredation may be occuring.
By  contrast,  the  higher  activities  observed  in  A.  maculatum alternative  oxidase 
extracted from native tissues to near homogeneity (Affourtit and Moore, 2004) cannot be 
explained  by  a  difference  in  enzyme  function  –  both  A.  maculatum and  S.  guttatum 
generate  the heat  required for pollination  via  the alternative  oxidase.  Although the two 
isoforms share 90% sequence similarity, the recent discovery and sequencing of a number 
of  A. maculatum alternative  oxidase AOX1 gene products expressed at  different  stages 
during the process of thermogenesis highlight important amino acid variations (Ito  et al., 
2011) in a region of the AOX previously identified as involved in regulation (Crichton et  
al., 2005). A three amino acid motif, QDC (found at positions 288-290 in the S. guttatum 
sequence) is thought to be responsible for pyruvate sensitivity (Crichton et al., 2005); in the 
recently  sequenced  A. maculatum AOX mRNAs however,  the sequence  is  either  ENV, 
QDT or QNT. Crucially, the S. guttatum sequence is the only alternative oxidase sequence 
to date that contains the QDC motif,  which may account for the difference in observed 
activities presented below in Table 4.16a and above in Table 4.11. Additionally, it is likely 
that  the  rates  presented  by Affourtit  and Moore (2004) are  the result  of  the combined 
activities of two or more of the  A. maculatum AOX1 gene products.  As yet,  the exact 
mechanism for regulation at this site is unknown, although pyruvate and other α-keto acids 
are thought to play a major role (Crichton  et al., 2005). Furthermore, the activity assays 
performed on the A. maculatum samples were conducted in the presence of the detergent 
EDT-20 which is thought to stabilise the AOX protein (Affourtit and Moore, 2004; Carré et  
al., 2011).
Despite  the  considerable  differences  in  specific  and  total  activity  observed  in 
recombinant S. guttatum compared to native A. maculatum AOX and recombinant TAO, a 
greater percentage of the total activity (49%) can be retained when purifying  S. guttatum 
AOX compared to native A. maculatum (31%) and is comparable to the recovery achieved 
by Kido et al. (2010) when purifying recombinant TAO (53%).
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Fraction Total 
activity
(μmols/min)
Specific activity 
(μmols/min/mg)
Purification 
factor
% 
recovery
Total protein 
(mg)
Mitochondria 116 (58) 1.7 (0.85) - - 68
Soluble 84 (42) 5.8 (2.9) 3.4 81 16
Purified 36 (18) 64 (32) 38 31 0.57
Table 4.16a – Purification table for mitochondrial A. maculatum AOX. This Table shows total activity, 
specific activity, purification factor, % recovery and total protein for mitochondrial, solubilised and purified 
alternative oxidase isolated from A. maculatum tissues, adapted from Affourtit and Moore (2004). Total and 
specific activities refer to μmols of duroquinol  consumed and the figures in brackets refer to μmols of O2 
consumed as quoted in the referenced research article. Purification factor indicates the factor by which 
specific activity is increased compared to the mitochondrial specific activity and % recovery indicates the % 
of total activity recovered compared to the total mitochondria activity.
Fraction Total 
activity 
(μmols/min)
Specific activity
(μmols/min/mg)
Purification 
factor
% 
recovery
Total protein 
(mg)
Inner 
membrane
3500 23.3 - - 150
Soluble 2400 63.2 11 69 37.9
Purified 1860 207 35.4 53 8.95
Table 4.16b – Purification table for recombinant TAO expressed in FN102. This Table shows total 
activity, specific activity, purification factor, % recovery and total protein for inner membrane, solubilised 
and purified recombinant TAO expressed in FN102, adapted from Kido et al. (2010). Total and specific 
activities refer to μmols of substrate consumed when 150μM ubiquinol-1 was used as a substrate. Purification 
factor indicates the factor by which specific activity is increased compared to the inner membrane specific 
activity and % recovery indicates the % of total activity recovered compared to the total inner membrane 
activity.
4.4.6 Concluding remarks
For the first time, two different prokaryotic expression systems can be reliably used 
to express recombinant S. guttatum alternative oxidase protein. One system (C41) produces 
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a  higher  recombinant  protein  concentration,  whilst  the  other  system (FN102)  produces 
recombinant protein which exhibits a higher activity, albeit in smaller quantities. Given the 
lower specific activity observed in protein expressed in the C41 strain, the FN102 strain is 
the better choice for expressing protein to use for kinetic profiling as the protein is more 
likely to reach Vmax.
Recovery  of  total  activity  following  solubilisation  and  purification  of  the 
recombinant protein is comparable with other recombinant alternative oxidases (TAO, Kido 
et al.,  2010) and greater  than the recovery of total  activity  of alternative oxidase from 
native tissues (Affourtit and Moore, 2004). The use of the detergent DDM for solubilisation 
of recombinant  S. guttatum alternative oxidase is very effective. Furthermore, retaining a 
lower  concentration  of  DDM  and  OG  post-solubilisation  appears  to  be  important  for 
maintaining recombinant protein activity and stability. Therefore, a concentration of 0.5% 
(w/v) of both DDM and OG should be used in conjunction with magnesium sulphate and 
glycerol  in  all  post-solubilisation  buffers.  Crucially,  pyruvate  should  be  present  in  all 
buffers post-harvest, as pyruvate has the most positive effect on stability and activity of 
recombinant S. guttatum alternative oxidase.
Even  when  using  similar  growth,  solubilisation  and  purification  protocols,  the 
specific activity observed in recombinant TAO is considerably higher than that observed in 
recombinant  S. guttatum AOX. This indicates that the activity may be affected by protein 
structure, as there are differences in sequence, structure and activity in vivo between TAO 
and  S. guttatum  AOX. Although the optimised protocols are not suitable for scaling up 
much beyond volumes described herein,  they can be repeated often with ease allowing 
quantities of active protein to be produced, pooled and stored. Whilst this approach has the 
disadvantage that protein quality may vary from preparation to preparation, there is less 
protein to be lost  from one small  preparation than there would be for one much larger 
preparation should an error occur.
With an expression and purification protocol optimised for recombinant S. guttatum 
alternative oxidase,  this is a significant advancement towards producing protein for other 
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experimental procedures to further elucidate the structure and catalytic mechanism of the 
plant alternative oxidase. 
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Chapter 5
Structural Biology of the Alternative Oxidase
5.1 Background
The structure of a protein can be described on a number of different levels, from the 
specific order of amino acids as determined genetically, to the highly complex and stable 
tertiary and quaternary native states. It is possible to ascertain the global structure of a 
protein using methods such as X-ray crystallography, but to further probe the relationship 
between the structure and function of a protein, local structure must also be investigated. 
Whilst no crystal structure is available for any of the plant alternative oxidases, two TAO 
structures have been solved in recent months (Shiba et al., 2013). In addition, site-directed 
mutagenesis  of  key  residues  identified  through sequence  alignments  has  been gathered 
previously  for  a  number  of  AOX  isoforms,  which  has  lead  to  the  identification  and 
predicted structures of the active site, the substrate binding pocket and the inhibitor binding 
site.
The  results  presented  in  this  Chapter  show  for  the  first  time  analysis  of  the 
alternative oxidase secondary structure, and describe efforts to define a protocol for the 
crystallisation  of  the  S.  guttatum alternative  oxidase,  which  has  previously  not  been 
attempted.
5.1.1 Primary and secondary structure of the alternative oxidase
The primary structure of a protein is determined by the gene from which it has been 
transcribed. The amino acids, in specific order, are joined through covalent peptide bonds 
and unlike the secondary, tertiary and quaternary structures it is not subject to changes in 
state unless enzymatically  cleaved.  The primary structure of the alternative oxidase has 
been known for two decades, with the first amino acid sequence published in 1991 (Rhoads 
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and McIntosh; S. guttatum). To date, there are ~280 reviewed alternative oxidase sequences 
in  the UniProt database  (http://www.uniprot.org),  from both prokaryotic  and eukaryotic 
organisms. Early sequence alignments were carried out when relatively few sequences were 
known  (cf Moore  et  al.,  1995a)  and  areas  of  high  conservation  became  immediately 
apparent.  Additionally,  similarities  between  alternative  oxidase  and  diiron  carboxylate 
sequences (as reported in Moore  et al., 1995a and Moore  et al., 1995b) were observed. 
Furthermore,  the  alternative  oxidase  appeared  to  share  physical  properties  with  diiron 
carboxylates (like methane mono-oxygenase, MMO) such as the absence of a spectroscopic 
signal above 340nm (Vincent et al., 1990; Wilkins 1992; and Lipscomb 1994), leading to 
the suggestion that the similar functions of the AOX and diiron carboxylate (the activation 
of molecular oxygen)  might indicate that their structures may also be similar (Moore et al, 
1995a). This was supported by the similarity observed in the structures (Nordlund  et al., 
1992) of several diiron carboxylate proteins (hemerythrin, Holmes  et al., 1991; methane 
mono-oxygenase, Rosenzweig et al., 1993; and ribonucleotide reductase R2, Nordlund and 
Eklund, 1993).  Whilst  the number of monomers varies  for each diiron carboxylate,  the 
monomers have predominantly  α-helical structure, with four helices lying anti-parallel to 
one another to form a scaffold for the diiron active site. Using homology modelling based 
on another diiron carboxylate,  Δ9-desaturase, Andersson and Nordlund predicted that the 
alternative oxidase active site was similarly constructed (Andersson and Nordlund, 1999).
Secondary  structure,  which  is  the  formation  of  intrinsically  coded,  locally  co-
ordinated α-helices and β-sheets, is the result of hydrogen bonding. The resultant structures 
have regular geometry, as the amide bonds holding the residues together have restricted 
torsion angles (Ramachandran  et al., 1963). Helices, for example, are permitted to adopt 
either 3.613, 310 or  π-helix conformation,  with the latter  two occurring less frequently in 
nature than the former. In the 3.613 helix, often referred to simply as an α-helix, there are 3.6 
amino acids per turn,  which results  in  hydrogen bond formation between the backbone 
C=O group of the  nth atom of the chain and the backbone N-H group of every  nth + 4 
residue. The lone pair of electrons found in the C=O group act as an acceptor to allow 
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hydrogen bonding to take place with the N-H group acting as the donor. One full hydrogen 
bond – spanning residue n to n+4 – contains approximately 13 atoms. The resulting helical 
structure has a square appearance when viewed lengthways through the core of the helix. 
This is the most commonly occurring helical conformation observed in nature.
By contrast, the 310 formation, which occurs in nature less frequently, contains 3 
residues per turn, and a single closed hydrogen bond loop spans 10 atoms. Bonding still 
occurs between the C=O and N-H groups, but the participating N-H group is found on the 
nth+3 residue, rather than the  nth+4 residue as it is in the  α-helix. The 310 helix appears 
triangular  when  viewed  lengthways  along  the  core,  and  offers  a  more  tightly  packed 
conformation. In the π-helix, hydrogen bonding occurs between the C=O and N-H moieties 
found on the nth and nth+5 residues respectively. Recent research suggests that π-helices are 
more common than previously thought, and may play a role in the formation of kinks in α-
helices  of  some active  sites (Cooley  et  al.,  2010). All  three helices  adopt  a  right-hand 
conformation in nature.
The physical construction of α-helices was both predicted (Pauling et al., 1951) and 
verified experimentally (cf Kendrew et al., 1960). In 1983, Kabsch and Sander devised the 
Dictionary  of  Secondary  Structure,  and  developed  the  algorithm  “Define  Secondary 
Structure  of  Proteins”  (DSSP),  which  allows  the  user  to  assign  secondary  structure 
elements (SSE) within a 3D structure given the atomic coordinates. The DSSP algorithm 
identifies  SSEs based on hydrogen bonding and atom geometry; for example it can assign 
α,  310,  and  π  helices  by  calculating  theoretical  hydrogen  bond  energies  between  two 
residues (n + 4, 3 or 5 respectively) given their distance and the angle relative to each other. 
This algorithm cannot be used to predict secondary structure from sequence information, 
but the description of hydrogen bonding and atom geometry in a mathematical way has 
been an fundamental tool when taking a knowledge-based approach to structure prediction. 
Algorithms exist which are able to predict the propensity for any given sequence of amino 
acids to form particular secondary structure elements. Early calculations were based either 
on the frequency with which certain residues occur in each structure (Chou and Fasman, 
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1974)  for  example,  or  calculating  probability  both  on  residue  frequency  and  the 
neighbouring amino acid residues (Garnier et al., 1978). Both algorithms have since been 
adapted and improved, and are freely available and widely used.
5.1.1.1 Determining secondary structure experimentally – circular dichroism
Secondary  structure  may  be  verified  experimentally  by  a  number  of  different 
methods,  such  as  X-ray  crystallography,  nuclear  paramagnetic  resonance  (NMR) 
spectroscopy and UV circular dichroism (CD). Of particular interest to this project has been 
X-ray crystallography and CD, and the latter has been used to estimate the extent of α-
helical structure within the plant alternative oxidase protein.
CD is a spectroscopic technique in which the differential absorption of left- or right-
hand circularly polarised light  by chiral  molecules,  such as proteins,  is  monitored over 
several  wavelengths.  The  data  obtained,  if  correctly  analysed,  can  provide  information 
relating to the secondary structure of the protein under investigation (cf Chen et al., 1974; 
Chang et al., 1978; and more recently Whitmore and Wallace, 2004; Greenfield, 2006b). 
CD has been used successfully to investigate membrane proteins such as bacteriorhodopsin 
(cf Cogdell and Scheer, 1985). Furthermore, the limitations of using CD in the investigation 
of membrane protein secondary structure and the implications for data analysis have been 
described and critically evaluated (cf Wallace et al., 2003; Whitmore and Wallace, 2008). 
For example, shifts in the CD peaks associated with α-helices are observed between soluble 
and membrane proteins, especially when membrane proteins have been solubilised from 
their  native  membrane  environments  (Swords  and  Wallace,  1993).  As  such,  careful 
interpretation of CD data obtained from membrane protein samples – whether membrane-
bound or solubilised – is advised (Whitmore and Wallace, 2008).
In addition to providing information about the secondary structure of proteins, CD 
can be used to assess the thermal stability of proteins (Yadav and Ahmed, 2000; Greenfield, 
2006a)  by monitoring  absorbance  at  a  single wavelength  (such as  222nm for  α-helical 
proteins)  from  low  to  high  temperature.  If  interpreted  correctly,  data  obtained  could 
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indicate not only the temperature at which a protein begins to unfold, but also the extent to 
which secondary structure is diminished after heating to 90oC. This is of particular interest 
in the case of  S. guttatum alternative oxidase, which is responsible for the dissipation of 
energy  not  coupled  to  ATP  synthesis  but  released  as  heat  during  the  process  of 
thermogenesis (Meeuse, 1975; Meeuse and Raskin, 1988).
5.1.2 Tertiary and quarternary structure of the alternative oxidase
The tertiary structure of globular proteins is the native state where the elements of 
secondary structure are both brought closer together and stabilised through the sequestering 
of hydrophobic residues at the core of the molecule. This state may be further stabilised by 
the exclusion of water from the core, and formation of intra-molecular disulphide bonds in 
some cases. In addition, hydrophilic interactions between the solvent-exposed residues and 
the external environment aid in the maintenance of the compact structure. Relatively little is 
known about the tertiary structure of the alternative oxidase, and what is known is inferred 
from experimental evidence and algorithmic prediction.
As  previously  stated,  in  light  of  both  homology  modelling  (Andersson  and 
Nordlund,  1999) and recent  TAO crystal  structures  (Shiba  et  al.,  2013),  the secondary 
structure elements of the AOX are highly likely to form an anti-parallel, four-helix bundle, 
accounting  for  the  vast  majority  of  the  tertiary  structure.  Specific  residues  involved in 
stabilising  hydrophobic  interactions  have  not  been  identified.  Predicted  loop  regions 
between the helices are relatively short and most likely relatively inflexible, aiding in the 
maintenance of tertiary structure stability. However, relatively little is known about the N- 
and  C-terminal  regions,  which  even  in  the  TAO  crystal  structures  appears  to  be 
unstructured. It has previously been suggestion that the N-region in particular – the region 
with the greatest sequence dissimilarity between species – may act to increase activity of 
the molecule through interaction with α-keto acids (Crichton et al., 2005) in some species. 
The exact mechanism for this has not been fully elucidated experimentally.
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It is thought that the extent of the quaternary structure of most plant alternative 
oxidases is homodimerisation, which is responsible for regulation of activity (Moore and 
Seidow,  1991;  Umbach  and  Seidow  1993)  in  many  non-thermogenic  species. 
Homodimerisation is facilitated by the formation of sulphide bonds between the two highly 
conserved cysteine (C122 in S. guttatum numbering) residues present in all plant sequences. 
In  other  organisms  such  as  fungi  and  trypanosomes  it  is  not  clear  whether 
homodimerisation occurs, as an equivalent conserved cysteine residue is absent. When both 
native and recombinant TAO has been purified, no evidence of dimerisation was observed 
on SDS-PAGE gels (cf Chaudhuri  et al., 1998; Fukai  et al., 2003). However, the recent 
structures of TAO show it as a homodimer – despite the absence of a conserved cysteine.  
This suggests the potential presence a second site for homodimerisation, which may also be 
applicable to other non-plant alternative oxidase structures.
Further  to  the  regulation  of  alternative  oxidase  activity  through  dimerisation, 
stimulation by α-keto acids such as pyruvate is also thought to involve the conserved C122 
residue (cf  Rhoads  et  al.,  1998 and Carré  et  al.,  2011).  It  is  thought  that  through the 
formation of a thiohemiacetal bond between the pyruvate and the C122 residue, the tertiary 
and  potentially  the  quaternary  structure  of  α-keto  acid-sensitive  alternative  oxidase 
isoforms  may  be  altered.  Mutation  of  the  cysteine  122  residue  renders  the  protein 
insensitive to pyruvate (Rhoads et al., 1998), which confirms the importance of the residue, 
but not the exact mechanism by which the conformational change is facilitated or what the 
conformational  change may be.  This  implies  a  certain  amount  of  flexibility  within  the 
alternative  oxidase  structure  exposed  to  the  cytosol  –  which  is  perhaps  aided  by  the 
stabilisation of the membrane-associated regions of the protein. It is widely acknowledged 
that  proteins  rarely  have  a  fixed  or  inflexible  single  structural  conformation;  there  is 
thought to be considerable movement associated with catalytic activity in ATP-synthase, 
for example (Boyer, 1975; Abrahams et al., 1994). Therefore, the relative flexibility within 
the  cytosolic, non-membrane regions of the alternative oxidase structure is considered an 
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essential  part  of  its  structural  biology  and  an  intrinsic  part  of  the  structure-function 
relationship.
5.1.3 Structure-function relationships – mutants
Sequence  homology  data  as  analysed  by  Moore  et  al.  (1995a)  led  to  the 
identification of several conserved residues proposed to be essential to activity; this list was 
refined by Andersson and Nordlund (1999). When mutated, the six residues involved in the 
binding of the two iron ions in the active site (E178, E217, H220, E269, E319, H322) cause 
complete loss of activity in the protein, even though the protein is expressed (cf Albury et  
al., 2002). Mutation of the equivalent conserved residues in TAO causes the same loss in 
activity (Ajayi et al., 2002), suggesting that the active sites of the AOX and TAO isoforms 
function in the same way. Highly conserved residues outside of the active site have also 
been investigated through mutagenesis, and these are listed below in Tables 5.1a and 5.1b 
along with proposed function. The location of each mutant in the protein is illustrated in 
Figure 5.1.
5.1.4 The nature of alternative oxidase membrane association
When first exploring the primary structure of the alternative oxidase, Moore and 
Siedow (1991) performed an in silico hydrophobicity analysis of the AOX sequence which 
revealed that there were several regions of predominantly hydrophilic residues, and two 
large regions of hydrophobicity spanning ~25 residues. Initially it was proposed that the 
hydrophobic  regions  formed  two  membrane-spanning  helices,  with  the  active  site 
comprised of several smaller helices located on the matrix-facing side of the mitochondrial 
membrane (Moore et al., 1995a), based on previous localisation experiments (Rasmusson 
et al., 1990). However in the subsequent homology model (Andersson and Nordlund, 1999) 
it was proposed that there were no transmembrane helices in light of similarities between 
the alternative  oxidase and the  diiron carboxylates,  and that  the protein was largely  α-
helical. The membrane association is now known to be monotopic, and the larger spans of 
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Residue and 
mutation
Function Effect of mutation Reference
T179A Proximal to E178 
(iron binding), found 
near active site
Decreases vmax and 
increases oxygen 
affinity
Crichton et al., 2010
W206F/Y Radical formation Inactive Crichton et al., 2010
Q242N Inhibitor/substrate 
binding in 
hydrophobic pocket 
between helices 2 
and 3; possible 
membrane binding.
94% activity lost Albury et al., 2010
N247Q 4% activity lost
Y253F
Y253A
F 39% activity lost; 
A 72% activity lost
S256T 93% activity lost
H261A HR pair motif found 
in quinone-binding 
proteins; also in 
hydrophobic pocket 
between helices 2 
and 3; possible 
membrane binding.
95% activity lost
Albury et al., 2010R262K 94% activity lost
E270N
Proximal to E269 
(iron binding), found 
in active site
Inactive
Albury et al., 1998
Y275F Radical formation Inactive Albury et al., 2002
Y299F Radical formation Retained 100% 
activity
Crichton et al., 2010
Table 5.1a – Previously mutated residues and the effect on activity once mutated. This Table lists 
previously mutated residues, their proposed function, and the effect of the mutation on activity. Where the 
expressed isoforms are inactive, expression was confirmed using Western Blotting. Residues highlighted in 
bold have been expressed as part of this thesis and the results are detailed in Section 5.3.5.
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Residue Function Effect of mutation Reference
C122E
Dimerisation site; 
site of probable α-
keto acid interaction; 
potential interaction 
with oxygen
Constitutively active; 
insensitive to 
pyruvate
Rhoads et al., 1998
C122K/R (positive 
charge added)
Insensitive to 
pyruvate and 
succinate; more 
active than wild type 
in absence of 
pyruvate
Umbach et al., 2002
C122Q/L 
(uncharged)
Inactive
C172A Possible second 
dimerisation site; 
putative α-keto acid 
binding site
Oxygen affinty 
decreased
Albury et al., 2002; 
Crichton et al., 2010
Table 4.1b – The effect of mutating two key cysteine residues. This Table details previous mutagenesis of 
the two conserved cysteine residues involved in regulation of AOX activity. Residues highlighted in bold 
have been expressed as part of this thesis and the results are detailed in Section 5.3.5.
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Figure 5.1 – A diagrammatic representation of three residues investigated in this thesis. This Figure 
shows the location of the mutated residues investigated during this project: C172 is shown in red; T179 in 
green, and Y253 in blue. The model was generated as described in Chapter 3, Section 3.2.3.
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hydrophobicity  are  more  likely  to  correspond  to  the  substrate  binding  region  (as  the 
substrate is hydrophobic;  cf Hoefnagel  et al.,  1997) rather than forming transmembrane 
helices. 
In the absence of structural data, bioinformatic approaches may provide useful – 
albeit limited – information. In order to predict whether a protein contains transmembrane 
helices, for example, servers such as PredictProtein (cf Rost et al., 2004) are able to apply 
several algorithms to user-submitted sequences. Most of the prediction algorithms  focus on 
larger  areas  of  membrane association,  such as  transmembrane  helices  (see  Nugent  and 
Jones (2012) for a recent review); there are no specific algorithms to predict whether a 
protein is associated with the membrane in a monotopic manner, as is the case with the 
alternative  oxidase.  The  lack  of  monotopic  membrane  prediction  algorithms  is  partly 
because monotopic membrane proteins are not as clearly defined as some other protein-
membrane  association  mechanisms  (anchors  or  transmembrane  helices  for  example)  – 
though  they  are  mainly  included  in  training  sets  for  machine  learning  approaches  to 
membrane-association prediction in order to aid distinction between transmembrane and 
non-transmembrane proteins  (cf Jayasinghe  et  al.,  2001).  Another  factor  in  the  lack  of 
monotopic  membrane  prediction  algorithms  is  the  under-representation  of  monotopic 
membrane  protein  crystal  structures  in  the  relevant  databases.  Of  the  ~74,000  crystal 
structures available in the Protein Data Bank (PDB), only 65 are identified as monotopic 
membrane proteins – which represents 0.08% of the database. Included in the 65 structures 
is the prostaglandin H2 synthase-1 protein (first solved by Picot et al., 1994, PDB reference 
1PRH),  which  has  previously  been  proposed  as  a  template  for  the  membrane-binding 
region of the alternative oxidase, as the diiron carboxylate structures used as templates for 
previous  models  (i.e.  Andersson  and  Nordlund,  1999)  are  not  membrane  associated 
proteins, and therefore lack any membrane-binding regions.
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5.1.5 Elucidation of the quaternary structure through crystallography
The first  protein structure to  be solved using X-ray crystallography was that  of 
myoglobin in 1958 (Kendrew  et al.,  1958). The technique had previously been used to 
elucidate smaller biologically relevant molecules such as Vitamin B12 (Brink et al., 1954; 
Hodgkin et al., 1955), but elucidation of a structure several times larger than B12 presented 
a very different challenge.
The  first  stage  in  protein  crystallography  is  the  production  of  suitable  protein 
crystals,  which  can  be  a  time-consuming  and  non-trivial  task.  Suitably  homogeneous, 
folded protein is mixed in small volumes with multiple screen solutions (often less than 1μl 
of  protein  to  an  equal  volume  of  solution),  covering  a  wide  variety  of  pH,  salt  and 
precipitant  concentrations  and  conditions.  The  protein-solution  mixture  can  then  be 
aliquoted on to a coverslip and placed above a reservoir containing a larger volume of the 
screen solution (hanging drop method) and sealed with a lubricant such as silicon grease. 
Alternatively,  the  protein-solution  mixture  can  be  placed  on to  a  ledge  next  to  a  well 
containing a larger volume of the screen solution in a 96-well plate (sitting drop method). 
In both cases  diffusion of vapour allows movement  of molecules  between the solution 
contained in the well and the solution in the sitting or hanging drop, encouraging protein 
aggregation and ultimately ordered precipitation. In order to achieve ordered precipitation, 
commercially  prepared  screen  kits  contain  between  28 and 96 non-redundant  solutions 
ranging from a sparse matrix of conditions previously successful for crystallising proteins 
(after Jancarik and Kim, 1991), to specialist screens tailored to specific protein classes such 
as membrane proteins  (cf Newstead  et  al.,  2008).  While  the protein is  initially  soluble 
within the screen solution, the protein solubility must be gradually decreased in order  to 
cause  ordered  protein  precipitation  and  crystal  formation.  Since  protein  solubility  is 
effected by pH, salt concentration and the presence of solvents and precipitants (Chernov, 
2003), it is these factors which are varied in crystal growth solutions. The effects of each 
factor are summarised above in Table 5.2.
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Factor Effect on protein solubility
Salts
Addition of kosmotropic salts (sulphates, phosphates etc.) decreases 
protein solubility through the removal of water molecules from the 
surface of the protein. This leads to protein aggregation and 
precipitation due to hydrophobic protein-protein attraction. Addition 
of chaotropic salts (iodide, lithium etc.) increases water-protein 
interactions, leading to increased protein solubility and often 
denaturation as concentration of the salt increases.
pH
Protein molecules in a solution with a pH above or below their pI 
will be repelled due to exposure of negative and positive charges 
respectively on the protein surface. Proteins close to their pI 
experience attractive forces, which contributes to the process of 
aggregation and precipitation.
Solvents
Addition of organic solvents such as alcohols results in protein 
aggregation and precipitation as water molecules are gradually 
removed from the surface of the protein, leading to hydrophobic 
attraction between protein molecules. However, addition of solvents 
may cause protein denaturation above 0oC.
Other precipitants
Addition of polymers such as polyethylene glycol (PEG) leads to 
protein aggregation and precipitation through the removal of water 
molecules from the surface of the protein, causing hydrophobic 
attractions between protein molecules. Precipitants such as PEG are 
less likely to denature the protein at temperatures above 0oC.
 Table 5.2 – Factors which affect protein solubility.
Initially the individual crystallisation solutions containing the protein of interest are 
kept at a constant temperature with minimal movement to encourage nucleation. Nucleation 
is the process by which protein molecules begin to aggregate and align in a regular pattern 
required  to  generate  crystals.  The nucleation  event  may be as  a  result  of  a  number of 
protein  molecules  aligning  in  a  regular  order  whilst  moving  through  the  solution  and 
forming  a  surface  onto  which  more  molecules  may  adhere  (homogeneous  nucleation). 
Alternatively protein molecules begin to adhere and align on a surface which is not made 
from other protein molecules (heterogeneous nucleation)  such as silicon (Chayen  et al., 
2001). The rate of nucleation is dependent on both the number of clusters formed in the 
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early stages, which may take a few hours to form for some proteins or considerably longer 
for others; and the rate at which the protein molecules can diffuse through the solution 
towards existing clusters. Nucleation and subsequent crystal growth can be described using 
a phase diagram, which can be derived for a protein by varying the individual parameters 
for a particular  screen condition (cf Haas and Drenth,  1999).  Following nucleation,  the 
protein molecules should continue to aggregate and align in a regular order in part initiated 
by the reduction in protein concentration as molecules forming the nuclei are removed from 
the solution. However, the conditions required for nucleation are often not the same as the 
conditions required for further crystal growth and it is at this point that the small sites of 
nucleation  can  be  removed  from  the  original  drop  solution  and  placed  in  a  highly 
concentrated  protein  solution.  The  nuclei  are  transferred  to  the  concentrated  protein 
solution using a fine gauge needle and act as seeds for further crystal growth. Predictive 
models of the process of nucleation and subsequent crystal growth have been attempted 
(Rupp  and  Wang,  2004),  although  the  models  require  large  quantities  of  data  from 
previously successful crystallisation conditions. As such the models cannot confidently be 
applied to proteins with no previous crystals, or those classes of protein which are under-
represented in the database – especially  membrane proteins (see Section 5.1.3.4 below; 
Rupp and Wang, 2004). Once conditions have been identified which consistently lead to 
nucleation  and initial  crystal  growth,  further  optimisation  is  required.  A range  of  new 
reservoir solutions can be created by gradually altering the original conditions one factor at 
a time, as illustrated in Table 5.3 below, to give a new matrix of conditions. Following 
optimisation  and  successful  crystal  growth,  the  process  of  collecting  and  analysing 
diffraction data can begin, the final result of which is the production of a three-dimensional 
description of the protein structure.
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pH Salt concentration Precipitant
Original 5.6 0.1M NaCl 30% PEG 400
Variation 4.6-6.6 0.1M NaCl 20-40% PEG 400
Table 5.3 – An example demonstrating the variants created from an original solution. In this example, 
48 new, unique solutions were created.
5.1.6 The challenges of membrane protein crystallography
To date, there are in excess of 74,000 X-ray crystal structures available in the PDB. 
However,  there  is  a  distinct  under-representation  of  certain  classes  of  protein,  such  as 
membrane proteins. Of the ~600 structures identified as membrane-associated proteins in 
the PDB, just under half (281) are described as integral membrane proteins, suggesting that 
of the 74,000 crystal structures3, only 0.8% are membrane-associated proteins, while just 
0.38% are integral membrane proteins. Compared to the prevalence of membrane proteins 
within  eukaryotic  organisms  –  approximately  30%  of  the  proteome  corresponds  to 
membrane  proteins  (Bill  et  al.,  2011)  –  there  is  a  clear  discrepancy  between  natively 
expressed protein and solved structures within the database.
This does raise the question as to why there are so few membrane-associated protein 
structures in structural databases – is it due to lack of research interest, or are there other 
inhibitory factors involved? As far as the former is concerned, it is not down to a lack of 
interest or impetus; with membrane proteins playing vital roles in processes such as cell 
signalling and respiration, they are not a class of proteins of limited merit – indeed, they are 
often  identified  as  important  drug targets.  So  on to  the  latter,  and the  relatively  well-
documented difficulties associated with the crystallisation of membrane proteins.
The first membrane protein crystal structure was presented in 1985 – some 33 years 
after the first protein structure (Deisenhofer et al., 1985). While there are specific problems 
associated with expression of membrane proteins in hosts  such as  E. coli (as described 
previously in Chapter 4), there are further limitations experienced when expressing and 
3 As of September 2012; http://www.rcsb.org/
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purifying membrane proteins for the purpose of crystallography (Carpenter et al., 2008). A 
major obstacle in the crystallisation of membrane proteins is the requirement of detergent 
for  protein  stability:  membrane  proteins  often  rely  on  areas  of  hydrophobicity  for 
conformational stability, which is provided by the membrane. When extracting expressed 
recombinant  protein from the membrane,  detergent  is required to disrupt the membrane 
itself. Whilst this is not necessarily problematic from the perspective of protein purification 
(as detergent can easily be incorporated into purification buffers), it is often inhibitory to 
the  production  of  crystals  as  the  resultant  detergent-protein  complexes  can  disrupt 
formation  of  well-ordered  crystals  (Privé,  2007).  Therefore,  the  smaller  the  detergent 
micelle,  the  more  likely  successful  crystallisation  is;  octyl-glucoside  is  preferred  over 
dodecyl-maltoside for this  reason.  Additionally,  the presence of detergent  decreases the 
likelihood  of  sufficient  protein  aggregation  and  precipitation;  the  protein  molecules 
sequestered  in  the  detergent  micelles  may  not  be  affected  by  the  factors  leading  to 
precipitation described above in Table 5.2.
In order to avoid excessive use of detergent, lipidic materials may be incorporated 
into  the  crystallisation  solutions,  providing  both  sites  of  nucleation  and  a  lipidic 
environment required for membrane protein stability (Landau and Rosenbusch, 1996; and 
more recently reviewed in Caffrey, 2009 and Cherezov, 2011). Such systems have proven 
successful in the field of membrane crystallography, with several structures solved in recent 
years using Lipidic  Cubic Phase (LCP) techniques (notable examples are Katona  et al., 
2003 and Cherezov et al., 2007). 
5.2 Methodology
5.2.1 Circular dichroism
Purified  recombinant  S.  guttatum protein expressed  in  FN102 and  TAO protein 
(provided by Dr Yasutoshi Kido, University of Tokyo, Japan) was concentrated using the 
PEG precipitation method as previously described in Chapter 2. When required the PEG 
precipitated  pellets  were gently  thawed on ice and resuspended in chilled  (4oC) buffer, 
146
before being loaded into a 1mm glass CD cuvette (Hellma). Absorption measurements were 
taken with a Jasco J715 spectrophotometer, and the block temperature was controlled using 
a Jasco Peltier-type system. Data was recorded using the Jasco Spectra Manager software 
suite and exported to Microsoft Excel or Gnumeric for analysis. Two experiments were 
conducted – multiple wavelength scans and single-wavelength variable temperature assays 
to asses secondary structure and thermal stability respectively.
In order to predict the percentrage of each secondary structure element from the raw 
CD data, three algorithms were used via the Dichroweb server (Whitmore and Wallace, 
2008; http://www.dichroweb.cryst.bbk.ac.uk/html/home.shtml): K2D  (Andrade  et  al., 
1993), CDSSTR and SELCON3 (cf Sreerama  et al., 1999; Sreerama and Woody, 2000). 
The K2D algorithm was selected as it did not require selection of a Reference set in order 
to perform the analysis. This was considered important because the Reference proteins used 
to generate the Reference sets provided by Dichroweb  are all soluble proteins (with the 
exception of SMP180, described below) and therefore may be biased against membrane 
proteins (cf Wallace  et al.,  2003 and Whitmore and Wallace,  2008). The Reference set 
SMP180 (Abdul-Gader  et  al.,  2011)  does  contain  membrane  proteins  (albeit  large  and 
transmembranous proteins) and is suitable for use with the SELCON3 algorithm. It was not 
possible to analyse the TAO data using SMP180 Reference set, as it requires data from 
180nm, whilst the TAO dataset contained data from 190nm and above only. The CDSSTR 
algorithm was chosen along with Reference set 4 (optimised for 190-240nm) as CDSSTR is 
considered relatively accurate (cf Whitmore and Wallace, 2004) as the algorithm selects 
reference proteins  from the Reference set  with similarities  to the protein of interest  (cf 
Sreerama and Woody, 2000) and the Reference set most closely matched the wavelength 
range of the S. guttatum AOX data where the HT was less than 600 volts.
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5.2.2 Prediction of secondary structure
The S. guttatum protein sequence (UniProt accession number P22185; full sequence 
can be found in Appendix 1) was input into the programs listed below in Table 5.4 to 
predict secondary structure.
5.2.3 In silico investigation of dimerisation site
In  lieu  of  experimental  evidence  confirming  the  nature  of  the  dimerisation 
mechanism, an homology model of the S. guttatum alternative oxidase (based on TAO, see 
Chapter  3  Section  3.2.7)  was  studied  in  PyMOL (http://www.pymol.org)  to  assess  the 
likelihood of dimerisation through salt bridge formation, hydrogen bonding networks and 
interfacial water hydrogen bonding. Other structures with non-sulphide dimer linkage were 
studied for comparison; especially those with a known monotopic membrane association 
such as external NADH dehydrogenase (PDB accession numbers 4G9K, 4GAP and 4GAV 
– all Iwata et al., 2012).
Program Server/URL Reference
PSIPRED 3.0
PSIPRED 
http://bioinf.cs.ucl.ac.uk/psipr
ed/
Jones, 1999; Buchan et al., 
2010
CFSSP http://www.biogem.org/tool/c
hou-fasman
Chou and Fasman, 1974
GOR
NPS@
http://pbil.ibcp.fr/htm/index.p
hp
Garnier et al., 1978; Combet 
et al., 2000 
JPred3 http://www.compbio.dundee.
ac.uk/www-jpred/
Cuff et al., 1998; Cole et al., 
2008
PROFphd
PredictProtein
http://www.predictprotein.org
Rost and Sander, 1993; 
Rost, 1996; Rost et al., 2004
PROSITE Bairoch et al., 1997
Table 5.4 – Algorithms used to predict secondary structure for the S. guttatum alternative oxidase.
148
5.2.4 Crystallography
Protein for  crystallisation  screening was prepared using concentrated  eluate  (see 
Chapters  2  and  4)  containing  expressed  recombinant  alternative  oxidase  protein. 
Concentration was carried out using PEG precipitation (as described in Chapter 2) and final 
protein concentration was typically <10mg/ml.  Initially,  to ensure that the concentration 
was optimal, a pre-crystallisation test (PCT; Hampton Research) was carried out as per the 
manufacturer’s guidelines. 
Concentrated protein was then used to set up crystal screen trays using both hanging 
and sitting drop methods. 1μl of protein was used for both methods. A variety of screens 
were  used  in  the  laboratory  of  Dr  Darren  Thompson  (University  of  Sussex,  UK),  the 
laboratory of Professor Kiyoshi Kita (University of Tokyo, Japan) and the laboratory of 
Professor  So  Iwata  (Imperial  College  London  and  Diamond  Light  Source,  UK).  The 
screens used are listed below in Table 5.5. It should be noted that initial screens (at Sussex 
and  Diamond)  were  chosen  because  they  had  been  specially  designed  for  membrane 
proteins, while the screens used in the Tokyo lab were recommended by Dr Shiba based on 
previous success when crystallising the TAO.
Sussex Tokyo Diamond
Mem Start (MD1-21) CS I (HR2-110) Mem Start (MD1-21)
Mem Sys (MD1-25) CS II (HR2-112) Mem Sys (MD1-25)
MembFac (HR2-114) Mem Gold (MD1-39)
Table 5.5 – Crystal screens. This Table shows the crystal screens used in the three labs where screening took 
place. The manufacturer (MD Molecular Dimensions; HR Hampton Research) and product reference 
number are shown in brackets.
In the laboratory at the University of Sussex, the hanging drop method was used 
(see Section 2.6.1), whilst at the University of Tokyo, the sitting drop method (see Section 
2.6.2) was used exclusively. At the Membrane Protein Laboratory at the Diamond Light 
Source, both hanging and sitting drop methods were used. In all  cases, the plates were 
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checked  regularly  and  care  was  taken  to  avoid  crystal  degradation  by  excessive  plate 
handling. 
5.2.5 Expression of mutant isoforms
A variety of S.gutattum mutants were created by Dr Mary Albury (as detailed above 
in Tables 5.1a and 5.1b in bold and Figure 5.1) and expressed using FN102 E. coli. The 
purification of these recombinant mutant proteins was carried out as described in detail in 
Chapter  4,  and  assays  were  performed  using  50mM  TRIS,  pH7.4  buffer.  A  substrate 
(ubiquinol-1) concentration of 150mM was used in each assay, and 100nM ascofuranone 
was  used  as  the  inhibitor.  Assays  were  carried  out  on  a  Shimadzu  UV-3000 
spectrophotometer. SDS PAGE and Western blots were performed as previously described 
in Chapter 2.
5.2.6 Variable temperature activity assays
Membrane-bound  and  purified  recombinant  S.  guttatum protein  was  assayed  to 
determine the effect of temperature on AOX activity. The protocol as defined in Section 
2.5.2 was modified to control buffer and protein temperature using a Fisher (DriBlock DB1, 
Techne) heating block prior to assay, Cary Temperature Controller connected to a Cary 400 
spectrophotometer (Varian) to control the sample temperature for the duration of the assay. 
The inhibitor (octyl-gallate) was not heated due to the small quantity added to the cuvette; 
the substrate (ubiquinol-1) was not heated to avoid evaporating the acidified ethanol  in 
which it was suspended. The assay buffer used in all experiments was 50mM TRIS, pH 7.5, 
10mM pyruvate; 150mM of ubiquinol-1 was used as the substrate, with 1μM octyl-gallate 
used as an inhibitor. 
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5.3 Results
5.3.1 Circular dichroism
5.3.1.1 Wavelength scan
Figure 5.2a below shows mean residue ellipticity,  [θ] (mdeg cm2 dmol-1) against 
wavelenght for purified  recombinant  S. guttatum alternative oxidase at a concentration of 
5μM, whilst Figure 5.2b shows the same trace overlaid with purified recombinant TAO at a 
concentration of 4.25μM. Figure 5.4 shows the effect of varying TAO concentration on 
mean residue ellipticity.
Table 5.6 below shows the outcome of raw CD analysis by the K2D, CDSSTR and 
SELCON3 algorithms (as accessed via Dichroweb) along with the Reference protein set 
used. For K2D, wavelengths 200-260nm were selected (as the HT values shown in Figure 
5.2a) exceed 600 volts for absorbance readings below 200nm; for CDSSTR wavelengths 
190-240nm  were  used  and  for  SELCON3,  wavelengths  of  180-240nm  were  used,  as 
required by the algorithms.
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Figure 5.2a – Circular dichroism of purified recombinant S. guttatum AOX expressed in FN102. This 
CD trace shows the mean residue ellipticity ([θ] (mdeg cm2 dmol-1)) of purified S. guttatum recombinant 
alternative oxidase at 5μM. The second plot (top, right) shows the high tension (HT, in volts) values for the 
data shown to demonstrate why the data has been truncated at 200nm.
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Figure 5.2b – Comparison of circular dichroism of purified recombinant S. guttatum AOX and TAO 
expressed in FN102. This CD trace demonstrates the trace from Figure 5.2a overlaid with the mean residue 
ellipticity ([θ] (mdeg cm2 dmol-1)) of purified TAO at a concentration of 4.25μM.
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Figure 5.3 – Circular dichroism of recombinant TAO expressed in FN102. This trace shows mean residue 
ellipticity ([θ] (mdeg cm2 dmol-1)) of purified TAO at 4.25μM, 8.5μM and 17μM.
5.3.1.2 Variable temperature
Figure 5.4 below shows the degree of conformational change observed as a function 
of  mean residue ellipticity  versus  temperature  for  purified  S.  guttatum AOX and TAO 
respectively at a wavelength of 222nm.
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Figure 5.4 – The effect of temperature on mean residual ellipticity at 222nm. This Figure demonstrates 
the effect of temperature on mean residual ellipticity at 222nm ([θ] (mdeg cm2 dmol-1)) of purified S. guttatum 
alternative oxidase (○) and purified TAO (□) from 10oC to 90oC.
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Sequence Algorithm and
Reference set
Predicted secondary structure elements (%)
α1 α2 β1 β2 Turn Coil
S. guttatum 
AOX
K2D, no set 49 - 0 - - 51
TAO K2D, no set 36.5 - 26 - - 37.5
S. guttatum 
AOX
CDSSTR, Set 4 45 10 12 9 3 21
TAO CDSSTR, Set 4 36 6 18 12 7 21
S. guttatum 
AOX
SELCON3,
SMP180
54 22 8 2 4 10
Table 5.6 – Calculated % secondary structure from raw CD data submitted to Dichroweb. Data from 
wavelengths 190-240nm was analysed by CDSSTR, 180-240nm by SELCON3 and 200-260nm for K2D. The 
Reference set chosen for each analysis is indicated, except for K2D which required no Reference set. α1 refers 
to regular α-helices, α2 refers to disordered α-helices, β1 refers to regular β-strand. β2 refers to disordered β-
strand, Turn refers to turns and Coil refers to random coil (after Sreerama et al., 1999). K2D Andrade et al., 
1993; Set 4, CDSSTR and SELCON3 cf; SMP180 Abdul-Gader et al., 2011.
5.3.2 Predicted secondary structure
Results of the prediction programs detailed above in Table 5.4 are shown below in 
Table 5.7.
Number of residues per secondary structure element [%]
ProgramHelix Strand Coil
163       [46.7] 0                [0] 186       [53.3] PSIPRED
251       [71.9] 151       [43.3] 30           [8.6] CFSSP
126       [36.1] 30           [8.6] 193       [55.3] GOR
164       [47.0] 15           [4.3] 170       [48.7] JPred3
173       [49.6] 4             [1.1] 172       [49.3] PROFphd
Table 5.7 – Predicted secondary structure elements by different programs. The data is displayed as 
number of residues and [percentage] of the total sequence length (286)
156
Additionally, the PROFphd algorithm predicted the presence of two transmembrane 
helices between residues 175-193 and 237-255; and that residues 194-236 would be found 
within the membrane – but not as transmembrane helices.
5.3.3 Identification of potential dimerisation sites
Using the dimeric homology model generated from the TAO crystal structure (see 
Chapter 3 Section 3.2.7), 12 residues on helices 2 and 3 were identified which may form a 
dimer interface (Table 5.8). The criteria for selection was that the residues must be within 
10Å and oriented towards the counterpart  helix  and furthermore must be relatively well 
conserved across most species. The residues identified are shown in Table 5.5 below and 
the  conservation  of  these  residues  is  indicated  on  Figure  3.1.  Dimerisation  through 
interfacial water molecules was discounted as a mechanism, as the limited space between 
helices  2  and  3  would  not  permit  water  molecules  to  form hydrogen  bonds  with  the 
residues.
Residues on Helix 2 Residues on Helix 3
T179 I207
A182 R208
M186 L211
V190 E215
H193 R218
L194
L197
Table 5.8 – Potential dimer interface residues. This list shows the residues identified on helices 2 and 3 as 
potentially involved in formation of a dimer interface. The conservation of these residues are indicated on 
Figure 3.1.
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Table 5.5 – A diagrammatic representation of the potential dimer interface. This Figure shows the 
residues on helices 2 (red) and 3 (teal) that may form a dimer interface. The four helices are shown in their 
relative positions in the dimer images (top).Residues on helix 2 (red, bottom helix of the pair) from left to 
right: T179, A182, M186, V190, H193, L194, L197. Residues on helix 3 (teal, bottom helix of the pair) from 
left to right: I207, R208, L211, E215, R218.
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5.3.4 Crystallography
No  crystals  of  diffraction  quality  were  produced  from  purified  recombinant  S.  
guttatum alternative oxidase. Any microcrystals produced (a sample of which can be seen 
below in Figure 5.6) either disintegrated during viewing (i.e. moving the screen tray from 
the  bench  or  refrigerated  unit  to  the  light  microscope)  or  during  seeding.  The  few 
microcrystals  which  continued  to  grow  following  seeding  disintegrated  spontaneously 
within  1-2  days  of  transfer.  However,  several  conditions  consistently  produced 
microcrystals and they are listed in full in Appendix 1. Figure 5.7 below shows the salt 
type, precipitant type, and pH found in these conditions.
5.3.5 Mutants
Activity assays were conducted on  S. guttatum mutants (C172A, T179A, Y253F) 
expressed in FN102, using both membrane-bound, soluble and purified fractions. For all 
assays ubiquinol-1 was used as a substrate, and at least 95% inhibition was demonstrated 
using 100nM ascofuranone. SDS PAGE gels and Western blots are shown for each mutant. 
Activities are shown below for each mutant in Tables 5.9, 5.10 and 5.11. Figure 5.8 shows 
expressed S,guttatum mutants as membrane, soluble and purified fractions on SDS PAGE 
gels and Western blots.
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Figure 5.6 – A selection of images taken during crystallographic screening. White scale bars indicate a 
length of1μM. A an early crystal, when detergent concentrations were too high; B a small crystal, which 
disintegrated when an attempt was made to seed from it; C microcrystals from Memstart, condition #21 (see 
Appendix 1 for a full list of screen conditions); D microcrystals from Memstart #23; E microcrystals formed 
after seeding from Memstart #23 (same conditions); F amorphous precipitate, the result of seeding from 
Memstart #31.
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Figure 5.7 – A graphic representation of the number of screens with particular conditions. This Figure 
shows the number of screens in which particular salt (top), precipitant (middle) and pH (bottom) conditions 
occurred (out of the 16 screens detailed in Appendix 1)
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4.3.5.1 C172A
Fraction Protein
(mg ml-1)
Total protein
(mg)
Specific activity 
(μmols min-1 mg-1)
Total activity 
(μmols min-1)
Membrane 1.0 0.6 3.05 1.83
Solubilised 0.2   0.12 0.54   0.065
Purified   0.27   0.11 0.01   0.001
Table 5.9 – Specific and total activities for the S. guttatum C172A mutant expressed in FN102.
4.3.5.2 T179A
Fraction Protein
(mg ml-1)
Total protein
(mg)
Specific activity 
(μmols min-1 mg-1)
Total activity 
(μmols min-1)
Membrane 1.8 1.1 0.19 0.21
Solubilised 0.2   0.11 0.11   0.012
Purified   0.28 0.1  0.01   0.001
Table 5.10 – Specific and total activities for the S. guttatum T179A mutant expressed in FN102.
4.3.5.3 Y253F
Fraction Protein
(mg ml-1)
Total protein
(mg)
Specific activity 
(μmols min-1 mg-1)
Total activity 
(μmols min-1)
Membrane 1.9 1.1 0.15 0.165
Solubilised 0.3 0.2 0.04 0.008
Purified   0.22   0.09 0.02 0.002
Table 5.11 – Specific and total activities for the S. guttatum Y253F mutant expressed in FN102.
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Figure 5.8 – SDS-PAGE gels and Western blots for three S. guttatum AOX mutants expressed in 
FN102. This Figure shows SDS PAGE gels (left) and Western blots (right) for C172A (A), T179A (B) and 
Y253F (C). Abbreviations: Mr – marker, M – membrane, S – soluble fraction, E – eluate (purified) fraction.
163
5.3.6 Variable temperature activity assay
The activity of membrane-bound and purified  S. guttatum recombinant alternative 
oxidase expressed in FN102 was assayed at 4oC, 40oC, 50oC, 90oC and then returned to 4oC 
after heating to 90oC. Estimated protein and total  protein is shown in Table 5.12a,with 
specific  and total  activities shown in Table 5.12b. 150mM ubiquinol-1 was used as the 
substrate and inhibition of at least 95% by 1μM octyl-gallate was demonstrated in each 
assay.
Sample Protein (mg/ml) Total protein (mg)
Membrane 52 414
Purified 0.1 1
Table 5.12a – Estimated protein for samples used in the variable temperature assays.
Specific activity (μmol/min/mg) and [Total activity (μmol/min)]
Temperature (oC) 4 40 50 90 90 → 4
Membrane 0.58 [242] 0.57 [236] 0.8  [317] 0.71 [293] 0.26 [106]
Purified 15  [15] 4   [4] 10 [10] 0.01  [0.01] 1.7   [1.7]
Table 5.12b – The effect of temperature on activity of recombinant S. guttatum AOX protein expressed 
in FN102. This Table shows the specific and total activity for samples assayed at varying temperatures. 90 → 
4 represents assay carried out after the sample had been heated to 90oC and then cooled to 4oC.
5.4 Discussion
5.4.1 Secondary structure
For the first time the secondary structure of the plant alternative oxidase has been 
demonstrated experimentally. The data obtained from circular dichroism when converted to 
mean residue ellipticity and plotted against wavelength provides a relatively strong signal 
in the 222nm region, which is associated with helical structure (Figure 5.2a). However, 
when comparing the data obtained from TAO (Figures 5.2b and 5.3), it is evident that there 
is  differential  absorption  in  the  190-200nm  range,  usually  indicative  of  random  coil 
secondary structure elements. This may be indicative of the longer unstructured N-terminal 
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region of the S. guttatum alternative oxidase, which has been implicated in the regulation of 
activity (Crichton et al., 2005). By comparison, the TAO has a much shorter unstructured 
region at the N-terminal.
Another  factor  affecting  the  differing  far-UV absorbances  observed  between  S. 
guttatum AOX and TAO is the contribution of solvent noise.  The solvent used for CD 
experimentation remained the same for both proteins (0.04% DDM in dH2O) and the choice 
of solvent was based on low UV absorption coupled with the ability of DDM to aid the 
structural stability of recombinant alternative oxidase. However, the TAO protein used for 
the  CD  experimentation  had  been  dialysed  prior  to  PEG  precipitation,  whilst  the 
recombinant  S. guttatum had not. As a result, it is possible that there were other ions and 
buffer  components  present  in  small  quantities  in  the  S.  guttatum sample  that  were  not 
present in the TAO sample – such as Tris, imidazole, chlorine ions and magnesium ions – 
which are known to absorb in the far UV range (cf Kelly et al., 2005). In order to overcome 
these effects, a smaller cell pathlength may be used if possible and alternative methods for 
eliminating  buffer  components  remaining  from  the  purification  process  should  be 
investigated. Furthermore, experimentation to identify other solvents which may be used in 
CD analysis of recombinant S. guttatum AOX (and mutants thereof) would be beneficial in 
obtaining improved CD data in the future and may even provide insight into conditions 
under which the protein is most stable that may be applied to any further crystallisation 
attempts.
Following analysis  of  the  raw CD data  with  three  algorithms  accessed via the 
DicrhoWeb server  (cf  Whitmore  and Wallace,  2004;  Whitmore  and Wallace  2008) the 
evidence for helical structure in S. guttatum is compelling (Table 5.6) if unexpected given 
the apparently poor quality data. All three algorithms predict that approximately 50% of the 
protein is α-helix (49%, 54% and 45% by K2D, SELCON3 and CDSSTR respectively) and 
attribute between 10 and 20% of the total structure to  β-sheet. K2D predicts the greatest 
amount of disorder (51%) whilst CDSSTR and SELCON3 predict approximately 20%. It is 
worth  noting  that  of  the  three  algorithms used,  only K2D allowed for  the  selection  of 
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wavelengths of 200nm and above and thus is the only algorithm where the noise observed 
in the  S. guttatum AOX data could be avoided (as indicated by increasing HT voltage, 
Figure  5.2a).  None of  the  Reference  sets  available  at  the  time  of  analysis  permitted  a 
minimum wavelength of 200nm, so Reference set 4 (optimised for 190-240nm) was chosen 
for use with the CDSSTR algorithm. Similarly, all the Reference sets with the exception of 
one (SMP180) contain  soluble proteins,  so analysis  of  the CD data using the SMP180 
Reference  set  and  SELCON3 algorithm  was  chosen  to  reflect  the  fact  that  AOX is  a 
membrane protein.  The outcome of the analysis  of  S. guttatum AOX CD data by these 
algorithms is an interesting starting point which could be vastly improved in the future with 
the collection of higher-quality CD data.
By comparison,  analysis  of  TAO CD data  using K2D  and CDSSTR algorithms 
calculates  that  approximately 36%  of  the  protein  is  α-helix,  30%  is β-sheet  and  that 
between 28 and 37% is random coil.  This is not in agreement with the recnently solved 
TAO structure  (Shiba  et  al.,  2013)  which  exhibits  53%  α-helical  structure,  and  no  β-
structures. The difference between percentage  helical  structure in TAO and  S. guttatum 
AOX cannot be explained by the sequence difference between the two alternative oxidase 
isoforms alone, and is likely to due to a combination of partial unfolding of the S. guttatum 
AOX and a  more  homogeneous  sample  used  for  the  TAO experiments.  As previously 
discussed in Chapter 4, the plant alternative oxidase has proven difficult to purify to the 
level  of  homogeneity  to  which  the  TAO  has  been  purified;  therefore,  any  potential 
contaminating  proteins  left  in  the  S.  guttatum sample  may  case  interference  with  the 
circular dichroism data collection. Therefore, it is likely that these differences in protein 
concentration and homogeneity is the cause of the discrepancy in outcome. However, in the 
case of the structure prediction analysis (Table 5.8), the difference in algorithmic approach 
leads  to  a varied set  of predictions  which should be used with caution  when ascribing 
potential secondary structure of the alternative oxidase.
One unexpected outcome from the circular dichroism experiments is the apparent 
partial retention of the helical absorbance signal at 222nm (Figure 5.4) in both S. guttatum 
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and TAO isoforms. In each case, approximately 58% and 64% (respectively) of the signal 
remained  after  heating  to  90oC.  When the  same sample  was  cooled  to  10oC following 
heating to 90oC, the ellipticity was not equal to the signal observed before heating; it had 
decreased to approximately 75% of the original (data not shown) – indicating that there was 
significant  unfolding  during  the  heating  process,  which  was  not  completely  recovered 
during the cooling period. Activity data collected at different temperatures (Table 5.12b) is 
somewhat contradictory to the circular dichroism data collected at higher temperatures. The 
latter  implies  that secondary structure is being lost  during heating,  while activity  in the 
membrane fraction actually increases between 4oC and 50oC temperature conditions. Once 
the protein had been re-cooled to 4oC however, the activity was reduced by 77% of the 
maximum  (at  50oC)  and  54% of  the  original  activity  at  4oC.  The  increase  in  activity 
observed when heating cannot be explained by increased auto-oxidation at the increased 
temperature, as activity was inhibited by 98% at both 50 and 90oC. The increase in activity 
could be explained by an increase in kinetic energy (supplied by the increased temperature), 
although this is speculative and warrants further investigation.
The loss of activity when the sample is re-cooled was not the expected outcome, as 
many globular proteins which unfold due to increased temperature refold to their native 
state spontaneously when the temperature is returned to optimum. In this case, there could 
be aggregation of the  E. coli membrane – and therefore the alternative oxidase protein – 
due to the rapid change in temperature. It may be, that in plants and other organisms where 
the  alternative  oxidase  is  natively  expressed  there  would  be  chaperones  or  heat-shock 
proteins available to aid in refolding should unfolding occur, which are not present in the 
membrane-bound sample used for these experiments. It should be noted that no expressed 
AOX proteins have been confirmed in prokaryotic organisms, although the gene is present 
in  several  prokaryotic  genomes.  The  requirement  for  chaperones  to  aid  in  alternative 
oxidase protein folding in vivo is contraindicated by the ability of E. coli to express a fully 
folded and functional complement of alternative oxidases and further supported by the fact 
that approximately 10% of the original activity can be restored to the non-membrane bound 
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protein after heating to 90oC accompanied by a 99% loss of activity. Conversely, it could be 
argued that functional expression of a recombinant eukaryotic protein in E. coli is not proof 
of a  spontaneously folding protein.  E. coli systems express  chaperone proteins  such as 
GroEL which could responsible for folding directly after translation, but 10% restoration of 
activity in the purified alternative oxidase activity after heating could be explained by a 
small  proportion of protein molecules refolding spontaneously,  while  the majority  were 
unable to do so. Again, auto-oxidation of the substrate cannot account for activity, as more 
than 95% inhibition could be demonstrated in each assay by the addition of octyl-gallate.
While the apparent increase in activity at temperatures above the optimum (for most 
enzymes, at least) was unexpected, it is perhaps pertinent to consider the function of the 
alternative oxidase found in thermogenic tissue – to generate heat. While no thermogenic 
tissue has ever been recorded to have reached temperatures of >50o, it is not unrealistic to 
suggest that it may be advantageous to be able to do so. However, in consideration of the 
other proteins present in thermogenic tissues, raising the tissue temperature to one where 
most other proteins would be damaged most likely does not support the suggestion that 
thermogenic plants would routinely do so.
5.4.2 Crystallography
No suitable  crystals  were  grown during  this  project.  This  can  be  explained  by 
several contributory factors including low protein quantity and concentration, difficulties 
purifying recombinant S. guttatum AOX, the requirement for detergent during purification, 
the large region of potentially unstructured residues found at the N-terminal region of the 
protein, as well as practical and experimental limitations.
There  were  many  difficulties  encountered  when  expressing  and  purifying  the 
alternative oxidase – namely low expression levels and the lengthy process of optimising 
the  purification  protocol.  Even  with  the  protocol  significantly  improved,  protein  yields 
were still  low (<2mg per  preparation)  and concentrating  the protein  without  losing too 
much enzyme activity is only possible using PEG. The protein produced was also not 100% 
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pure, which negatively impacted on the ability  to crystallise  the  S. guttatum AOX. The 
lower  boundary  for  protein  quantity  for  crystallography  is  typically  10mg;  in  order  to 
achieve this for the  S. guttatum AOX, between 8 and 10 purification preparations would 
need to be pooled. In itself this is not difficult, although at one week per preparation, time 
was a constraint.
The requirement  for detergent  to be present  during the purification  of AOX (as 
described in Chapter 4 Sections 4.4.2 and 4.4.3) led to the first crystal screen experiments 
producing virtually  no stable  microcrystals  and only one larger  crystal  (see Figure 5.6, 
image A) from a total of eight attempts (i.e. 768 screens). Since alternative oxidase activity 
is lost when detergent is removed from the protein solution, it is perhaps unwise to exclude 
detergent from the protocol entirely, as the lack of activity may indicate a deterioration in 
structure. A lack of tertiary and quaternary structure would make the formation of crystals 
extremely  unlikely.  Early  attempts  to  remove the  detergent  through ultrafiltration  were 
unsuccessful and it was only after successful precipitation with PEG that the buffer could 
be  changed  following  purification  and  the  detergent  levels  significantly  reduced  for 
crystallography.  As  previously  stated  (Table  4.8a)  absence  of  detergent  during 
solubilisation resulted in reduced specific activity,  so detergent could not be completely 
eliminated from the protein solution. Similarly, inclusion of glycerol into later purification 
protocols  led  to  the  same problem as  excessive  detergent  levels  (i.e.  increased  protein 
solubility and decreased aggregation, leading to the inhibition of crystal formation); though 
glycerol  can  be  relatively  easily  removed  through  PEG  precipitation  and  the  overall 
concentration  of  glycerol  was  reduced  from 20% to  5% in  the  most  recent  and  most 
successful purification protocols.
As previously stated,  the alternative  oxidase isoforms from plant  species  differs 
from the TAO significantly in the N-terminal region, with the plant sequences possessing 
an additional 35 residues which represents ~12% of the whole structure. These additional 
residues are most likely to be unstructured and as a result, the high level of conformational 
freedom in this  region alone would decrease the likelihood of the molecules  to form a 
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highly ordered crystal structure required to create diffraction-quality protein crystals. One 
possible solution to this problem would be to create a truncated version of the S. guttatum 
alternative oxidase, which lacks the N-terminal region; although there is no guarantee that 
this would leave the activity and native structure of the expressed protein intact.
Much knowledge has  been gained about  the conditions  which consistently  form 
microcrystals (i.e. microcrystals were formed on at least three occasions when the condition 
was used) and as this is the first time that crystallisation of the plant alternative oxidase has 
been  attempted,  this  represents  a  significant  step  towards  understanding  how  to 
reproducibly  create  high-quality  AOX protein  crystals.  Of the  crystallisation  conditions 
listed in Appendix 1 and represented graphically in Figure 5.7 above, there are some trends 
in salt type and precipitant type, although pH seems to be less significant. In 5 out of the 16 
conditions, there were sulphate or phosphate salts, which are ranked high in the Hofmeister 
series  (cf Collins,  2004  for  a  recent  review)  of  precipitating  salts  and  in  2  of  the  4 
conditions where no salt was listed, the precipitants were either phosphate or sulphate. Of 
the  16,  6  conditions  contained  0.1M NaCl,  with  both  the  anion and cation  of  the  salt  
towards the middle of the Hofmeister series. This suggests that choosing either NaCl or 
other  salts  high  in  the  Hofmesiter  series  may  be  advantageous  when  attempting  to 
precipitate the protein. Regarding precipitant choice, 12 of the screen conditions contained 
PEG (either 30% w/v PEG 400 or 12% w/v PEG 4000), suggesting that PEG is a suitable 
precipitant to use; furthermore PEG precipitant experiments described in Chapter 4 indicate 
that PEG does not disrupt AOX protein structure. In future this knowledge may be applied 
to create custom screens for crystallisation of the alternative oxidase.
Finally,  a major  problem encountered with the crystallisation of the  S. guttatum 
alternative oxidase was the tendency for any crystalline deposits (both microcrystals and 
larger formations) to become unstable and disintegrate when the screen plate was moved 
from the refrigerated unit to the microscope. Whilst this may not be a problem in cases 
where proteins  form more stable  crystals,  it  was a significant  limitation in this  project. 
Therefore, in an attempt to improve the likelihood of stable crystal formation, trays were 
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not moved for the first week. Whilst this did reduce the number of disintegrating crystals, it 
was  not  always  practical  and  made  full  observation  and  photography  of  the  crystals 
difficult.  The  only  practical  solution  to  this  problem  is  to  use  a  system  such  as  that 
employed at the Membrane Protein Laboratory within the Diamond Light Source4 where 
sitting and hanging drop plates are automatically checked by a robotic camera mounted 
inside  the  plate  storage  unit  (ThermoFisher  Rhombix  Cs 750i)  without  the  plate  being 
moved. However, when crystallography was attempted in the facility (12 separate screen 
plates were set up), no crystals were formed which does not confirm whether the system 
would prevent AOX crystal disintegration.
It  is  worth noting that  the only group to have successfully  grown AOX protein 
crystals and gathered sufficient diffraction data to solve the structure (Shiba  et al., 2013) 
began the process of producing crystals over a decade ago, whilst attempts to crystallise the 
S. guttatum AOX have been ongoing for less than half of that time.
5.4.3 Expression of mutant S. guttatum isoforms
The activities and SDS PAGE gels shown above in Tables 5.9, 5.10 and 5.11 and 
also in Figure 5.8 demonstrate the first time these particular mutants have been expressed in 
E.  coli,  as  all  previous  expressions  have  been in  the  S.pombe yeast  expression system 
(Albury  et al., 1996). The specific activities of the T179A and Y253F mutants reported 
above  are  62%  and  70%  less  active  (on  average)  than  the  S.  guttatum wild  type 
recombinant  alternative  oxidase,  which is  not entirely consistent  with previous findings 
(Albury et al. 2001; Crichton et al., 2010), who reported that the mutants lost less activity 
compared to the wild type.  The activities  reported above – whilst  lower than might  be 
expected – generally support the previously described roles of the residues, although they 
do not add any further information to the structure-function relationship.  As previously 
discussed in Chapter 4, expression in the non-native E. coli system may have an impact on 
the AOX isoform activities and therefore direct comparison between activities observed in 
4 http://www.diamond.ac.uk/Home/MPL/equipment.html; last accessed 16/09/12
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E.  coli recombinant  protein  and  S.  pombe recombinant  protein  should  be  viewed  with 
caution. 
Finally, the C172A S. guttatum mutant displayed a higher activity than most of the 
wild type S. guttatum preparations made during the course of this project, which is in direct 
contradiction  with  previous  findings  (Crichton  et  al.,  2010),  where  expression  of  the 
C172A mutant resulted in lower activities than that of the wild type. Therefore, it is not 
possible  to  further  elucidate  the  role  that  this  particular  residue  plays  in  the  structure-
function relationship of the alternative oxidase.
5.4.4 Identification of a possible dimer interface
As no evidence of cysteine-associated dimerisation has been found in the recent 
TAO structures which indicates that there must be another mechanism – either in addition 
to, or instead of – the sulphide linkage proposed previously. This is likely due to hydrogen 
bonding between two complementary regions of the individual monomers (helices 2 and 3; 
Table 5.8. Table 5.5). Without detailed knowledge of exactly how and why dimerisation 
leads  to  increased  activity,  this  does  lead  to  the  question  of  whether  there  are  other 
physiological advantages to existing as a dimer versus a monomer. As there is no evidence 
to  suggest  that  the  alternative  oxidase  requires  extensive  folding  interaction  through 
chaperones (i.e. a self-folding recombinant eukaryotic protein expressed in a prokaryotic 
expression system), and in light of the gene coding for a single unit (not a dimer, with no 
identifiable dimerisation peptide signal) it  can be assumed with a reasonable amount of 
confidence  that  the  dimerisation  occurs  spontaneously  in  vivo.  As  such,  it  could  be 
postulated that the formation is driven by a requirement for a minimal energy state. It is 
generally  accepted  that  proteins  existing  as  dimers  and  other  oligomers  have  a  lower 
minimal  energy state  than  monomers  (cf Goodsell  and Olson,  2000)  and  are  far  more 
prevalent  in  structural  databases  than  monomers.  Crucially,  49%  of  the  monomeric 
homology  model  surface  area  is  solvent  accessible,  compared  to  39%  of  the  dimeric 
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homology model surface. This reduction is likely an important factor in the stabilisation of 
the AOX, which in turn may lead to an increase in activity.
5.4.5 Concluding remarks
For  the  first  time,  alpha  helical  secondary  structure  has  been  demonstrated  in 
alternative oxidase using circular dichroism. Whilst the CD data observed for recombinant 
S.  guttatum alternative  oxidase  appears  to  be  of  lower  quality  than  that  observed  for 
recombinant TAO, statistical analysis of the S. guttatum raw data does provide evidence of 
a high proportion (on average 65%) of helical structure. Furthermore, the observation of an 
unfolding curve at 222nm through temperatures 10o-90oC without complete loss of signal at 
the upper temperature range, coupled with observable AOX activity above 50oC suggests a 
hitherto  undiscovered  characteristic  of  S.  guttatum alternative  oxidase  –  a  degree  of 
thermostability.
Mutant S. guttatum alternative oxidase has been successfully expressed and purified 
which is essential to the continuation of the investigation of the structural biology of the 
alternative oxidase. Of particular interest for future experimentation is the use of mutant S. 
guttatum alternative oxidase isoforms for crystallisation trials, should they produce more 
stable crystals than the wild type. Similarly, investigation of the effect of mutations on the 
helical content and thermostability offers an exciting future research direction.
Whilst  no  crystals  of  diffraction  quality  have  been  obtained  to  date  for  the  S. 
guttatum alternative oxidase, our knowledge of the factors negatively affecting production 
of AOX crystals has been considerably increased. For future attempts at crystallising  S.  
guttatum AOX,  intensive  screening  of  crystallisation  conditions  using  PEG  as  the 
precipitant  should  be  carried  out,  along  with  further  investigation  of  the  negative  and 
positive effects of individual ions from the Hoffmeister series on successful crystallisation.
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Chapter 6
General Discussion
The alternative oxidase, a monotopic integral membrane protein associated with the 
inner  mitochondrial  membrane,  catalyses  the  oxidation  of  quinol  to  quinone  and  the 
reduction of oxygen to water and dissipates the free energy as heat. It is ubiquitous to plants 
and is found in several species of fungi, proteobacteria and parasitic protists such as  T. 
brucei and C. parvum; importantly, it is not found in higher mammals. The release of heat 
from the catalytic function of AOX is used by thermogenic plants to volatilise aromatic 
compounds to attract insect pollinators. AOX is insensitive to several respiratory inhibitiors 
and  thus  facilitates  the  continuation  of  glycolysis  and  the  Kreb's  cycle  when  other 
respiratory complexes are inhibited or not functioning correctly.
The alternative oxidase found in the human parasite, T. brucei – the causative agent 
of African Sleeping Sickness – is the sole terminal oxidase during the infectious stage of 
the parasite's life cycle. Crucially, inhibition of the trypanosomal alternative oxidase during 
this  stage  of  infection  results  in  the  death  of  the  parasite  in  vivo and  is  therefore  an 
important drug target. The alternative oxidase has also been implicated in the fungicide-
resistant respiration exhibited by pathogenic fungi affecting both mammals and plants. 
Given the chemotherapeutic importance of the alternative oxidase as a drug target, it 
is essential  to understand the structure-function relationship of the enzyme and species-
specific differences in protein behaviour.
Therefore, the aim of this project was to develop overexpression and purification 
protocols with the objective of producing purified recombinant plant alternative oxidase 
protein. for structural studies. These expression and purification protocols are intended to 
complement  the  existing  S.  pombe expression  vector,  offering  a  system  to  express 
functional recombinant protein that may be readily and reproducibly purified.
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Also within the scope of this project was investigation of the alternative oxidase 
structure  using  bioinformatic  resources;  initially  to  attempt  to  replicate  the  previously 
devised model  and subsequently to re-evaluate  and refine the current  model  using new 
modelling techniques.
6.1 Expression of recombinant S. guttatum alternative oxidase
For the first time, recombinant S. guttatum alternative oxidase has been functionally 
expressed in  two  E.  coli expression  systems.  The C41 strain,  optimised  for  membrane 
protein over-expression, offers reproducible quantities of total protein (~12mg per litre of 
growth media) with reasonable specific and total activity (Table 4.4). The FN102 strain, 
chosen for its  inability  to synthesise haem – and therefore any other quinol oxidases – 
expresses on average less protein per litre of growth media than the C41 strain, but the 
specific  and total  activity  of the expressed protein is consistently higher.  Expression of 
recombinant  S. guttatum in C41 therefore is preferable when greater quantities of protein 
are required, but where high activity is less important (such as crystallography, Western 
blotting or circular dichroism). However, when highly active protein is required in smaller 
quantities, such as for kinetic profiling, FN102 is the preferred strain. 
Following growth, the recombinant S. guttatum AOX can be solubilised and further 
purified using affinity  chromatography,  with retention  of  total  activity  compared to  the 
membrane  fraction  of  99% post-solubilisation  and  49% post  purification  (Table  4.11). 
Identification of several key requirements for retaining protein activity and stability has 
been crucial to the development of a robust and reproducible purification protocol (Figure 
4.6). As such, the expression of recombinant  S. guttatum alternative oxidase in C41 and 
FN102  is  a  practical  and  complementary  system  to  that  of  S.  pombe,  from  which 
recombinant protein cannot be so readily extracted (Albury et al., 1996). Whilst extraction 
of AOX from native tissues provides a clear insight into the kinetics of the enzyme in vivo 
(which it is not possible to achieve using recombinant AOX expressed in a prokaryotic 
system),  it  has  historically  proven  to  be  relatively  unstable  once  released  from  the 
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mitochondrial  membrane  (cf Moore  and  Siedow,  1991).  Expression  of  the  alternative 
oxidase in C41 and FN102 offers an improved purification outcome; the protein is more 
stable both in the short and long term and is simpler to extract.
However, despite the advantages of expressing recombinant AOX in E. coli, there 
are  also  drawbacks,  such as  reduced specific  protein  activity  and protein  concentration 
compared to native extraction (A. maculatum; Affourtit and Moore 2004) and recombinant 
expression of other AOX isoforms (TAO; Kido et al., 2010) as summarised in Tables 4.16a 
and 4.16b respectively.  This raises an interesting question as to why the activity  of the 
recombinant S. guttatum AOX should be so low by comparison to A. maculatum and TAO. 
Higher activities observed in TAO can be explained by the necessity for the enzyme to 
function at a high rate in an unregulated manner, as it is the sole terminal oxidase expressed 
during a stage in the organism's life cycle when the only source of cellular ATP is provided 
by glycolysis  (Clarkson  et  al.,  1989;  Chaudhuri  et  al.,  1995;  Minagawa  et  al.,  1996). 
Similarly, the higher activity recorded for native A. maculatum AOX (Table 4.16a) is likely 
due to the combined activities of a number of different AOX isoforms expressed in native 
tissues during thermogenesis (Ito et al., 2011). This may also account for the high protein 
concentration observed in the A. maculatum solubilised and purified samples (Table 4.16a). 
S. guttatum and TAO recombinant proteins in this thesis and the data reported by Kido et  
al. (2010) respetively are under the control of the same promoter and expressed in the same 
strain (FN102).  The significantly greater  protein concentration observed of recombinant 
TAO (cf 8.95mg of  purified  protein)  compared  to  recombinant  S.  guttatum alternative 
oxidase (typically <1mg of purified protein) may suggest that after  the point of protein 
synthesis,  S. guttatum recombinant alternative oxidase is becoming degraded. The exact 
cause of any potential degradation is not known, although the presence of S. guttatum AOX 
signal on Western blots of the membrane fraction supernatant (supernatant from the final 
ultracentrifugation  step;  Figure  4.4,  lane  8)  would  indicate  that  at  least  some  of  the 
recombinant AOX is being lost from the membrane during growth or harvest. A very small 
proportion of AOX activity is also observed in the membrane supernatant fractions from 
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both C41 and FN102 cells (Table 4.9), which suggests that if AOX protein is present in the 
supernatant, most of the enzymes may well be denatured or otherwise inactivated.
The  double  band  present  on  almost  all  gels  and  Western  blots  of  recombinant  S. 
guttatum (a clear exmple of which is shown in Figure 4.8, lane 2) may be the result of such 
degradation  products.  Whether  these  degradation  products  are  active  or  inactive  is  not 
known, but the consistency with which the bands appear on Western blots would indicate 
that the degradation process occurs frequently and always produces similar  size protein 
fragments. One way to investigate this would be to excise the bands from an SDS PAGE 
gel and analyse them using mass spectrometry.
Interestingly,  the  presence  of  ALA  in  the  growth  media  for  FN102  cells  after 
induction and therefore expressing recombinant  S. guttatum AOX, leads to a reduction in 
AOX specific  and total  activity  (Table 4.4),  although the effect  on total  protein is  less 
pronounced. Therefore, if the ALA is either being retained in the media or the effect of the 
ALA (continued expression of other quinol oxidases) persists after removal, this may be 
negatively affecting the activity of – and possibly expression of – recombinant S. guttatum 
alternative oxidase. In order to investigate this further, the amount of ALA added to the 
starter  culture  should  be  decreased.  If  the  reduction  in  ALA concentration  leads  to  an 
increase in recombinant AOX activity this may be one strategy to increase the activity of 
recombinant S. guttatum AOX expressed in FN102. However, this may also lead to slower 
growth from inoculation to induction, which would make the protocol less practical and 
may not provide a better strategy overall.
Another  factor  which  contributes  to  low  observed  recombinant  S.  guttatum 
alternative  oxidase  activity  is  the  use  of  different  substrates  (Table  4.15)  during 
spectrophotometric assays.  Whilst using ubiquinol-1 as a substrate for alternative oxidase 
protein activity assays is preferred, other substrates such as duroquinol will suffice. The 
activity recorded using the latter is lower than that of ubiquinol-1 and this is most likely due 
to differences in chemical structure; duroquinol lacks the isoprenyl chain present in both 
ubiquinol-1  and  decylubiquinone  (containing  1  and  10  isoprenyl  units  in  the  chain 
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respectively) and is highly hydrophobic as a result. This may negatively affect uptake of 
duroquinol by the enzyme in the aqueous assay media, leading to reduced recorded specific 
activities.  Similarly  this  structural  difference  may  affect  uptake  into  the  hydrophobic 
quinone-binding pocket located in the membrane as this may be more selective for the 
ubiquinol-1  tail  rather  than  the  single  six-membered  ring  structure  of  duroquinol  (cf 
Hoefnagel et al., 1997). This preference is most likely mediated by specific residues which 
are responsible  for facilitating  the movement  of the respiratory substrate  into the AOX 
active site from the Q-pool located in the inner mitochondrial membrane.
Following the identification of a possible quinone-binding pocket between helices 1 
and 4 (see “Cavities.pse”), any of these residues (150-164 and 232-255) could potentially 
be  involved  in  substrate  preference  and  this  could  be  investigated  further  using 
mutagenesis.  This  is  particularly  worth elucidating,  given that  the previously  identified 
quinone-binding residues (cf Fisher and Rich, 2000; L137, H141, T147, H261, R262) are 
not proximal to the most likely quinone-binding region.
Without knowing the exact composition of the membrane local to each expressed 
protein it is not possible to say whether the membrane is capable of permitting a substrate 
added to the media (whether ubiquinol-1 or duroquinol, both of which are hydrophobic) to 
pass  into  the  membrane  and  subsequently  into  the  alternative  oxidase  quinol  binding 
region. When the protein has been solubilised or purified and no such membrane structure 
is present, it remains unclear whether the substrate passes directly into the AOX protein, or 
whether it must temporarily associate itself with one of the hydrophobic substances within 
the  local  media  (for  example  PEG,  DDM or  glycerol).  Apparent  decreases  in  activity 
should therefore not necessarily be assumed to be a reflection on protein conformation, but 
may in fact reflect the ineffective movement of the substrate to the protein. Furthermore, 
relying  on  total  protein  concentration  of  membrane,  soluble  and  purified  fractions 
containing  S.  guttatum alternative  oxidase  rather  than  the  exact  concentration  of 
recombinant  protein  has  undoubtedly  affected  the  outcome  of  the  activity  assays.  As 
previously stated an over-estimation of protein leads to artificially lower activity, whilst 
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under-estimated protein concentration results in artificially inflated activity. Combined with 
the  uncertainty  of  the  efficiency  of  substrate  movement  within  the  assay  media,  the 
resulting rates of activity should be regarded as an estimate rather than a definitive figure.  
Whilst this has not presented a constraint during this project, it would need addressing if 
further and more comprehensive kinetic profiling were to be carried out.
6.2 Structural studies of the S. guttatum alternative oxidase
No diffraction-quality recombinant  S. guttatum crystals were produced during this 
project. Small crystals could be reproducibly grown as described in Chapter 5, but these 
particular crystals were susceptible to disintegration whenever the plate was moved. This 
frustrating  occurrence  could  be  eliminated  if  the  plates  could  be  viewed  in  situ,  as  is 
possible at the Membrane Protein Laboratory (MPL) at  the Diamond Light Source, but 
unfortunately  the  screens  used  at  that  laboratory  were  not  the  screens  which  produced 
consistent crystal growth, as these screens were discovered some time after the visit to the 
MPL had taken place.
It is not known exactly why the crystals formed were so small and so susceptible to 
degradation. One possible explanation is that the apparently unstructured N-terminal tail 
region of the  S. guttatum alternative oxidase may be preventing the formation of larger, 
more ordered crystals. In order to ascertain the effect that the N-terminal region has on the 
production of stable crystals, a truncated S.guttatum alternative oxidase mutant which lacks 
the  N-terminal  region  could  be  expressed  recombinantly  and  crystallisation  attempted. 
However, as the N-terminal region is important for the regulation of alternative oxidase 
activity in some isoforms (Crichton et al., 2005) it may be unlikely that this mutant would 
be fully active,  if at  all.  Nevertheless,  provided the expressed protein is fully folded, it 
could still be used for attempting crystallisation screening. 
In  light  of  the  recent  TAO  crystal  structure,  which  forms  a  homodimer,  the 
oligomeric state of the S. guttatum alternative oxidase may be important when attempting to 
crystallise  it.  Iwata  et  al.  (2012)  used  chemical  cross-linkers  to  dimerise  the  internal 
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NADH-dehydrogenase (NDI1) complex. As the internal NADH-dehydrogenase is also an 
integral  monotopic  membrane  protein,  the  use  of  chemical  cross-linkers  to  potentially 
improve the outcome of AOX crystallisation trials could be a rewarding investigation.
 For the first time, circular dichroism has been successfully used to demonstrate the 
α-helical  nature of  the  S.  guttatum alternative  oxidase and TAO (Table 5.2 and Figure 
5.2b). Using three CD analysis algorithms via Dichroweb, the estimated helical content for 
S. guttatum AOX is ~50%, with the remaining 50% attributed to either random coil (K2D) 
or a combination of  β-sheet and random coil  (CDSSTR and SELCON3). Following the 
optimisation of the buffers for CD experiments, the technique should be used to collect data 
for not only mutants of S. guttatum, but also other AOX isoforms. Additionally, the effect 
on secondary structure of stabilising detergents such as EDT-20 as well as pyruvate (Carré 
et al., 2011) could be determined to address whether these substances cause changes to the 
secondary  structure  rather  than  the  tertiary  or  quaternary  structure  of  the  alternative 
oxidase.
The use of circular dichroism in this project has revealed a particularly interesting 
and  unexpected  characteristic  of  the  alternative  oxidase  –  apparent  thermostability. 
Biologically, in spadix tissues, it is necessary for the alternative oxidase to have at least 
some heat  stability,  in  order  to  dissipate  the heat  generated  during thermogenesis.  The 
structure  of  the four-helix  bundle  of  this  relatively  small,  simple protein  is  maintained 
within its core. Additionally, the protein is very closely associated with the membrane in  
vivo, which may help to minimise excess heating of the protein molecule as the heat would 
be lost through conduction to the membrane and convection to the surrounding matrix.
Regarding the extent of the thermostability – losing approximately 40% of helical 
conformation  at  90oC  (Figure  5.4)  –  it  is  likely  that  if  the  protein  can  withstand 
temperatures in excess of 40oC (above which most proteins begin to denature), it may be 
relatively easy to withstand further temperature increases. Whether this ability to maintain 
60%  of  helical  conformation  at  high  temperatures  is  an  evolutionary  development  is 
unclear. Thermogenic plants are found in many climates around the World, from the hot 
180
and humid equatorial forests of Sumatra where the famous corpse flower (Amorphophallus 
titanum) grows; to the boggy wetlands of North America and Canada, home of the Western 
skunk cabbage (Lysichiton americanus); the cold snows of America, Canada, China and 
Japan, where the Eastern skunk cabbage (Symplocarpus foetidus) uses thermogenesis to 
melt the snow; to the mild spring-time woodlands of the UK, when the Lords and Ladies 
(Arum maculatum)  appear  in  April  and May.  Perhaps,  therefore,  the  range of  ambient 
temperatures coupled with thermogenic activity would perhaps place selective pressure on 
a protein which would remain stable across a wide range of temperatures.
6.3 In silico modelling of the alternative oxidase – beyond the computer
Attempts  to  use algorithms to  provide information  about  the  alternative  oxidase 
have  in  part  been  successful.  Comparison  of  the  homology  model  of  recombinant  S. 
guttatum alternative  oxidase  created  using  Δ9-desaturase  as  a  template  to  that  of  the 
homology  model  created  using  TAO  indicates  that  the  basic  four-helix  scaffold 
coordinating the diiron binding site is very similar (Figure 3.4b). As described previously, 
the section of the Δ9-desaturase used as the template is not in any way associated with the 
membrane and is part of the core of a much larger multi-domain protein; therefore, whilst it 
was a useful template for the four-helix bundle at the core of the alternative oxidase, as a 
template for the membrane-associated regions of the protein Δ9-desaturase was limited. Z-
scores provided by ProSA (Table 3.2) showed the quality of the TAO-based homology 
model to be within an acceptable range for other proteins of similar size. However, the 
QMEAN4  score  (Table  3.2)  was  low,  although  this  could  be  as  a  result  of  under-
representation  of  membrane  protein  models  in  the  database  against  which  the  user-
generated  models  are  compared.  By  acknowledging  the  weakness  of  the  models,  this 
perhaps allows for experiments to be designed that do not assume that the model is 100% 
accurate,  allowing a greater  amount of experimental  flexibility.  The models are,  in this 
case, a very useful tool, a guide – nothing more.
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6.4 Readdressing the questions posed in Chapter 1 and consideration of future directions
• Is it possible to over-express recombinant S. guttatum alternative oxidase protein in 
a bacterial system?
◦ Yes. Further refinement of the growth conditions for the C41 and FN102 strains 
should be minimal.
• Is it possible to the purify the expressed protein, to provide relatively pure protein?
◦ It  has been possible  to  purify expressed recombinant  S.  guttatum AOX to a 
reasonable level but further refinement is needed to ensure the reproducibility of 
the protocol defined in Chapter 4.
• Its is possible to crystallise recombinant S. guttatum alternative oxidase?
◦ It  has  not  been  possible  to  crystallise  recombinant  S.  guttatum alternative 
oxidase to date. Significant steps have been made towards defining a suitable 
crystallisation protocol, but extensive refinement is required in the future.
• Will  recombinant  S.  guttatum alternative  oxidase  share  a  similar  sensitivity  to 
pyruvate as other AOX isoforms?
◦ Recombinant  S. guttaum does appear to be pyruvate sensitive.  Moreover, the 
inclusion  of  pyruvate  to  harvest,  solubilisation  and  purification  buffers  is 
important  for  maintaining  protein  stability.  Whilst  pyruvate  is  unsuitable  for 
addition to CD buffers, it may prove to be an equally important component in 
the protocol  for the crystallisation  of  S. guttatum AOX. The exact  nature of 
pyruvate-AOX interaction is still unknown and should be an area to investigate 
in the future.
• What is  the structure of  S. guttatum AOX and is  it  similar to that  of TAO and 
predictions made previously?
◦ In lieu of crystallographic structural data for S. guttatum alternative oxidase, it 
has been possible to model the protein on the recently-elucidated TAO structure 
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with  reasonable  confidence.  The  previously  predicted  four-helix  bundle 
coordinating  the  diiron  active  site  of  the AOX appears  to  be correct,  which 
provides valuable information towards the understanding of the exact catalytic 
cycle responsible for AOX activity.
• Does recombinant  S. guttatum expressed in a bacterial system form dimers and if 
so, is it possible to identify the mechanism of dimerisation?
◦ It  appears  that  recombinant  S.  guttatum AOX  does  form  dimers.  Whilst  a 
possible  dimerisation  interface  has  been  proposed  in  this  thesis,  further 
investigation using mutagenesis and cross-linking studies is required.
• Is  it  possible  to  replicate  and  expand  upon  previous  attempts  to  model  the 
alternative  oxidase,  taking  into  consideration  the  large  volume  of  new  AOX 
sequences now available in databases?
◦ It has been possible to replicate the previously proposed Andersson-Nordlund 
(1999)  general  model  of  the  alternative  oxidase.  Furthermore  it  has  been 
possible  to  model  the  S.  guttatum AOX  on  the  recently-elucidated  TAO 
structure. The addition of other alternative oxidase sequences to the databases 
has not improved the ability to predict AOX structure from sequence alone, but 
has  been  essential  in  the  creation  of  detailed  and  useful  multiple  sequence 
alignments  and phylogenetic  trees.  New sequences  should  be reviewed after 
they are published to continue understanding the nature of residue conservation 
and the relation of residues to structure and function.
• How do previous models of the alternative oxidase compare to the newly elucidated 
TAO structure?
◦ The models generated previously by Andersson and Nordlund (1999) and the 
models generated during this project compare somewhat favourably to the TAO 
structure. Furthermore, the TAO structure data has provided key insights into 
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the nature of membrane association, dimer formation and the conservation of the 
diiron-coordinating four helix bundle at the heart of the alternative oxidase.
6.5 Concluding remarks
Over-expression and purification protocols have been established for recombinant 
S. guttatum alternative oxidase, thus allowing future expression and purification of other 
interesting AOX sequences. Several requirements have been identified to maintain AOX 
activity  throughout  solubilisation  and  purification,  namely  DDM,  pyruvate,  magnesium 
sulphate and glycerol. If ~50% of the total activity of the membrane can be retained in the 
purified  fraction,  then  this  purification  protocol  produces  results  comparable  to  the 
purification protocol for TAO (Kido et al., 2010).
Significant  steps  have  been  made  towards  implementation  of  a  crystallisation 
protocol to produce stable crystals, but work should continue in this area with the inclusion 
of more mutants and other AOX proteins in the screening trial. It may prove that a mutant 
could crystallise  more readily  than the  wild type,  but  still  provide  the essential  crystal 
structure of the plant alternative oxidase.
The presence  of  large regions  of  helical  structure  have been confirmed through 
circular dichorism, which is in accordance with in silico predictions of the same. Whilst the 
exact extent of helical structure remains elusive, reliable estimates have been obtained. The 
thermostability discovered during the course of this project has indicated the presence of 
thermally robust protein, which when viewed biologically in relation to function is a logical 
extrapolation.  Further  experimentation  of  denaturation  using  heat  on  recombinant  S. 
guttatum alternative oxidase mutants is required to see whether the exact residues which 
maintain large proportions of helical structure can be identified.
In silico modelling of the alternative oxidase has proven to be a useful exercise, 
both as a tool for experimental design, but also as a visual aid for further understanding the 
structure-function relationship. Caution has been used when asserting the validity of the 
models as anything more than guides and further modelling of the alternative oxidase as a 
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dynamic protein can be undertaken when the crystal structure of the plant protein is finally 
elucidated.
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Appendix
A. Full S. guttatum alternative oxidase sequence (P22185):
MMSSRLVGTALCRQLSHVPVPQYLPALRPTADTASSLLHGCSAAAPAQRAGLWPPSWFSP
PRHASTLSAPAQDGGKEKAAGTAGKVPPGEDGGAEKEAVVSYWAVPPSKVSKEDGSEWRW
TCFRPWETYQADLSIDLHKHHVPTTILDKLALRTVKALRWPTDIFFQRRYACRAMMLETV
AAVPGMVGGVLLHLKSLRRFEHSGGWIRALLEEAENERMHLMTFMEVAQPRWYERALVLA
VQGVFFNAYFLGYLLSPKFAHRVVGYLEEEAIHSYTEFLKDIDSGAIQDCPAPAIALDYW
RLPQGSTLRDVVTVVRADEAHHRDVNHFASDVHYQDLELKTTPAPLGYH
B. Crystal screen solutions producing microcrystals (Section 4.3.4):
Screen Salt pH Precipitant
Memstart 9 - 6.5 -
Memstart 10 0.1M (NH4)2SO4 7.5 K2HPO4 + Na2HPO4
Memstart 15 0.1M (NH4)2SO4 4.6 4M formate
Memstart 21 0.1M NaCl 5.6 30% PEG 400
Memstart 22 0.1M LiSO4 5.6 30% PEG 400
Memstart 23 0.1M LiSO4 6.5 30% PEG 400
Memstart 24 0.1M MgSO4 7.5 30% PEG 400
Memstart 29 0.1M (NH4)2SO4 4.6 12% PEG 4000
Memstart 31 0.1M NaCl 5.6 12% PEG 4000
Memstart 35 0.2M MgCl2 8.5 12% PEG 4000
Memstart 41 0.1M (NH4)2HPO4 8.5 12% PEG 4000
Memsys 8 0.1M NaCl 6.5 30% PEG 400
Memsys 16 0.1M NaCl 7.5 30% PEG 400
Memsys 24 0.1M NaCl 9.5 30% PEG 400
Memsys 25 0.1M NaCl 9.5 1.5M NaPO4
Memsys 28 0.1M NaCl 5.5 12% PEG 4000
C. Sequences used in multiple alignments can be found on the CD at the back of this thesis.
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D. ProSA-web output graphs for homology models (Section 5.3.3):
Left: for S. guttatum alternative oxidase using Δ9-desaturase as a template; Right for S. 
guttatum alternative oxidase using TAO as a template (black dot represents z-score for the 
model).
